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Abstract 
 
Early mammalian embryogenesis involves complex cellular and molecular mechanisms to 
guide cell fate. The embryo itself is a complex system, whose molecular circuitry tightly 
controls the emergent properties of that system, including cell differentiation, proliferation, 
morphology, migration and communication. These molecular circuits include those responsible 
for the control of gene and protein expression, as well as signalling and metabolism. Due in 
part to the complexity of this circuitry, and the relative inaccessibility of the mammalian 
embryo, in vitro models have proved a facile and informative approach to understanding the 
molecular mechanisms of development. Here we use cultured mouse embryonic stem cells 
(mESCs) as a tool to study the molecular mechanisms underlying embryonic development 
towards neural fate. We show for the first time that the conditionally essential amino acid, L-
proline, can act like a growth factor to drive pluripotent mESCs to mature neural cell fates via 
pluripotent early primitive ectoderm-like (EPL) cells, the multipotent germ layer, definitive 
ectoderm, and the founder cells of the nervous system, neurectoderm. 
 
Based on published protocols using the complex HEPG2 conditioned media MEDII (of which 
L-proline is a known bioactive component) (Harvey et al., 2010; Washington et al.,  2010), we 
have developed an L-proline-based protocol to drive the differentiation of mESCs to 
neurectoderm and more mature neural cell types. mESCs (both D3 and 46C cell lines) were 
cultured as embryoid bodies (EBs) for nine days in time-dependent combinations of 0 or 1000 
U/ml LIF (0 L or 1000 L), 400 µM L-proline (P) and 10 µM ALK–4/5/7 receptor 
inhibitor/mesendoderm inhibitor, SB431542 (SB) (Inman et al., 2002). For the first five days, 
cells were grown in L-proline ± LIF (P/1000 L or P/0 L) to drive the differentiation of mESCs 
to a second pluripotent population, EPL cells. From Days 6–9, LIF was removed (if present) 
to permit the loss of pluripotency, 400 µM L-proline was retained, and SB431542 was added 
(P/1000 L then P/SB or P/0 L then P/SB) in order to drive the differentiation of EPL cells 
towards definitive ectoderm and neurectoderm. As a control, EBs were grown in Basal Medium 
(medium without additional factors) suitable to allow spontaneous (rather than directed) 
differentiation of the mESCs. At the end of Day 9, EBs were seeded down in Serum-Free 
Medium for a further six days, after which they were assessed for the presence of neural cell 
types, and here again L-proline was found to be an important component in directing 
differentiation. During the course of this 15-day protocol, EBs were tested for the expression 
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of selected genes and proteins and photographed to assess morphology for the presence of 
various neural cell types.  
 
Using qPCR, flow cytometry and immunofluorescence imaging, we showed that L-proline acts 
at multiple stages of the development pathway to induce the sequential differentiation of Rex1+ 
mESCs to Dnmt3b+/Fgf5+ EPL cells between Days 3–7 (Day 5: Dnmt3b: 3 ± 0.5, Fgf5: 5 ± 0.3, 
n≥3; log2 fold change compared to mESCs) in EBs cultured in P/0 L then P/SB. This was 
followed by differentiation to a transient population of Penk1+/Pard6b+ definitive ectoderm 
beginning at Day 5 (Penk1: 1 ± 0.6, Pard6b: 1 ± 0.6, n≥3; log2 fold change compared to 
mESCs). Cells then up-regulated the expression of Sox1 (the first and most specific 
neurectoderm marker in the mouse) between Days 5–9 (2.5 ± 0.3, n≥3; log2 fold change 
compared to mESCs) along with the early neural progenitor marker Nestin (1.9 ± 0.3, n≥3; log2 
fold change compared to mESCs), and down-regulated the expression of the mesendoderm 
marker Mixl1 (-2.0 ± 1, n≥3; log2 fold change compared to mESCs). The up-regulation of 
expression of Sox1 was also observed at the level of protein expression whereby GFP was 
expressed in 68 ± 2% cells at Day 9 in 46C cells cultured in P/0 L then P/SB. GFP continued 
to be expressed in the core of Day 15 EBs cultured in Serum-Free Medium (which contains 
150 µM L-proline), whilst GFP expression was down-regulated in cells that differentiated to 
neural progenitors and neurons. The expression of Sox1 gene and protein in EBs cultured in 
P/0 L then P/SB was observed prior to the addition of SB431542, showing that L-proline alone 
is sufficient to drive differentiation to neurectoderm without the addition of other cytokines, 
inhibitors or growth factors. When L-proline was removed from Day 10–15 Serum-Free 
Medium, a significant decrease in the percentage of EBs with more mature neural phenotypes 
(e.g., neural progenitor cells and neurons) was observed. This highlights that L-proline is also 
able to drive neurectoderm to these more mature cell types – again consistent with it acting like 
a growth factor to induce differentiation.  
 
Together these results recapitulate the gene expression changes observed when mESCs are 
cultured in MEDII (Harvey et al., 2010), and provide evidence that induction of the 
neurectoderm lineage occurs by a process of instructive differentiation rather than via a default 
pathway. This was also highlighted by the fact that ~70% of EBs cultured in P/0 L then P/SB 
produced neural cells by Day 15 and this percentage was not significantly different to when 
EBs were cultured in P/0 L then P (i.e., without SB431542 from Days 6–9). Similarly, when 
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EBs were cultured in P/1000 L then P/SB, ~60% (D3 cells) and 50% (46C cells) of EBs gave 
rise to neural cell types and this was not significantly different to EBs cultured in P/1000 L 
then P. However, an important difference occurs between mESCs cultured in P/1000 L then 
P/SB compared to those cultured in P/0 L then P/SB: qPCR analysis showed that differentiation 
to neurectoderm occurred six days slower in the latter compared to the former in the D3 cell 
line. Furthermore, differentiation in P/1000 L then P/SB was more asynchronous and 
heterogeneous and did not recapitulate the gene expression changes observed when EBs were 
cultured in P/0 L then P/SB or MEDII (Harvey et al., 2010).   
 
This is the first study to our knowledge that shows a novel growth factor-like role for a simple 
amino acid – in this case, L-proline. We have shown that L-proline alone acts at multiple stages 
of the development pathway to drive the differentiation of mESCs to neural cells via a series 
of embryologically relevant cell populations including EPL cells, definitive ectoderm and 
neurectoderm. Based on the data presented in this thesis, we provide evidence that induction 
of neurectoderm can occur via an instructive mechanism of differentiation rather than by a 
simple default mechanism. It is anticipated that this L-proline-based protocol will be used to 
gain a more comprehensive understanding of the molecular mechanisms that underlie the 
differentiation towards the neural lineage and the role that L-proline plays during early nervous 
system development.  
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Chapter 1  
Introduction 
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Embryos are complex systems whose development depends on the intricate, time-dependent 
interplay between very large numbers of circuits operating at the molecular, cellular, organ and 
whole organism level (Barabási and Oltvai, 2004; Wennekamp et al., 2013). Collectively, these 
circuits control the emergent properties of the system, which include key features of normal 
development: Cell differentiation, proliferation, movement, and communication. For example, 
cell differentiation depends, in part, on molecular circuitry controlling genome-wide 
expression patterns which both promote cell-lineage commitment and, where appropriate, 
maintain cell identity (Parfitt and Shen, 2014; Perrimon et al., 2012).  
 
Much has been learnt about mammalian embryos by studying them in vivo or isolating them at 
specific stages of development (Beddington et al., 1992; Ferri et al., 2004; Komatsu and 
Fujimori, 2015; Li et al., 2013). In vivo, all of the correct signals for normal development are 
available and to some extent can be manipulated (e.g., by altering maternal diet or applying 
drugs). The use of transgenic, knockout and knock-in animals has greatly assisted in 
understanding key regulatory mechanisms of developmental processes (Ferri et al., 2004; 
Beddington et al., 1992; Hall et al., 2009; Mitsui et al., 2003; Hoshino et al., 2015; Aubert et 
al., 2002). Nevertheless, there are, at present, restrictions to in vivo studies which include: The 
relative inaccessibility of the mammalian embryo and the difficulty in observing it in real time 
(Jones et al., 2002); the difficulty in manipulating the embryo in the face of maternal control 
and that of the embryo itself; and many critical steps in development are fleeting and involve 
a very small number of cells (Anderson and Stern, 2016; Bachiller et al., 2000; Bouwmeester, 
2001; Brennan et al., 2002; Davidson and Tam, 2000; Gilbert, 2006). 
 
For these and other reasons, pluripotent stem cells such embryonic stem cells (ESCs), epiblast-
derived stem cells (EpiSCs) and induced pluripotent stem cells (iPSCs) have been used as facile 
in vitro models of in vivo mammalian (including human) development (Evans and Kaufman 
1981; Martin 1981; Takahashi and Yamanaka 2006; Takahashi et al., 2007; Tesar et al., 2007). 
Cultured pluripotent stem cells have the capacity  to undergo differentiation into all three germ 
layers, and subsequent elaboration into all of the cells of the developing embryo and adult, 
including most extraembryonic cell types.  
 
Importantly, cultured pluripotent stem cells can be directed specifically down selected lineages 
by careful control of the culture environment including, for example, the addition and removal 
of exogenous factors, altering the concentration of those factors, control of oxygen 
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concentration and cell density, and the removal of waste products (van der Sanden et al., 2010). 
Under favourable circumstances, a series of near-homogeneous cell populations can be 
produced which mimic the ontogenetic series observed in development (Rathjen et al., 2002; 
Harvey et al., 2010; Ying et al., 2003).   
 
The advantage, then, in using pluripotent stem cells for lineage studies is that selected aspects 
of development can be analysed: Cell types generally can be readily identified (e.g., through 
marker and/or functional analysis), the molecular mechanisms at play can be identified, and 
the contribution of the molecular mechanisms to emergent properties of the system such as 
differentiation, changes in proliferation and apoptosis, and changes in morphology, motility 
and functional capacity can be quantified.  
 
In more recent years, mathematical modeling of large data sets (e.g., micro- and kinome arrays, 
DNA methylation and histone modification analyses) has provided insight into the complex 
nature of molecular control in development. This modeling is helping to uncover, for example, 
key gene circuitry, signalling pathway crosstalk, as well as important nonlinear interactions 
between the various layers of regulatory control within and between cells (Herberg et al., 2015; 
Lu et al., 2009; MacArthur et al., 2010). These advances are bringing us closer to understanding 
the laws that govern the self-organising properties of biological systems (Barabási and Oltvai, 
2004; Prudhomme et al., 2004) and how the disruption of critical circuitry can compromise 
normal development. 
 
Our understanding of embryonic development has increased significantly since the isolation of 
ESCs from the mouse in 1981 (Evans and Kaufman 1981), but much is still unknown about 
the induction of the nervous system during which the multipotent germ layer of definitive 
ectoderm commits to form neurectoderm. Instead, attention has focused on generating more 
mature neural cells directly from mammalian ESCs or from endogenous neural stem cells 
cultured ex vivo (Cai and Grabel, 2007; Li et al., 2009; Parisi et al., 2010). This introduction 
will focus on what has been learnt from mouse embryo and mouse ESC (mESC) studies about 
how the neurectoderm lineage arises, with a focus on the role that amino acids, including L-
proline, play in the process.  
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1.1 Mouse pre- and post-implantation embryogenesis  
 
1.1.1 Formation of the bilaminar embryonic disc 
 
Following fertilization of the oocyte, the resulting zygote undergoes a series of cell divisions, 
such that between 2–3 days post coitum (dpc) the embryo consists of 8–16 identical 
blastomeres (Loebel et al., 2003; Nagy et al., 2003). Each blastomere within the morula is 
totipotent and expresses genetic markers of the future pluripotent inner cell mass (ICM) (e.g., 
Oct4, Nanog and Rex1) as well as extraembryonic lineages (e.g., Gata6 and Sox17) (Kellner 
and Kikyo, 2010; Medvedev et al., 2008; Niakan et al., 2010; Toyooka et al., 2008; Wamaitha 
et al., 2015) (Figure 1.1). These cells therefore maintain the ability to differentiate into all of 
the embryonic and extraembryonic cells that contribute to the development of the embryo. By 
3.0 dpc, the embryo compacts to form the morula, resulting in the formation of E-cadherin-
mediated adherens junctions between the outer blastomeres, and establishing the first apical-
basal polarisation of the embryo (Alarcon, 2010). The outer and inner cells are now destined 
for different fates. 
 
The up-regulation of ion pumps and exchangers in the outer blastomeres accompanies 
compaction, and allows the transport of ions including Na+ and Cl−, followed by the passive 
diffusion of water, into the center of the embryo (Barr et al., 1998). Thus, by 3.5 dpc, the 
blastocoelic cavity has formed (Watson and Barcroft, 2001) and the embryo, now known as a 
blastocyst, consists of an outer multipotent trophectoderm population, and the pluripotent ICM 
attached underneath to the polar trophectoderm (Figure 1.1). In keeping with these changes in 
cell fate, the trophectoderm down-regulates the expression of the pluripotency marker Oct4 
whilst maintaining the expression of Cdx2, restricting these cells to the placental lineage. In 
contrast, the ICM down-regulates Cdx2 and, in addition, some cells maintain the expression of 
Nanog and Rex1 whilst others express Gata6 and Sox17 to produce a mosaic ‘salt-and-pepper’ 
pattern of cells across the ICM (Artus et al., 2011; Chazaud et al., 2006; Pelton et al., 2002; 
Toyooka et al., 2008). Oct4 continues to be expressed in all the cells of the ICM at this stage, 
indicating maintenance of pluripotency (Chazaud et al., 2006) (Figure 1.1). 
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Figure 1.1: Early pre- and post-implantation mouse embryonic development until the egg 
cylinder stage. (A) Following fertilization, the embryo undergoes a series of cleavage divisions as it 
travels down the fallopian tube. Between 3.5–4.5 dpc, the embryo, now known as a blastocyst, consists 
of two cell populations: An outer multipotent trophectoderm (TE) (expressing Cdx2), and a mosaic 
inner pluripotent inner cell mass (ICM) population. At 4.0 dpc, the blastocyst hatches from the zona 
pelucida and implants into the uterine wall. (B) Cells of the 4.5 dpc ICM expressing Gata6 and Sox17 
move to the blastocoelic cavity, lose pluripotency, and differentiate into the extraembryonic hypoblast 
(or primitive endoderm). By 5.0 dpc, cells of the pluripotent epiblast that have not moved to be in 
contact with the extracellular matrix laid down between the hypoblast and the epiblast undergo 
apoptosis to help form the proamniotic cavity. The remaining surviving epiblast cells differentiate into 
a second pluripotent population known as the primitive ectoderm (PreEct) whilst the primitive 
endoderm differentiates into visceral endoderm (VE). At 5.5 dpc, the VE and the PrEct form the 
bilaminar disc and the embryo is now known as the egg cylinder and cells of the TE transition into the 
extraembryonic endoderm (EXE). Figure composed with assistance from Glover, H.  	
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Just prior to the blastocyst hatching from the zona pellucida (4.0 dpc) cell migration within the 
ICM occurs, giving rise to two distinct cell lineages: A combination of actin-dependent cell-
sorting and positional induction promotes the movement of Gata6+/Sox17+ cells to the 
blastocoel surface of the ICM (Artus et al., 2011; Meilhac et al., 2009) (Figure 1.1). This 
monolayer is known as the extraembryonic primitive endoderm (or hypoblast), and in keeping 
with its loss of pluripotency switches off expression of pluripotency markers such as Oct4. 
Primitive endoderm and its successor, the Hnf4+ visceral endoderm (VE) (Duncan et al., 1994), 
lay down an extracellular matrix (ECM) that separates them from the remaining ICM (Chazaud 
et al., 2006; Niakan et al., 2010; Wamaitha et al., 2015). The ICM now consists of a 
Nanog+/Oct4+ population, known as the epiblast. At this stage, the epiblast is squeezed 
between its multipotent neighbours; the Gata6+/Sox17+/Oct4– hypoblast and Cdx2+/Oct4– 
polar trophectoderm (Artus et al., 2011; Nichols et al., 2009; Strumpf et al., 2005) (Figure 1.1).  
Following implantation (4.5 dpc), epiblast cells that are not in contact with the ECM produced 
by the extraembryonic endoderm undergo apoptosis, resulting in the formation of the 
proamniotic cavity beginning at ~5.5 dpc (Coucouvanis and Martin, 1999). Failure to apoptose 
and cavitate results in embryonic lethality by ~5.5 dpc (Smyth et al., 1999). These processes 
can be modeled in vitro through embryoid body (EB) differentiation: When mESCs are 
cultured in suspension in conditions that allow spontaneous differentiation, they give rise to 
aggregates that are structurally similar to the 4.5 dpc mouse embryo. They contain an outer 
layer of primitive endoderm separated from a pluripotent epiblast-like population of cells by 
an ECM (Coucouvanis and Martin, 1995; Murray and Edgar, 2000). The primitive endoderm, 
in response to paracrine BMP4 signalling initially produced by the pluripotent ICM, 
differentiates into VE (which then itself, secretes BMP4) (Coucouvanis and Martin, 1995, 
1999).  
Two lines of evidence exist for the formation of the proamniotic cavity. The commonly 
accepted model, performed using EB culture, relies on BMP4-mediated apoptosis of epiblast 
cells that are not in contact with the VE (Coucouvanis and Martin, 1999). Inhibition of BMP4 
signalling in EB culture (by expression of a dominant negative form of BMP receptor) results 
in failure to form Hnf4+/Afp+/Trt+ VE from the primitive endoderm. As a result, the inner 
epiblast cells within the EBs fail to undergo apoptosis, and thus the EB does not undergo 
cavitation (Coucouvanis and Martin, 1999; Graham et al., 2014). In support of this, LAMC1–/– 
EBs (which are unable to express laminin type-1 and establish a functional basement membrane 
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(Smyth et al., 1999)) also fail to cavitate. Addition of 20 µg/ml exogenous laminin to  
LAMC1–/– EBs rescues basement membrane production, and the EBs are able to cavitate as 
normal. In keeping in line with the importance of the ECM during normal embryonic 
development, a more recent discovery found that rather than providing ‘survival’ signals for 
epiblast cells during cavity formation, the ECM provides cell polarizing cues instead. In 
response to integrin-mediated signalling from the basement membrane, epiblast cells 
reorganise into cells with apico-basal polarity, forming a central lumen within the epiblast 
(Bedzhov and Zernicka-Goetz, 2014).  
The remaining epiblast cells now undergo a transition to a second pluripotent population of 
pseudostratified columnar epithelium known as primitive ectoderm (Pelton et al., 2002). The 
transition includes an increased rate of proliferation of the surviving epiblast cells that expands 
the pluripotent cell pool from ~120 cells at 5.5 dpc to ~660 by 6.5 dpc (Snow, 1977), preparing 
the embryo for gastrulation. During this time, the cell cycle reduces from ~12 h to as little as 
4.8 h (Snow, 1977). The expression of pluripotency markers such as Oct4 are maintained, while 
that  of ICM markers such as Rex1 (Pelton et al., 2002) are down-regulated (Nichols et al., 
2009). The expression of primitive ectoderm markers such as Fgf5 are up-regulated (Haub and 
Goldfarb, 1991; Hébert et al., 1991; Khoa et al., 2016; Pelton et al., 2002).  
The embryo has now taken the form of a cup-shaped bilaminar disc known as the egg cylinder 
(Arnold and Robertson, 2009; Nichols and Smith, 2012) (Figure 1.1). The pluripotent primitive 
ectoderm is primed for gastrulation and will give rise to the three multipotent germ layers of 
the embryo proper (Pelton et al., 2002). Concurrently, the polar trophectoderm proliferates and 
differentiates into the extraembryonic ectoderm (EXE) and the ectoplacental cone in response 
to Fgf4 signalling from the underlying pluripotent cells (Goldin and Papaioannou, 2003; 
Haffner-Krausz et al., 1999). This extraembryonic tissue differentiates into the support 
structures, including the placenta and yolk sac. 
 
1.1.2 Nutrient supply during early embryogenesis: The role of amino acids 
 
As the embryo travels down the fallopian tube towards the uterus, it is exposed to changes in 
nutrient and gas availability supplied by the maternal environment. Oxygen concentrations 
within the reproductive tract are low: In the fallopian tube, oxygen tension is ≤7.5% and 
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decreases to ≤2% in the uterus (Fischer and Bavister, 1993). During this time, cells of the 
embryo rely heavily on anaerobic metabolism for energy production and have poor aerobic 
capacity (Harvey, 2007). Development at this pre-implantation stage is also accompanied by 
changes in energy substrate requirements: The zygote requires pyruvate for the first cleavage 
to occur, and following this, up until compaction, lactate is the preferred energy source 
(Gardner and Leese, 1988). Following compaction, the embryo relies on glucose as its major 
source of energy (Martin and Leese, 1995). Consistent with this is the up-regulation in the 
expression of the glucose transporter GLUT-3 on the apical membrane of the trophectoderm 
(Pantaleon et al., 1997), facilitating influx of glucose. Glucose is then transported into the 
blastocoelic cavity via GLUT-1 on the basolateral membrane of trophectoderm cells, after 
which it is taken up by ICM cells (also via GLUT-1) (Pantaleon et al., 1997). Cells of the ICM 
have fewer mitochondria compared to the TE (Houghton, 2006), and therefore rely more 
heavily on anaerobic metabolism of glucose rather than oxidative phosphorylation for ATP 
production. An up-regulation in the expression of enzymes involved in aerobic glycolysis is 
also observed at the time of blastocyst formation (including glucose-6-phosphate 
dehydrogenase X (G6PDX), lactate dehydrogenase A (LDHA) and pyruvate kinase muscle 
isoenzyme (PKM2)) to accommodate these changes in energy demands (Fu et al., 2014).  
 
Along with pyruvate and lactate, early embryos can use amino acids as a source of nitrogen, in 
addition to their primary role as building blocks in protein production. Amino acids are now 
also appreciated for their roles as pH regulators, osmolytes and signalling molecules within 
various cell types, including those of the early embryo (Gardner, 1998; Kermack et al., 2015). 
In the mouse and human, the preimplantation embryo is exposed to all 20 common amino acids 
in the maternal tubal fluid (Cetin et al., 2005; Kermack et al., 2015): Most non-essential amino 
acids (NEAA) are present at concentrations in the submillimolar range (≤600 µM) while 
essential amino acids (EAA) tend to be present at lower concentrations (≤200 µM) (Lane et 
al., 2001; Aguilar and Reyley 2005; Miller and Schultz 1987).  
 
Whilst preimplantation mouse embryos can develop to blastocysts in very simple culture media 
(McLaren and Biggers, 1958; Whitten and Biggers, 1968), including those without amino 
acids, this development is associated with a reduction in cleavage rates, blastocyst cell number, 
and embryo viability compared to their in vivo counterparts. Addition of all 20 amino acids to 
the culture medium significantly improves the number of zygotes that reach the blastocyst stage 
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by 96 h of culture compared to embryos cultured without amino acids (Lane and Gardner, 
1997a). Hatching rates are also improved (Gardner and Lane, 1993; Lane and Gardner, 1997a). 
However, addition of just NEAA + glutamine is more efficacious, with development to the 
blastocyst stage occurring by 72 h, equivalent to the time taken for this to occur in vivo 
(Gardner, 1998; Gardner and Lane, 1993; Lane and Gardner, 1997a, 1997b). Hatching rates in 
the presence of NEAA + glutamine are also improved compared to the addition of all 20 amino 
acids (Gardner and Lane, 1993). NEAA + glutamine enhances development in two important 
ways: Firstly, embryos from outbred strains are liberated from the 2-cell block (Gardner and 
Lane, 1996; Goddard and Pratt, 1983). This in vitro arrest in development, which also occurs 
in other mammalian species including the 4–8 cell human embryo (Bolton et al., 1989), marks 
the time when the embryonic genome becomes activated (Braude et al., 1988; Goddard and 
Pratt, 1983; Latham, 1999). Secondly, cleavage rates for the first three cell divisions are 
increased (Gardner, 1994; Gozales et al., 1995; Lane and Gardner, 1997b). In contrast, addition 
of EAA to the culture medium prior to the 8-cell stage impairs viability and development to 
the blastocyst stage, but if added from the 8-cell stage stimulates blastocyst development, 
trophectoderm cell number, and hatching (Lane and Gardner, 1997a).  
 
In keeping with this poorly understood complexity, embryos dynamically express a range of 
amino-acid transporters in the pre-implantation stages suggesting they temporally exploit the 
use of amino acids to promote normal development (Van Winkle, 2001). However, the 
mechanisms by which individual amino acids drive the various stages of pre-implantation 
development are largely unknown and the many efforts to improve media for cultured embryos 
(to be used, say, in in vitro fertilization (IVF)) have been mostly empirical. The use of 2-stage 
media, where the amino acid content is switched largely from NEAA to EAA, is one of many 
examples (Gardner and Lane, 1998).  
 
Maternal and umbilical blood also contains amino acids (Kermack et al., 2015; Miller and 
Schultz 1987; Aguilar and Reyley 2005) suggesting that these molecules play important roles 
in post-implantation development. For example, L-proline is present in circulating maternal 
plasma and umbilical venous plasma at a concentration of ~150 µM (Cetin et al., 2005). This 
in vivo concentration of L-proline is consistent with that required to stimulate the in vitro 
differentiation of mESCs to a second pluripotent population of early primitive ectoderm-like 
(EPL) cells, a differentiation process analogous to the in vivo ICM to primitive ectoderm 
transition (discussed below) (Rathjen et al., 1999; Tan et al., 2011; Washington et al., 2010). 
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The embryo itself may be a source of L-proline via storage within its cells (Baltz, 2001) and/or 
within the blastocoel cavity (Gardner, 1998; Schultz et al., 1981). Other possible in vivo sources 
of L-proline include turnover of the collagen-rich ECM that separates the VE from the ICM, 
as well as ECM turnover that occurs during the process of implantation (Glass et al., 1983).  
 
1.1.3 Gastrulation and the formation of the three definitive germ layers 
 
Shortly after implantation, the bilaminar disc of the embryo containing the pluripotent primitive 
ectoderm gastrulates to form the trilaminar disc containing the three multipotent germ layers 
of endoderm, mesoderm and ectoderm. This process, known as gastrulation, begins in the 
mouse at 6.5 dpc (Nagy et al., 2003; Rivera-Pérez and Magnuson, 2005) with the formation of 
the primitive streak on the posterior side of the embryo and which reaches its final length by 
~7.5 dpc (Williams et al., 2012).  
 
During gastrulation, some primitive ectoderm cells undergo an epithelial-to-mesenchyme 
(EMT) transition allowing them to migrate through the streak and emerge as mesoderm and 
endoderm (collectively known as mesendoderm) in response to secreted factors by surrounding 
tissues (discussed below). In addition, a transient population of ~250 Hnf-3b+ cells, collectively 
known as the node, form at the distal tip of the embryo at ~7.5 dpc (Collignon et al., 1996; 
Conlon et al., 1994; Lee and Anderson, 2008; Sulik et al., 1994; Yamanaka et al., 2007; Zhou 
et al., 1993). These specialized cells, which exist until ~9.0 dpc in the mouse (Yamanaka et al., 
2007) and express cilia which rotate in a clockwise direction, producing a leftward flow of 
fluid rich in morphogens, including Nodal. The distribution of Nodal across the embryo helps 
to establish the embryonic left-right axis (Babu et al., 2013). Improper cilia development and 
function disrupts left-right axis formation which results in organs developing on the incorrect 
side of the body (Okada et al., 1999). 
 
Cells that migrate through the node give rise to the prechordal plate and notochord, which 
further give rise to midline mesendoderm structures of the embryo. The notochord, which arises 
from cells on the ventral aspect of the node (Sulik et al., 1994), is an important signalling centre 
involved in neural tube patterning (discussed below), and failure to form the node and/or 
notochord results in embryonic lethality (Ang and Rossant, 1994).  
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Between 6.5 dpc and 7.5 dpc, the primitive streak elongates towards the distal tip of the embryo 
in response to the carefully orchestrated actions of three secreted growth factors (Nodal, Wnt3 
and BMP4) from the surrounding tissues (Figure 1.2) (Arnold and Robertson, 2009; Rivera-
Pérez and Magnuson, 2005; Tam et al., 2006).   
 
Nodal is a member of Transforming Growth Factor-beta (TGF-β) superfamily. It is secreted as 
a proprotein, pro-Nodal, and usually requires cleavage by the convertases Furin and Pace4 to 
be biologically active (Schier, 2003). In this mature form, it binds to and activates cell-surface 
Activin-Like Kinase (ALK) receptor complexes (ActR-I/ActR-II) resulting in SMAD2/3-
regulated modulation of gene expression. The stability of Nodal is compromised following the 
cleavage, restricting its ability to signal long distances (Le Good et al., 2005).  
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Figure 1.2: Formation of the primitive body plan following gastrulation in the mouse. (A) Right hand panel: Pro-Nodal secreted from the extraembryonic 
ectoderm (EXE) is converted to Nodal in the presence of the convertases Furin (F) and Pace4 (P). Nodal acts on the visceral endoderm (light green cells) to 
regulate its own expression from these cells. A feedback system is established between Nodal, BMP and Wnt3 causing primitive ectoderm (PrEct) cells on the 
posterior side to ingress through the primitive streak, which continues to elongate in a proximal-distal direction from 6 dpc. Cells that migrate through the 
primitive streak form the mesoderm and endoderm germ layers. Left hand panel: On the anterior side of the embryo, the anterior visceral endoderm (AVE; dark 
green cells) secretes the Nodal antagonists Cer1 and Lef1, and the Wnt3 antagonist Dkk1, inhibiting Nodal and Wnt3 signalling and thus establishing the 
definitive ectoderm germ layer. BMP4 is secreted from the extraembryonic ectoderm (EXE) whilst the BMP4 antagonists including Noggin (Ngn), Chordin 
(Chd) and Follistatin (Fsn) are secreted from the Node (N) to help establish a gradient of BMP4 across the definitive ectoderm. BMP4-mediated SMAD 
signalling in the proximal definitive ectoderm produces surface ectoderm (SE) whilst the distal definitive ectoderm differentiates into neurectoderm (NE) in the 
absence of SMAD signalling. (B) By 7.5 dpc, the embryo has completed gastrulation and is now composed of the three primary germ layers: The definitive 
endoderm (DEnd), mesoderm (ME) and ectoderm, which is now committed to either SE or NE. (C) Between 7.5 and 8.5 dpc, the ME differentiates gives rise 
to the paraxial mesoderm (pME) and lateral plate mesoderm (lpME), the DEnd produces the gut tube (GT) and the DEct gives rise to the neural tube (NT).  
Key: EXM/En: extraembryonic mesoderm/Endoderm; Prox: proximal, Dist: distal; A: anterior; P: posterior. Figure composed with assistance from Glover, H.  
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Nodal is secreted by the VE and acts on the VE and surrounding EXE as early as ~5.5 dpc to 
promote its own expression (Le Good et al., 2005) (Figure 1.2). By ~6.0 dpc, Nodal expression 
is restricted to the posterior side of the primitive ectoderm where it assists in the induction of 
the primitive streak (Shen, 2007) (Figure 1.2) by stimulating the expression of streak genes 
including Mixl1 and Goosecoid (Gsc) (Izzi et al., 2007; Yamamoto et al., 2001). Following 
this, Nodal signalling is also essential for mesendoderm specification of pluripotent cells 
moving through the streak (Ben-Haim et al., 2006; Shen, 2007). 
 
Pro-Nodal, though immature, also has biological activity and has been shown to act on the EXE 
to induce the expression of BMP4, which in turn causes the EXE to secrete Wnt3 (Beck et al., 
2002; Le Good et al., 2005) (Figure 1.2). Wnt3 activates the canonical Wnt pathway in 
primitive ectoderm cells causing β-catenin to translocate to the nucleus where it binds to the 
promoter of the primitive streak marker Brachyury (T) (Tortelote et al., 2013) and the proximal 
enhancer of Nodal, inducing transcription of T and Nodal on the posterior side of the embryo. 
As a result, Nodal, BMP4 and Wnt3 expression are maintained along the posterior axis of the 
embryo, allowing for the establishment, elongation and maintenance of the primitive streak 
(Figure 1.2). Concurrently, Wnt3 signalling causes posterior primitive ectoderm cells to 
undergo an EMT, by down-regulating the expression of E-cadherin, allowing them to migrate, 
converge at, and ingress through, the streak.  
 
Gastrulation proceeds from ~6.5–7.5 dpc (Wurst and Bally-Cuif, 2001) as the primitive streak 
elongates distally along the posterior primitive ectoderm. Cells that migrate through the streak 
differentiate to form cells of the definitive mesoderm and endoderm germ layers (Arnold and 
Robertson, 2009; Loebel et al., 2003) (Figure 1.2 and Figure 1.3) depending on the time and 
place in the streak through which they migrate. Anterior primitive ectoderm cells do not 
undergo an EMT (due in part to Nodal and Wnt3 signalling inhibition in this part of the embryo; 
Figure 1.2) and therefore do not ingress through the streak. These cells form the third 
multipotent germ layer, the definitive ectoderm (Figure 1.2; and see below). The embryonic 
portion of the embryo is now referred to as the trilaminar disc. 
 
Failure to gastrulate results in embryonic lethality shortly after implantation (Conlon et al., 
1994; Loebel et al., 2003). For example, embryos lacking functional Nodal, Wnt and/or BMP4 
signalling show delayed and/or failure to initiate primitive streak formation, and abnormal 
mesendoderm development (Miyamoto et al., 2015; Rivera-Pérez and Magnuson, 2005; 
15		
Tortelote et al., 2013; Yoon et al., 2015). These embryos die shortly after the time at which 
gastrulation should take place (Conlon et al., 1994; Mishina et al., 1995; Yoon et al., 2015; 
Zhou et al., 1993). 
Following the completion of gastrulation at ~7.5 dpc (Wurst and Bally-Cuif, 2001) and before 
the initiation of organogenesis (~8.0 dpc), the mouse embryo inverts, bringing the definitive 
ectoderm to the outside, and the definitive endoderm to the inside of the embryo, whilst the 
definitive mesoderm remains as the middle layer. 
 
		
Figure 1.3: Gastrulation gives rise to the three primary germ layers of the embryo proper. The 
inner cell mass (ICM) is a pluripotent population of cells that arises between 3.5–4.5 dpc within the 
blastocyst. By 5.5 dpc, the ICM differentiates into the multipotent extraembryonic primitive endoderm 
lineage and a second pluripotent population, the primitive ectoderm. At 6.5 dpc, the primitive ectoderm 
undergoes gastrulation in response to various signals including Nodal, resulting in a subset of cells 
undergoing an epithelial-to-mesenchymal transition (EMT), allowing them to ingress through the 
primitive streak and form the definitive mesoderm and definitive endoderm germ layers. Cells which 
fail to come in contact with Nodal do not move through the streak and give rise to the definitive 
ectoderm germ layer, which further differentiates into the surface ectoderm and neurectoderm in 
response to the presence and absence of BMP4 signalling, respectively. Key: PNS: peripheral nervous 
system; ENS: enteric nervous system; CNS: central nervous system; GIT: gastrointestinal tract 
(epithelial lining); RT: respiratory tract (epithelial lining). Figure composed with assistance from 
Glover, H. 
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1.1.4 The definitive ectoderm 
 
Definitive ectoderm is bipotential, being able to differentiate into surface ectoderm or 
neurectoderm at 7.0 dpc (Li et al., 2013). Unlike the mesendoderm lineages, which have a 
variety of lineage markers that have been studied and confirmed both in vitro and in vivo 
(including Mixl1, T, Flk1, Sox17) (Arnold and Robertson, 2009; Ishitobi et al., 2011), there is 
a paucity of definitive ectoderm markers. Two potential markers, Penk1 and Pard6b, have been 
suggested based on a neural differentiation protocol for mESCs (Harvey et al., 2010). The 
expression of these potential in vitro markers has yet to be confirmed in the 6.5–7.0 dpc 
embryo. The lack of markers and the transient appearance of definitive ectoderm (Harvey et 
al., 2010; Li et al., 2013) means that much is still unknown about the molecular mechanisms 
driving its formation (Arnold and Robertson, 2009; Li et al., 2013; Loebel et al., 2003; Tam et 
al., 2006). Our current understanding of the definitive ectoderm relies on the tissue’s 
differential response to BMP4 (Harvey et al., 2010; Li et al., 2013): Lineage commitment into 
surface ectoderm or neurectoderm relies in part, on the presence or absence of BMP4-mediated 
SMAD1/5/8 signalling, respectively. BMPR1a–/– embryos fail to produce surface ectoderm and 
instead up-regulate genes which result in neurectoderm differentiation (Davis et al., 2004; Di-
Gregorio et al., 2007).  
 
1.1.5 The role of the anterior visceral endoderm in establishing the 
definitive ectoderm 
 
As well as their roles in streak formation and mesendoderm production, Nodal, BMP4 and 
Wnt3 signalling are required for the anterior movement of the distal visceral endoderm (DVE) 
from the distal tip of the embryo and its differentiation to anterior visceral endoderm (AVE) 
(Ben-Haim et al., 2006; Hoshino et al., 2015; Srinivas et al., 2004; Stuckey et al., 2011). The 
AVE promotes definitive ectoderm formation by secreting Nodal antagonists including 
Cerberus-like 1 (Cer1) and Left-right determining factor 1 (Lefty1), and the Wnt antagonist 
Dickkopf1 (Dkk1) (Hoshino et al., 2015; Kong and Zhang, 2009; Rodriguez et al., 2005; 
Stower and Srinivas, 2014) (Figure 1.2). Thus, the feedback system between Nodal, Wnt and 
BMP4 present on the posterior side of the embryo is disrupted on the anterior side resulting in 
failure of the anterior primitive ectoderm cells to undergo EMT and migrate through the 
posterior-placed streak. This population of pluripotent cells is then fated to become the third 
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multipotent germ layer, the definitive ectoderm, by 7.0 dpc (Figure 1.2). ~6.5 dpc embryos 
cultured ex vivo in the presence of the Nodal inhibitor SB431542 (Inman et al., 2002) fail to 
produce mesendoderm on the posterior side of the embryo. Rather, both the anterior and the 
posterior primitive ectoderm differentiate into definitive ectoderm derivatives including 
neurectoderm and surface ectoderm (Li et al., 2013). Similarly, Nodal–/– epiblast explants fail 
to form mesoderm and instead (Lu and Robertson, 2004) prematurely differentiate into 
neurectoderm by ~6.5 dpc (Camus et al., 2006).     
 
1.1.6 The role of the node in patterning the definitive ectoderm 
 
The node is an organiser which assists in patterning the anterior side of the embryo during 
gastrulation. At ~7.0 dpc, the node secretes BMP4 antagonists, including Chordin, Noggin and 
Follistatin, which dampen the gradient of BMP4 secreted from the proximal EXE (Figure 1.2) 
(Bachiller et al., 2000; Brazil et al., 2015; McMahon et al., 1998). The portion of the definitive 
ectoderm closest to the node, where BMP4 activity is low, differentiates into neurectoderm – 
the neural plate – which expresses Sox1+ followed closely (in the mouse) by the expression of 
Pax6 (Suter et al., 2009; Timmer et al., 2002). The neural plate can be recognised 
morphologically as a pseudostratified columnar sheet of neurepithelium symmetrically placed 
along the anterior midline of the embryo. Its induction not only requires node-assisted 
mitigation of BMP4 activity but also signals from the underlying mesodermal tissue – the 
notochord (which is derived from the node) and the prechordal plate (Gilbert, 2006). 
In the proximal definitive ectoderm, where BMP4 activity is high, there is activation of the 
SMAD1/5/8 signalling pathway. SMAD complexes bind to epidermal DNA response elements 
resulting in the transcription of genes involved in surface ectoderm specification including 
members of the keratin family: Early markers include K8, K18 and K19, followed by the more 
mature markers, K14 and K17 (Harvey et al., 2010; Troy and Turksen, 2005). By 7.5 dpc, the 
definitive ectoderm is fully committed to either surface ectoderm or neurectoderm: BMP4 
exposure no longer has the ability to promote nor inhibit lineage commitment as cells have lost 
competence to form the opposing tissue (Li et al., 2013). 
Thus, in the mouse, Sox1 expression demarcates neural commitment (Aubert et al., 2003; 
Pevny et al., 1998). Its expression is restricted firstly to the developing neurectoderm and, 
following neurogenesis, to the mitotically active pool of neural stem cells (Pevny and Placzek, 
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2005). Sox2 and Sox3 expression are also required for neural specification though their 
expression begins earlier in development (Wood and Episkopou, 1999).  	
1.1.7 Neural tube formation and central nervous system patterning 
 
From 7.5 dpc, rapid symmetric cell division cause a thickening of the Sox1+ neural plate. By 
~8.5 dpc, the ventral side of the neural plate (i.e., the side closest to the underlying notochord 
and prechordal plate) transitions to the floor plate. The floor plate now itself acts as a primary 
signalling centre (Figure 1.4). Floor plate formation occurs in response to Sonic hedgehog 
(Shh) secreted from the node, prechordal plate and notochord prior to neural tube formation. 
Fate mapping studies show that floor plate cells may also arise from a common precursor cell 
that gives rise to both the notochord and floor plate, (Jeong and Epstein, 2003). In response to 
Shh from the node, the floor plate now produces Shh and does so until ~14.5 dpc (Ding et al., 
1998; Echelard et al., 1993), establishing a gradient that patterns the ventral side of the neural 
tube (Gilbert, 2006; Litingtung and Chiang, 2000; Ribes et al., 2010) (Figure 1.4).  
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Figure 1.4: Formation and patterning of the mouse neural tube. (A) The pseudostratified columnar 
epithelium of neural plate forms by 7.5 days post coitum (dpc) following rapid proliferation and 
differentiation of neurepithelium from ~8.5 dpc. The lateral edges of the neural plate then elevate (B) 
and fold (C) by ~8.0 dpc before converging at the midline and closing by ~8.5 dpc (D) Shh (red arrows) 
and BMP inhibitors secreted from the floor plate, and BMP4/7 (green arrows) secreted from the roof 
plate act to pattern the neural tube along its ventro-dorsal axis, giving rise layers of the spinal cord 
(Gilbert, 2006). Cells of the neural tube located dorsally differentiate in the order of V1, V2 and V3 
interneurons. Key: V: ventral, D: dorsal, L: left, R: right, MN: motor neuron. Figure composed with 
assistance from Glover, H. 	
At ~7.5 dpc the neural plate begins to elevate and fold, converging at the midline at 8.5 dpc 
(Gilbert, 2006; Ybot-Gonzalez et al., 2002) (Figure 1.4). In doing so, the lateral neural plate 
cells move medially and eventually come into contact with the overlying surface ectoderm. A 
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small population of these cells forms the roof plate, due in part to a response to BMP4/7 
signalling from the overlying surface ectoderm. The roof plate itself becomes a dorsal organiser 
and secretes BMP4/7, further establishing the dorsal–ventral gradients of these morphogens 
(Gilbert, 2006). The floor plate, notochord and prechordal plate further modify these gradients 
by secreting BMP antagonists including chordin and noggin (McMahon et al., 1998; Placzek 
and Briscoe, 2005).   
 
In the spinal cord, the dorsal–ventral activity gradients of Shh and BMP help gives rise to the 
unique architecture of the caudal neural tube: Those cells closest to the floor plate (which are 
exposed to the highest Shh activity) differentiate into cells that will ultimately give rise to V3 
ventral interneurons (Figure 1.4). The next layer of cells, which are exposed to ‘moderate’ Shh 
activity, differentiate into motor neurons. Moving further dorsally, Shh activity continues to 
decrease and that of BMP4/7 from the roof plate increases, resulting in dorsal neurepithelium 
differentiating into V2 and V1 interneuron layers (Figure 1.4). Mice that lack functional Shh 
signalling show disruptions to node and notochord function, followed by the inability to form 
floor plate (Ding et al., 1998), resulting in abnormal central nervous system patterning (Chiang 
et al., 1996). Shh mutant mice show craniofacial, visual and axial defects (Chiang et al., 1996; 
Hu and Helms, 1999). Similarly, central nervous system (CNS) patterning is disrupted in mice 
lacking functional roof plate cells. Selective genetic ablation of roof plate cells in ~9.5 dpc 
mouse embryos effectively disrupts the activity gradients of BMPs, resulting in failure to form 
dorsal interneurons (Jessell et al., 2000; Wine-Lee et al., 2004).  
 
Meanwhile, from ~8.5–10.5 dpc in the mouse, the developing neural tube undergoes 
bidirectional closure on the dorsal side at three to four sites. In mouse embryos, time-lapse 
imaging shows the hindbrain and spinal cord regions close in a zipper-like manner at a rate of 
~1 µm/min (Pyrgaki et al., 2010). In comparison, the midbrain region undergoes a ‘buttoning-
up’ process, whereby cell protrusions ~150 µm apart contact the opposing neural fold, forming 
closure points (Pyrgaki et al., 2010). Primary neural tube formation finishes with the rostral 
and caudal neuropores closing at 9.0 dpc and 10.5 dpc, respectively (Nagy et al., 2003). Failure 
of the neural tube and neuropores to close completely results in neural tube defects including 
anencephaly (rostral) and spina bifida (caudal) in both mice (Juriloff and Harris, 2000) and 
humans (Gilbert, 2006).  
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As the neural plate converges at the midline of the embryo from ~8.5 dpc, a single layer of 
neurepithelium continues to line the inside of the tube. This ventricular zone (VZ) (Hébert and 
Fishell, 2008)  is the region that will eventually form the adult ventricles of the matured brain. 
By 9.5 dpc, swellings along the neural tube become apparent (Joyner, 2002). The rostral-most 
swelling, known as the prosencephalon is the forebrain precursor and, subdivides into the 
telencephalon (which gives rise to the cerebral cortex) and the diencephalon (which gives rise 
to deep structures including the thalamus, hypothalamus and pineal gland) (Gilbert, 2006; 
Joyner, 2002). This division of the brain is predominantly patterned by two secondary-
organizers: The anterior neural ridge (ANR) and the zona limitans intrathalamica (ZLI) 
(Paridaen and Huttner, 2014). The ANR, which is derived from the neurectoderm lineage 
(Cajal et al., 2011), lies between the junction of the ~8.5 dpc neural and non-neural ectoderm. 
The ANR expresses both chordin and noggin to inhibit BMP4/7 signalling from the overlying 
ectoderm (Anderson et al., 2002; Paek et al., 2009), and is also responsible for the secretion of 
Fgf8, which induces the expression of the telencephalon marker, Brain Factor-1 (BF1) 
(Hanashima et al., 2002; Shimamura and Rubenstein, 1997). The ZLI arises after the ANR, at 
~9.5 dpc and is located rostral to the embryonic thalamus. The ZLI is responsible for Shh-
patterning of the diencephalon (Echevarria et al., 2001; Martinez-Ferre et al., 2013, 2016; 
Martinez-Ferre and Martinez, 2012).  
 
Posterior to the prosencephalon is the mesencephalon, which gives rise to structures of the 
midbrain, and then the rhombencephalon, which gives rise to structures of the hindbrain 
including the cerebellum. Patterning of the midbrain and hindbrain is predominantly done by 
Wnt and Fgf8 signalling arising from the isthmic organizer (IsO) (Chi et al., 2003). The IsO is 
located in the junction between the mesencephalon and rhombencephalon (for a detailed review 
see (Wurst and Bally-Cuif, 2001)).  
 
1.1.8 Neurogenesis 
 
Embryonic neurogenesis is the process by which functional neurons are generated from the 
precursor neurectoderm tissue (the neural plate). This complex and dynamic process occurs 
along the entire neural axis, beginning at ~8.5 dpc in the mouse. Following the rapid 
proliferation of the Sox1+ neurepithelium (induced by Fgf8 signalling from the ANR (Hoch et 
al., 2015; Storm et al., 2006)), these cells begin to differentiate into radial glia (RG) cells in 
response to Notch, Wnt and Fgf signalling from the neurepithelial population (Anthony et al., 
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2004; Dave et al., 2011; Hartfuss et al., 2001; Kang et al., 2009; Malatesta et al., 2008; Sahara 
and O’Leary, 2009) and the region of the telencephalon known as the cortical hem (Caronia-
Brown et al., 2014). In the telencephalic region of the neural tube (the area which will form the 
cerebral cortex), RG cells up-regulate the markers Brain Lipid Binding Protein (BLBP) and 
Glutamate-Aspartate Transporter (GLAST), Glial Fibrillary Acidic Protein (GFAP) and 
Vimentin.  
RG cells are the primary progenitor cells of the developing and post-natal CNS. They firstly 
giving rise to neurons from ~10.0–14.5 dpc, followed by the production of astrocytes and 
oligodendrocytes (glia) by ~15.0 dpc (Figure 1.5) (Anthony et al., 2004; Kriegstein and Gotz, 
2003).  
	
 
Figure 1.5: Cortical neurogenesis in the mouse. Following neural plate formation at 7.5 dpc, 
neurepithelial cells (NEC) differentiate into mitotically active neural progenitor cells known as radial 
glia (RG) by ~9.0 dpc. RG undergo either symmetrical division to produce two RG daughter cells, or 
asymmetric division to produce one RG daughter cell and either an intermediate progenitor cell (IPC), 
a terminally-differentiated neuron (N) or mature glial cell (G). IPCs are capable of undergoing 
symmetrical division to form neurons. N and IPCs migrate along the axons of the RG cells from the 
ventricular zone (VZ), through the subventricular zone (SVZ) to the upper cortical layers of the 
developing brain. Figure composed with assistance from Glover, H. 
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Cortical RG cells can divide both symmetrically and asymmetrically. In the presence of Fgf2 
(secreted from cortical progenitors throughout the VZ (Sahara and O’Leary, 2009)), they self-
renew to enlarge the progenitor pool, whilst in the absence of Fgf2 signalling they produce an 
intermediate progenitor cell (IPC – also known as a basal progenitor cell) (Raballo et al., 2000). 
IPCs migrate away from the apical surface of the subventricular zone (SVZ) where they divide 
symmetrically to produce two neurons. Between ~14.0–16.0 dpc, cortical RG cells can also 
directly produce neurons through symmetric division (Götz et al., 2002; Götz and Barde, 2005). 
Neurons that are produced during the initial waves of neurogenesis give rise to the deep layers 
of the diencephalon (e.g., thalamus), whilst neurons produced later migrate to the cortical plate 
and give rise to the cerebral cortex (McConnell and Kaznowski, 1991) (Figure 1.5). The 
importance of Fgf2 signalling is highlighted in FGFR1/2 knockout embryos, which display 
decreased neural progenitor and mature neuronal cell number and, as a result, decreased 
cortical size (Stevens et al., 2010; Vaccarino et al., 1999).  
 
As neurogenesis progresses, RG cells increasingly give rise to daughter cells that exit the cell 
cycle and undergo terminal differentiation, resulting in the progenitor pool gradually 
decreasing over time, and eventual near-cessation of neurogenesis (at least in mammals). From 
~15.0–19.0 dpc, gliogenesis begins as RG cells switch from producing neurons to producing 
glia: Newly born NeuN+ neurons secrete factors, including CT-1 and IL-6 family cytokine 
Leukaemia Inhibitory Factor (LIF), that instruct the production of GFAP+ astrocytes from RG 
cells (Barnabé-Heider et al., 2003) and O4+ oligodendrocytes (Qian et al., 1981). Following 
embryonic neurogenesis, the mammalian adult brain has limited capacity to produce neurons. 
Two regions, the SVZ and the dentate gyrus of the hippocampus, retain this ability (Fuentealba 
et al., 2012; Merkle et al., 2004; Ming and Song, 2011; Urbán and Guillemot, 2014). 
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1.2 Embryonic stem cells: An in vitro model of embryogenesis 
 
1.2.1 Properties of embryonic stem cells 
 
mESC lines are generally derived from blastocysts (3.5–4.5 dpc) (Evans and Kaufman 1981) 
and are defined by: (i) The ability to self-renew whilst maintaining a normal karyotype and (ii) 
pluripotency – the ability to differentiate into each of the ~200 somatic cell types of the 
developing embryo and adult, including germ-line cells (Evans and Kaufman 1981). These 
properties allow ESCs to be used as an in vitro model of embryogenesis. In particular, they 
provide the opportunity for employing more facile approaches to understanding the molecular 
mechanisms driving development compared to studying embryos themselves.  
 
ESCs can be used to recapitulate aspects of embryonic morphology. For example, when 
cultured in suspension, embryoid bodies (EBs) form, which self-assemble into an outer 
extraembryonic endoderm layer separated from a core of pluripotent cells by an ECM; i.e., 
mimicking the relationship of the 5.5 dpc bilaminar embryo (Bratt-Leal et al., 2009; 
Coucouvanis and Martin, 1999). Similarly, hESCs grown on micropattern plates (to control 
colony size and density) undergo differentiation and embryologically relevant self-organisation 
into cells of the three germ layers: An inner Sox2+ neurectoderm core, underlying a T+ 
mesoderm layer and Sox17+ endoderm layer surrounded by a Cdx2+ TE-like outer layer 
(Warmflash et al., 2014).  
 
ESCs can also be driven sequentially through populations of cells which recapitulate the 
ontogeny of embryonic lineage commitment in vivo (Harvey et al., 2010; Lees and Tuch, 2006; 
Rathjen et al., 1999; Sherwood et al., 2011; Torres et al., 2012). The close resemblance between 
ESC differentiation and lineage commitment in embryos in terms of cell signalling, gene and 
protein expression, and metabolic and epigenetic profiles provides further evidence that ESCs 
act as a good model system for understanding the molecular mechanisms underlying embryonic 
development.    
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1.2.2 Pluripotency and self-renewal in mESCs 
 
Originally, all mESC lines were derived from blastocysts and maintained as a self-renewing 
population on a feeder layer of mouse embryonic fibroblasts (a source of LIF) and in the 
presence of serum (a source of BMP4), both of which can usually be dispensed with by the 
addition of recombinant LIF and BMP4 (Niwa et al., 1998; Hirai et al., 2011; Ying et al.,  2003). 
hESC lines can be maintained on human foreskin fibroblast cells in serum (Hovatta et al., 2003) 
or without serum in chemically defined media containing Fgf2 ± activin (James et al., 2005; 
Vallier et al., 2005).  
Establishing the pluripotency of the line is crucial. The gold standard is tetraploid 
complementation (Eakin and Hadjantonakis, 2006; Nagy et al., 2010; Tam and Rossant, 2003) 
whereby diploid mESCs aggregated with tetraploid embryos produce chimaeras in which the 
embryo proper is almost completely (if not completely) derived from the mESCs, and with the 
chimaeras capable of germline transmission. The more commonly employed approach, 
however, is to generate chimaeras where the mESCs are injected into the ICM of diploid 
blastocysts and shown to contribute to all tissues of the animal including, preferably, the 
germline (Hentze et al., 2009). Less stringent tests of pluripotency are still informative. These 
include injecting cells under the kidney capsule of mice to produce teratomas containing cells 
derived from all 3 germ layers, and differentiation of the cells in tissue culture to produce cells 
from all 3 layers. For the latter, spontaneous differentiation to all 3 germ layers should occur 
with the removal of LIF. With hESC lines, teratoma formation (Hentze et al., 2009) and 
spontaneous differentiation in vitro (by removal or inhibition of Fgf2 and/or activin (James et 
al., 2005; Vallier et al., 2005)) have been the mainstay of assessing pluripotency. Recently, 
however, interspecies human–mouse chimeras have been made (to approximately the point of 
mouse mid-gestation) which strongly indicate pluripotent developmental potential of hESCs 
(Mascetti and Pedersen, 2016). 
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1.2.3 Regulation of pluripotency and self-renewal 
 
Unlike mammalian somatic cells, mESCs have a very short cell cycle (~12 h) (Orford and 
Scadden, 2008; Roccio et al., 2013), due in part to their (i) G1-phase lasting for only 1.5 h 
(Burdon et al., 2002) and (ii) lack of regulatory mechanisms that normally govern the G1-to-
S-phase transition (Roccio et al., 2013). The consequence is that mESCs undergo rapid cell 
division whilst maintaining pluripotency and self-renewal.  
 
The molecular circuitry at the heart of pluripotency and self-renewal is a core network of 
transcription factors comprised of Oct4, Nanog and Sox2 (Figure 1.6). The activity of this core 
network is delicately balanced and depends of the concentrations, interactions between, and 
various functions of the three principal transcription factors (Loh and Lim, 2011; Niwa et al., 
2000; Thomson et al., 2011; Xue et al., 2011). In particular, the transcription factors 
collectively regulate the expression of 353 genes, including themselves, as well as genes of the 
‘extended pluripotency network’, such as Fgf4, Rex1, Klf2 and Klf4 (Figure 1.6) (Boyer et al., 
2005; Okumura-Nakanishi et al., 2005; Xue et al., 2011). The purpose of the extended network 
is at least 2-fold: (i) Its circuitry feeds forward to sustain core network activity and (ii) it 
suppresses lineage commitment pathways (Casanova Eliza et al., 2011; Hall et al., 2009; Xue 
et al., 2011; Ivanova et al., 2006; Morris 2012; Boyer et al., 2005) (Figure 1.6) through, for 
example, promotion of the addition of repressive epigenetic marks to lineage-commitment 
genes. Many differentiation-associated genes contain bivalent histone modifications such that 
they have both active (H3K4me3) and repressive (H3K27me3) epigenetic marks (Bernstein et 
al., 2006). Genes exhibiting this profile (the majority of which are transcription factors, 
morphogens and cell surface molecules involved in developmental progression) are thought to 
be ‘primed’ for transcription when the conditions are favourable (Bernstein et al., 2006; Voigt 
et al., 2013). In comparison, the promoter regions of Oct4, Sox2 and Nanog are 
hypomethylated, enabling robust transcription from the genes of the core pluripotency network. 	
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Figure 1.6: Regulation of the core and extended pluripotency networks in mouse embryonic stem 
cells. Maintenance of pluripotency and self-renewal is governed by external stimuli (red), which act on 
various signalling pathways (green) that regulate the expression of the core (purple) and extended (blue) 
pluripotency networks. In turn, the expression of various transcription factors involved in this core 
circuitry regulate their own expression, as well as the expression of other factors involved in 
differentiation and/or self-renewal (orange). Figure produced from: (Hirai et al., 2011; J. Hall et al., 
2009; Niwa et al., 2009; Do et al., 2013; Posfai et al., 2014; Chen et al., 2008; Paling et al., 2004; 
Jirmanova et al., 2002; Storm et al., 2009; Storm et al., 2007; Mitsui et al., 2003; Hamilton and 
Brickman 2014; Binétruy et al.,  2007; Hamazaki et al.  2006; Kim et al.  2012; Lee, 2013; Nichols and 
Smith 2012; Kunath et al., 2007; Wray et al., 2011; Marks et al., 2012; Tosolini and Jouneau 2015; 
Medvedev et al., 2008; Ying et al., 2003; Romero-Lanman et al., 2012). Figure composed with 
assistance from Glover, H. 
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The net output of these interconnected circuits keeps ESCs poised: The activity of the core 
network is such that self-renewal and pluripotency are maintained but the system can rapidly 
tip over into differentiation (Figure 1.7). This can be achieved, for example, by perturbing the 
expression of one or more pluripotency network factors or by exposing cells to appropriate 
lineage commitment signals (Thomson et al., 2011). Pluripotency factors themselves can also 
act as lineage specifiers (Loh and Lim, 2011): A 2-fold increase in Oct4 expression promotes 
mesendoderm differentiation (Niwa et al., 2000), whilst overexpression of Sox2 favours 
neurectoderm and represses mesendoderm differentiation (Thomson et al., 2011). 
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Figure 1.7: Cell signalling events that mediate the switch between self-renewal and differentiation 
in mouse embryonic stem cells. (A) LIF binds to the LIF-receptor (LIFR) resulting in 
heterodimerisation with glycoprotein-130 (gp130). Downstream JAK proteins become phosphorylated, 
and in their active state, they phosphorylate tyrosine residues on the receptor complex. STAT3 can then 
dock to the receptor, is then phosphorylated at Y705, and homodimerises before translocating to the 
nucleus where it induces the transcription of self-renewal genes. LIF also activates the PI3K pathway, 
in which PIP2 is converted to PIP3 resulting in the downstream phosphorylation of AKT at S473 and T308. 
This enhances self-renewal by up regulating the expression of Nanog, and by promoting cell cycle. (B) 
BMP4 binds to its cognate BMP-receptor (BMPR) resulting in the phosphorylation of SMAD1/5/8. 
Once phosphorylated, SMAD1/5/8 forms heterodimers with SMAD4, and this heterodimer translocates 
to the nucleus and results in the transcription of inhibitor-of-differentiation (Id) genes. SMAD signalling 
also results in the up-regulation of the phosphatase DUSP9 which acts as a negative regulator of ERK, 
thereby inhibiting differentiation. (C) LIF also activates the MAPK/ERK pathway to promote 
differentiation in the face of maintaining self-renewal (A, B). The balance can be tipped towards 
differentiation by the presence of Fibroblast Growth Factor (Fgf)-4, which up-regulates the activity of 
the MAPK/ERK pathways and (D) L-proline. L-proline enters the cell via the Sodium-coupled Neutral 
Amino Acid Transporter (SNAT)-2 where it activates mTOR to induce the differentiation of mESCs to 
early primitive ectoderm-like (EPL) cells. Image produced from: (Paling et al., 2004; Hirai et al., 2011; 
Hamilton and Brickman 2014; Binétruy et al., 2007; Ying et al., 2003; Romero-Lanman et al., 2012; 
Washington et al., 2010). Figure composed with assistance from Glover, H. 	
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1.2.4 LIF-mediated signalling and the control of mESC self-renewal 
 
LIF exerts its effects on mESCs by binding to a receptor complex consisting of the LIF receptor 
(LIFR#) and the glycoprotein-130 (gp130). The signal is transduced via three main pathways: 
(1) JAK/STAT signalling, (2) PI3K/AKT signalling and (3) MAPK/ERK signalling (Figure 
1.7) (for a detailed review see (Hirai et al., 2011)). The first two pathways promote self-renewal 
while the third promotes differentiation. Under self-renewing conditions, the balance lies in 
favour of self-renewal but with the cells poised to differentiate. 
 
 
1. JAK/STAT3 signalling 
LIF binds to the LIFR-gp130 complex resulting in phosphorylation and homodimerisation of 
the transcription factor STAT3 (Figure 1.7). Activation of this pathway leads to the up-
regulation of target transcription factors including Kruppel-like zinc finger (Klf4), which 
preferentially activates the expression of Sox2. Sox2 protein forms a heterodimer with Oct4 
(Hall et al., 2009; Niwa et al.,  2009), which binds the Oct-Sox elements in promoter regions 
of target genes including Oct4 and Sox2 themselves, as well as Nanog (Chen et al., 2008; Do 
et al., 2013; Posfai et al., 2014), resulting in a self-reinforcing mechanism for maintaining the 
activity of the core pluripotency network and hence self-renewal (Figure 1.6). 
  
2. PI3K/AKT signalling 
Stimulation of the LIF receptor complex concurrently activates the class IA family of lipid 
kinases known as phosphatidylinositol-3 phosphate kinases (PI3K) (Figure 1.7). Through the 
downstream phosphorylation of AKT at threonine-308/serine-473 (T308/S473), cell cycle 
progression/proliferation is stimulated and, and as with the STAT3 pathway, self-renewal is 
maintained (Jirmanova et al., 2002; Paling et al., 2004). In the presence of the PI3K inhibitors, 
LY294002 or Deltap85, a reduced ability to self-renew is observed with the increased 
propensity of cells to undergo changes in morphology. Phosphorylated STAT3 levels are not 
altered, thus suggesting an independent mechanism by which PI3K maintains the self-renewal 
(Paling et al., 2004). The PI3K/AKT pathway activates the transcription of T-box (Tbx)-3, 
which is primarily responsible for up regulating the expression of Nanog (Figure 1.6) (Niwa et 
al., 2009; Storm et al., 2007, 2009). Nanog–/– mESCs are still capable of self-renewal (probably 
due to the compensatory mechanisms involving Oct4 and Sox2) and have a greater propensity 
to differentiate into Gata6+ extraembryonic endoderm (Mitsui et al., 2003).  
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3. MAPK/ERK signalling 
In the presence of LIF, mESCs retain the ability to self-renew. However, they must also be able 
to finely balance this with the ability to differentiate when stimulated to do so. The balance 
between self-renewal and differentiation is, in part, tightly regulated by LIF-mediated co-
stimulation of the (MAPK)/Extracellular signal-regulated kinase (ERK) pathway (Figure 7) 
(Binétruy et al., 2007; Hamilton and Brickman, 2014). Unlike the LIF-mediated JAK/STAT 
and PI3K/AKT pathways (which both promote self-renewal), the MAPK/ERK pathways is 
involved in promoting differentiation. LIF-mediated MAPK/ERK pathway represses the 
expression of Tbx3, Klf4 and Nanog (Hamazaki et al., 2006; Kim et al., 2012; Niwa et al., 
2009), thereby poising mESCs for differentiation when conditions are favourable.  
 
When cultured in the presence of LIF (to activate JAK/STAT signalling) plus the MEK 
inhibitor (PD0325091) and glycogen synthase kinase (GSK)-3# inhibitor (CHIR99021) (also 
known as the 2i + LIF system), mESCs are maintained in a naive ground-state (Marks et al., 
2012; Tosolini and Jouneau, 2015; Wray et al., 2011): MAPK/ERK pathway activity is no 
longer present to poise the system and CHIR99021 makes the cells resistant to other pro-
differentiation signals such as Fgf4 (Kunath et al., 2007; Lee, 2013; Nichols and Smith, 2012).  
 
1.2.5 BMP4-mediated signalling in mESCs suppresses lineage commitment 
 
BMP4, together with LIF regulates the expression of genes within the core and extended 
pluripotency networks as well as inhibiting genes involved in lineage commitment (Chen et 
al., 2008; Medvedev et al., 2008; Ying et al., 2003) (Figure 1.6). BMP4-mediated SMAD1/5/8 
signalling inhibits differentiation by inducing transcription of inhibitor of differentiation (Id) 
genes (specifically Id1) which act to repress lineage commitment during early embryogenesis 
(Figure 1.7) (Ying et al., 2003). Overexpression of Id1 in mESCs maintains self-renewal even 
in the absence of LIF and serum through up-regulation of Nanog expression (Ying et al., 2003; 
Romero-Lanman et al., 2012). In contrast, Id1−/− mESCs fail to self-renew and preferentially 
differentiate into Brachyury+ mesendoderm-derived cells (Romero-Lanman et al., 2012).  
 
BMP4 also supports self-renewal by attenuating the activity of differentiation-inducing 
MAPK/ERK pathway via upregulation of the expression of  the phosphatase DUSP9 (Li et al., 
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2012) (Figure 1.7). DUSP9 dephosphorylates ERK in mESCs (but not somatic cells) and its 
overexpression in mESCs results in further reduction of phosphorylated ERK (Li et al., 2012). 
In contrast, siRNA knockdown of DUSP increases ERK activity even in the presence of BMP4 
resulting in decreased expression of Nanog and Rex1 mRNA as well as decreased alkaline 
phosphatase staining (Li et al., 2012), all of which are hallmarks for movement away from 
pluripotency.  
 
Thus, provided the external environment continues to supply sufficient concentrations of LIF 
and BMP4 to mESCs, both the core and extended pluripotency networks will have sufficient 
activity and lineage commitment pathways will be sufficiently repressed to maintain 
pluripotency and self-renewal over extended periods of time. Once loss of pluripotency is 
instigated, however, BMP4 plays roles which then promote various stages of embryological 
development. For example, BMP4 is known to be a potent inducer of differentiation that is 
required for patterning definitive ectoderm in the embryo along the proximal/distal axis (see 
section 1.1.4). Similarly, once loss of pluripotency occurs in mESCs, BMP4 acts to direct 
lineage commitment; e.g., the production of mesendoderm and epidermal populations is 
favoured over neurectoderm (Ying et al., 2003; Harvey et al., 2010; Zhang et al., 2010; 
Romero-Lanman et al., 2012). 
 
1.2.6 The transition of embryonic stem cells to early primitive ectoderm-like 
cells 
 
In the mouse embryo, the pluripotent ICM transitions to the pluripotent primitive ectoderm due 
to the dynamic interplay of cell signalling, epigenetic modifications and cell metabolism and 
which also prepare the primitive ectoderm for gastrulation and loss of pluripotency. mESCs 
share genetic, metabolic and phenotypic qualities with their ICM counterparts (Table 1.1) and 
can respond to instructions from the extracellular environment that mediate cell fate in ways 
similar to those that occur during development. Therefore, mESCs have been used as a tool to 
investigate the molecular mechanisms governing the transition of the ICM to primitive 
ectoderm and subsequent differentiation to the germ layers.  					
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Table 1.1: Comparison of mouse embryonic stem cells (mESCs) and early primitive ectoderm-
like (EPL) cells. 
 mESCs EPL cells References  
In vivo 
equivalent  Inner cell mass Primitive ectoderm 
(Rathjen et al., 1999; Washington et al., 
2010; Casalino et al., 2011) 
Potency Pluripotent Pluripotent (Rathjen et al., 1999; Washington et al., 2010; Casalino et al., 2011) 
Lineage 
contribution 
Primitive ectoderm 
Primitive endoderm  
Definitive endoderm 
Definitive mesoderm 
Definitive ectoderm 
Germ cells 
(Loebel et al., 2003; Chenoweth et al.,  
2010) 
Chimera 
formation? Yes No (Rathjen et al., 1999) 
Gene and 
protein 
expression  
*denotes 
marker 
expression 
Oct4 Oct4 
(Okuda et al., 1998; Rathjen et al., 1999; 
Pelton et al., 2002; Harvey et al., 2010; 
Washington et al., 2010) 
Sox2 Sox2 
Nanog Nanog 
* Rex1 *Fgf5 
SSEA-1/2 *Dnmt3b 
Alkaline 
phosphatase 
Alkaline 
phosphatase 
Psc1   
Crtr1   
UTF1   
Colony 
phenotype 
Round, dome 
shaped, defined 
colony borders 
Flat, epithelial, 
visible individual 
cells 
(Rathjen et al., 1999; Washington et al., 
2010) 
Major extrinsic 
factors 
required for 
maintenance 
LIF and BMP4 LIF and L-proline 
(Raz et al., 1999; Burdon et al., 2002; 
Gangloff et al., 2004; Niwa et al., 2009; 
Washington et al., 2010) 
Major 
signalling 
pathways 
required for 
maintenance 
STAT3, PI3K/AKT, 
SMAD1/5/8 mTOR, MAPK/ERK 
(Burdon et al., 2002; Gangloff et al., 
2004; Niwa et al., 2009; Raz et al., 1999; 
Washington et al., 2010) 
Cell cycle time ~ 12 h ~ 8 h 
(Burdon et al., 2002; Ciemerych and 
Sicinski, 2005; Orford and Scadden, 
2008; White and Dalton, 2005) 
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This ICM-to-primitive ectoderm transition can be recapitulated in vitro using mESCs cultured 
in the presence of the conditioned medium from HEPG2 cells, MEDII (Rathjen et al., 1999). 
HEPG2 cells are an immortal human liver cancer cell line that express a similar gene and 
secreted-protein expression profile to both the mouse visceral yolk sac and foetal liver (Meehan 
et al., 1984; Shi and Heath, 1984). Given the role that the visceral endoderm plays in the 
transition of the ICM to primitive ectoderm (see section 1.1.1), it was hypothesized that MEDII 
would contain biologically active factors that would induce the transition of mESCs to early 
primitive ectoderm-like (EPL) cells. Fractionation of MEDII revealed the non-essential amino 
acid L-proline as a bioactive molecule involved in this differentiation process (Rathjen et al., 
1999; Washington et al., 2010). The concentration of L-proline contained in MEDII (~150 µM) 
is similar to that found in murine tubal fluid (Kermack et al., 2015; Washington et al., 2010).  
 
mESCs cultured in MEDII give rise to a homogenous population of pluripotent EPL cells that 
are phenotypically and genetically distinguishable from mESCs (Rathjen et al., 1999; 
Washington et al., 2010). EPL cells have down-regulated expression of the mESC markers 
Nanog, Rex1 and the cell surface marker Stage-Specific Embryonic Antigen (SSEA)-1. The 
expression of the primitive ectoderm marker Fgf5 is up-regulated as is that of Dnmt3b, whilst 
the expression of the pluripotency marker Oct4 is maintained (Harvey et al., 2010; Rathjen et 
al., 1999, 2002). Dnmt3b is suggested to function as a silencer of Nanog expression by 
methylating the Nanog promoter (Li et al., 2007). 
  
	
1.2.7 The effect of amino acids on ESCs 
 
It is now clear that specific amino acids can strongly influence the emergent properties of ESCs, 
including self-renewal versus differentiation, rate of proliferation, apoptosis, cell shape change, 
ESC-to-mesenchymal transition (esMT) and its reverse (MesT) (Casalino et al., 2011; Chen 
and Wang, 2014; Comes et al., 2013; Kilberg et al., 2016; Shan et al., 2013; Shiraki et al., 2014; 
Washington et al., 2010).  
 
L-glutamine (Carey et al., 2014) and L-threonine (Chen and Wang, 2014; Ryu and Han, 2011) 
in mESCs (or L-methionine instead of L-threonine in hESCs (Chen and Wang, 2014; Shiraki 
et al., 2014)) maintain self-renewal and growth/survival. In contrast, L-proline induces 
differentiation to EPL cells, increases the rate of proliferation, and induces a change to flattened 
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monolayer colonies in which cells undergo an esMT (Casalino et al., 2011; Comes et al., 2013; 
D’Aniello et al., 2015) 
 
Each of these amino acids control the emergent properties of ESCs using a broad spectrum of 
molecular machinery including signalling pathways, translational control, transcription factor 
regulatory networks, and modulation of the epigenetic landscape (Figure 1.6) (Casalino et al., 
2011; Chen and Wang, 2014; Comes et al., 2013; D’Aniello et al., 2015; Ryu et al., 2015; Ryu 
and Han, 2011; Shiraki et al., 2014; Shyh-Chang et al., 2013). A significant contributor to the 
last of these is the flux through, and the products produced by, the metabolic pathways specific 
to each amino acid, which lead to amino-acid-specific modulation of the epigenetic programs 
at both the DNA and histone levels (see below) (Carey et al., 2014; Comes et al., 2013; Shiraki 
et al., 2014). These amino acids also stimulate common signalling pathways including ERK, 
PI3K/AKT and mTORC1 (Carey et al., 2014; D’Aniello et al., 2015; Ryu et al., 2015; Ryu and 
Han, 2011; Shiraki et al., 2014; Washington et al., 2010), and this signalling takes place in 
conjunction with the common signalling milieu mediated by the presence of LIF and BMP4 
(see above) (Figure 1.7). Yet the cellular response of mESCs to L-proline is very different to 
that of L-glutamine and L-threonine. This indicates that the emergent properties of the ESC 
system can be very different even when the molecular mechanisms at play are largely similar. 
This is consistent with ESCs acting as a complex self-renewing and pluripotent system poised 
for differentiation and in which subtle changes to the activity of common molecular 
mechanisms, in addition to amino-acid-specific mechanisms, can result in very different cell 
fates. 
 
Two of these amino acids, L-threonine and L-methionine, are EAAs and therefore maternal 
sources of them are a requirement for normal mammalian development. The other two, L-
glutamine and L-proline, are conditionally-EAA; i.e., they can be produced within embryonic 
cells but not necessarily manufactured at a sufficient rate to drive all aspects of normal 
development (Wu, 2013; Wu et al., 2013). Thus, for these conditionally-EAAs, maternal 
supplementation is required for the embryo to pass some key developmental milestones. 
Threshold or higher concentrations of L-glutamine and/or L-proline in the maternal 
environment (e.g., in the tubal fluid) may be indicators of normal nutritional balance and act 
as ‘go signals’ for pregnancy/embryo development to continue.  
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1. L-glutamine acts as a survival and self-renewal factor for ESCs 
In mammalian cells, L-glutamine can be synthesized de novo from glucose via the tricarboxylic 
acid cycle (TCA) intermediate α-ketoglutarate (αKG) and L-glutamate. mESCs grown in the 
presence of serum and LIF plus exogenously added L-glutamine proliferate rapidly: The L-
glutamine provides a source of precursors for protein, purine and pyrimidine synthesis required 
for rapid cell division, and feeds back into the TCA cycle via L-glutamate and αKG to maintain 
anaplerosis. However, as with many types of mammalian cell, removal of exogenous L-
glutamine from the medium of mESCs halts proliferation (Carey et al., 2014). I.e., this amino 
acid is conditionally required as it cannot be synthesized in sufficient quantity de novo to meet 
mESCs’ proliferative capacity.  
 
Removal of L-glutamine also results in the down-regulation of expression of a number of 
pluripotency factors such Oct4, Rex1, and Nanog and the up-regulation of expression of 
trophectoderm and mesoderm markers. Conversely, the presence of L-glutamine inhibits 
differentiation and promotes mESC self-renewal and pluripotency (Ryu et al., 2015).  
 
These cellular responses to L-glutamine depend on its ability to rapidly up-regulate the 
PI3K/AKT pathway, which, via PKC and ERK, stimulates the mTORC1 pathway (Ryu et al., 
2015). Collectively, the flux through these pathways (i) maintains self-renewal and 
pluripotency by enhancing the expression of pluripotency markers, (ii) stimulates proliferation 
through up-regulation of the expression of cell-cycle proteins, (iii) enhances acetylation at 
specific marks on Histone 3 by inhibiting the expression of the histone deacetylase HDAC1, 
and (iv) results in hypomethylation of DNA through inhibition of DNA methyltransferases 
Dnmt3a and Dnmt3b. In particular, these histone and DNA modifications occur at the Oct4 
gene, resulting in enhanced expression of Oct4 and therefore increased activity of the core 
pluripotency network (Ryu et al., 2015).  
 
These effects by L-glutamine first depend on its conversion to L-glutamate, as inhibition of 
glutaminase, which converts L-glutamine to L-glutamate, blocks the effects (Ryu et al., 2015). 
L-glutamate can then be converted to the TCA-cycle intermediate αKG, thereby maintaining a 
high αKG-to-succinate ratio. A high ratio up-regulates the activity of both Jumonji C-domain-
containing histone demethylases and Tet family DNA demethylases. The extent and specificity 
of epigenetic modification via these demethylation mechanisms presumably complement those 
L-glutamine-regulated mechanisms (described above) involving increased histone acetylation 
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(via inhibition of HDAC expression) and DNA hypomethylation (via inhibition of DNMT 
expression) (Ryu et al., 2015). The result is a complex epigenetic landscape which allows 
mESCs to self-renew but poises the cells for rapid differentiation should the correct signals 
become available.  
 
Details of the role of the mTORC1 pathway in maintaining this L-glutamine-mediated mESC 
identity, presumably via its control of CAP-dependent and independent mRNA translation, 
remain poorly understood at this stage. 
 
2. L-threonine/L-methionine acts as a survival and self-renewal factor for ESCs 
Like L-glutamine, the restriction of L-threonine in the culture medium of mESCs results in 
greatly reduced proliferation, reduced expression of many self-renewal markers and increased 
expression of trophectoderm and mesoderm markers. The addition of L-threonine reverses 
these effects (Ryu and Han, 2011). 
 
Although ESCs are metabolically fairly quiet, their rapid proliferation requires bases for DNA 
synthesis. Partly to satisfy this demand, mESCs have a ‘high-flux backbone’ of metabolic 
activity involving threonine dehydrogenase (TdH), whose activity is 200-1000x higher than 
many other cells and tissues and which is rapidly down-regulated upon mESC differentiation 
(Shyh-Chang et al., 2013; Wang et al., 2009, 2011) Amongst other things, this backbone 
supplies metabolites that can be used in purine biosynthesis necessary for cell-cycle 
progression (Wang et al., 2009). 
 
A second consequence of this highly active metabolic circuitry is the maintenance of a high 
ratio of S-adenosylmethionine to S-adenosylhomocysteine (SAM/SAH). SAM is the universal 
substrate for protein methyltransferases, including histone methyltransferases, and these 
reactions are product-inhibited by SAH. The high SAM/SAH ratio results in maintenance of 
H3K4me3 (Shyh-Chang et al., 2013), a permissive expression mark critical for mESC self-
renewal (Shyh-Chang et al., 2013; Bernstein et al., 2006; Ang et al., 2011). Other H3 lysine 
methylation marks are not sensitive to the presence or absence of L-threonine (Shyh-Chang et 
al., 2013). This selectivity is due in part to the Trithorax group of proteins, which complexes 
with histone methyltransferases that methylate H3K4. In particular, the Trithorax group 
component Wdr5 binds to Oct4 thereby helping to target H3K4 trimethylation, and up-regulate 
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expression, of genes in the core and the extended pluripotency networks (Ang et al., 2011; 
Bernstein et al., 2006). 
 
As with L-glutamine, L-threonine rapidly activates a range of signalling pathways: ERK, p38, 
JNK/SAPK and the mTORC pathways all appear to be activated following initial activation of 
PI3K/AKT. Inhibition of these cooperating pathways (e.g., by the use of wortmannin to inhibit 
PI3K/AKT or rapamycin to inhibit mTORC1) prevents L-threonine-induced maintenance of 
self-renewal and proliferation (Ryu and Han, 2011). 
 
In humans, TdH is expressed as a nonfunctional pseudogene and hESCs cannot rely on 
maintaining SAM/SAH ratios via L-threonine metabolism. Instead, they strongly up-regulate 
flux through the L-methionine cycle, which lies downstream of TdH, and in which the 
conversion of L-methionine to SAM is catalysed by methionine adenosyltransferases (Shiraki 
et al., 2014).  
 
3. L-proline stimulates differentiation of mESCs 
The delicate balance of LIF-mediated pathway activities which maintains mESC self-renewal 
(section 2.4) is tipped by the exogenous addition of L-proline resulting in the differentiation of 
mESCs to EPL cells (Casalino et al., 2011; Lonic, 2007; Tan et al., 2016; Washington et al., 
2010) 
 
L-proline effects changes in a wide range of emergent properties in mESCs including an esMT, 
apoptosis, increased proliferation, as well as differentiation. As with the effects of other amino 
acids, a large number of interconnected mechanisms are involved, consistent with the response 
of a complex system. These include cell signalling, proline metabolism, autophagy, and 
changes in gene expression and the epigenetic landscape (Casalino et al., 2011; Comes et al., 
2013; D’Aniello et al., 2015; Lonic, 2007; Tan et al., 2011, 2016; Washington et al., 2010).  
 
L-proline enters mESCs via the sodium-coupled neutral amino acid transporter SNAT2 (Tan 
et al., 2011; Washington et al., 2010). There is prompt activation of the amino-acid sensing 
mTORC1 signalling pathway (Tan et al., 2011; Washington et al., 2010), the differentiation-
inducing MEK/ERK pathway (Lonic, 2007), and the p38 pathway (Figure 1.7) (Tan et al., 
2016). Inhibitors of each pathway prevent EPL-cell formation, indicating that each pathway is 
necessary but not sufficient for differentiation (Harvey et al., 2016; Lonic, 2007; Tan et al., 
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2011, 2016; Washington et al., 2010). L-leucine and glycine activate the mTORC1 signalling 
pathway but fail to induce the transition, also indicating this pathway is not sufficient for the 
transition (Washington et al., 2010). The fact that many of these pathways also respond to L-
glutamine and L-threonine, with the result that mESC self-renewal is maintained rather than 
differentiation induced, is again indicative of the delicately poised state of these cells between 
very different fates. 
 
mTORC1 activity is known to regulate the activity of proteins involved in cell cycle 
progression such as c-Myc and cyclin-D (Mendoza et al., 2011). This is consistent with the 
increased cell numbers observed upon the addition of L-proline to mESCs and the reduction in 
numbers when the mTORC1 inhibitor, rapamycin, is added (Tan et al., 2011; Washington et 
al., 2010). 
 
During early embryonic development, the importance of mTOR signalling is shown by  
mTOR–/– mouse embryos, in which the ICM and trophectoderm exhibit reduced proliferation 
and differentiation, and embryonic lethality just prior to implantation (Gangloff et al., 2004; 
Murakami et al., 2004). The mechanisms have not been elucidated but the results from mESCs 
are likely to provide important leads. 
 
L-proline triggers changes to the epigenetic landscape of mESCs, which are required for the 
esMT (Comes et al., 2013). In particular, L-proline enhances methylation at H3K9 and H3K36. 
On the other hand, vitamin C, a cofactor for Jumonji domain demethylases, reduces 
methylation at H3K9 and H3K36 and results in a MesT (Comes et al., 2013). 
 
As with L-threonine and L-glutamine, the effect of L-proline on mESCs depends, in part, on 
its metabolism and intracellular concentration. Due to its pyrrolidine ring, L-proline has a 
unique metabolism, via the proline cycle, which appears to contribute to differentiation 
(Casalino et al., 2011). In addition, though L-proline is usually considered a non-essential 
amino acid because it can be synthesised endogenously, mESCs limit their intracellular 
concentration of L-proline to about one quarter of that found in EPL cells and one tenth that 
found in mouse embryonic fibroblasts (D’Aniello et al., 2015). This self-limiting production is 
sufficient to allow mESC survival whilst maintaining mESC identity and proliferation rate but 
is insufficient to promote the esMT and differentiation (D’Aniello et al., 2015).  
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The balance between these very different fates is controlled in part by an autoregulatory loop 
mediated by the Gcn2-Eif2α-Atf4 axis and its control of the amino-acid starvation response 
(AAR) pathway (Figure 1.8) (D’Aniello et al., 2015; Harding et al., 2003). In the proline-
starved state, free prolyl-tRNA (i.e., not loaded with proline) binds Gcn2, which up-regulates 
AAR pathway activity including expression of genes in, for example, transport and synthesis 
of amino acids. In particular, the transcription factor Atf4 selectively up-regulates the 
expression of the enzymes responsible for the production of L-proline from L-glutamate 
(Figure 1.8). There is also, however, a concomitant general suppressing effect on translation, 
consistent with the conservation of energy in a low-nutrient environment. Negative feedback 
occurs when the L-proline that is endogenously produced reduces the pool of free prolyl-tRNA 
(D’Aniello et al., 2015).  																
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Figure 1.8: Model of L-proline- (L-pro) mediated differentiation from mESCs to EPL cells. L-Pro 
enters the cell via the SNAT2 transporter (Tan et al., 2011) where it (A) acts on various signalling 
pathways including the amino acid-sensing signalling mTOR pathway, as well as the ERK and P38 
pathways to induce differentiation (Lonic, 2007; Tan et al., 2016; Washington et al., 2010). (B) L-Pro 
is also metabolized in the mitochondria via the proline cycle. L-pro stimulates both glycolysis via the 
pentose phosphate pathway (PPP) and oxidative phosphorylation (OxPhos) via the breakdown of 
glutamate (Glu) into L-pro. Endogenous L-pro production from Glu is catalyzed by the enzymes 
pyrroline-5-carboxylate (P5C) synthase (P5CS) and reductase (P5CR) (Browne, 2017; Pandhare et al., 
2009; Phang et al., 2010; Vuong, 2017; Yurka, 2015). (C) When the cell is starved of L-pro, the amino 
acid response pathway is activated, to regulate L-pro production and uptake in the cell (D’Aniello et 
al., 2015). Figure composed with assistance from Glover, H. 
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When L-proline is added exogenously, this autoregulation is overwhelmed: The AAR pathway 
shuts down and its generalized suppression of translation is lifted allowing L-proline-mediated 
differentiation, esMT, and reduced cell-cycle time leading to increased proliferation (D’Aniello 
et al., 2015). The relief of translation suppression is probably also mediated by L-proline-
mediated up-regulation of the mTORC1 pathway (Washington et al., 2010) which controls 
CAP-dependent and CAP-independent translation. mESCs are also in relative torpor with 
respect to translation given that ribosomal machinery is abundantly available but poorly loaded 
with mRNA (Sampath et al., 2008). It is not known to what extent, if at all, the addition of L-
proline awakens mESCs from this form of torpor by facilitating ribosomal loading. 
 
These data contribute to a rapidly evolving paradigm across various fields of cell biology: That 
changes in metabolism are not merely passengers to differentiation but drivers of it. L-proline-
mediated differentiation of mESCs appears to be the first example of an amino acid effecting 
metabolism-based differentiation. In particular, mESCs appear primed to meet the metabolic 
load required for differentiation but will not do so until selected nutrients are available. 
Exogenous sources of L-proline may provide the key to unlocking this machinery within the 
embryo to allow normal development to proceed.  
 
1.2.8 MEDII treatment of mESCs produces a transient population 
consistent with definitive ectoderm  
 
The mechanisms driving the formation of definitive ectoderm are the least understood of the 
three germ layers. Mechanistic models of both neurectoderm and surface ectoderm induction 
from ESCs have been developed (Troy and Turksen, 2005; Engberg et al., 2010; Zhang et al., 
2010; Tonge and Andrews, 2010) but the intermediate formation of definitive ectoderm has 
generally been ignored. The use of MEDII has led to the proposal that Penk1 and Pard6b are 
markers of the definitive ectoderm population (Harvey et al., 2010): mESCs cultured as 
embryoid bodies (EBs) in the presence of MEDII differentiate to an Fgf5+/Dnmt3b+ EPL-cell 
population and eventually to a homogenous Sox1+ neurectoderm population (Harvey et al., 
2010). Between the loss of pluripotency and the up-regulation of Sox1, a transient population 
of Penk1+ and Pard6b+ cells arise between days 6–7 of culture (Harvey et al., 2010). This 
population is bipotent with properties consistent with that expected for definitive ectoderm: 
Treatment of this intermediate population with BMP4 rapidly stimulates SMAD signalling and 
after 2 days gives rise to K18+ epithelial cells with lowered nuclear:cytoplasmic ratio and well-
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defined intercellular junctions characteristic of epidermal progenitor cells associated with 
surface ectoderm (Harvey et al., 2010). In contrast, treatment of the intermediate population 
for 2 days in the absence of BMP4 produces rosette-forming neural cells with a higher 
nuclear:cytoplasmic ratio, axonal projections, and expression of NeuN (Harvey et al., 2010). 
Confirmation that Penk1 and Pard6b are markers of definitive ectoderm might come from 
observing their transient expression restricted to the definitive ectoderm of the mouse embryo. 
 
1.2.9 Neurectoderm induction and subsequent differentiation  
 
As with the embryo, Sox1, is the earliest expressed neurectoderm marker in differentiated 
mESCs upon neurectoderm induction (Aubert et al., 2003; Pevny et al., 1998). When mESCs 
are cultured in conditions that permit neurectoderm differentiation (low plating density, serum-
free medium supplemented with N2 and B27) they firstly undergo rapid down-regulation of 
Oct4, followed by the up-regulation of Fgf5 (Ying et al., 2003; Lowell et al., 2006). Under 
these same conditions, about 60% of 46C mESCs express Sox1 (as measured by a GFP reporter 
cell line) by day 4 of monolayer culture, followed then by the early neural progenitor marker 
Nestin by days 5–6 (Lowell et al., 2006). Furthermore, forced expression of Sox1 in mESCs 
triggers differentiation to neurectoderm (Suter et al., 2009), presumably via an Fgf5+ 
intermediate EPL-cell type, whilst siRNA knock-down of Sox1 in neurectoderm cells induces 
them to differentiate to Pax6+ RG cells (Suter et al., 2009). RG cells are considered the primary 
progenitor cell population of the embryonic nervous system that give rise to both neurons and 
glia via IPCs  (discussed in section 1.1.8; Figure 1.5) (Borrell and Götz, 2014; Pollard and 
Conti, 2007). Overexpression of Pax6 in mESCs induces the differentiation of 
BLBP+/Vimentin+ RG cells that later give rise into β-tubulinIII+/NeuN+ post-mitotic neurons 
(Suter et al., 2009). Pax6 is thus a key regulator involved in mediating the switch between 
mouse neurepithelial self-renewal and radial glial differentiation (Sansom et al., 2009). 
 
Since the initial ectopic transplantation experiments performed by Spemann and Mangold in 
1942 (Bouwmeester, 2001; Spemann and Mangold, 1924), much attention has been paid to the 
mechanisms driving neurectoderm induction. These experiments, initially performed in 
amphibians, introduced the concept of an organizer, which secretes signals to induce 
differentiation of nearby tissue. Rather than being instructive signals, many molecules shown 
to permit neurectoderm formation in the mouse (such as Chordin, Noggin and Follistatin) are 
antagonists of BMP4 signalling, which prevent downstream SMAD signalling (see section 
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1.1.6). Results from the following studies indicate that neurectoderm from ESCs arises by a 
default mechanism of differentiation (Tropepe et al., 2001; Munoz-Sanjuan and Brivanlou 
2002; Hemmati-Brivanlou and Melton 1997): (i) SMAD4–/– mESCs cultured in serum-free 
conditions even at a relatively high density (50 cells/µl) give rise to Nestin+ neural progenitors 
and then β3-tubulin+ neurons within 24 h (Tropepe et al.  2001). (ii) mESCs cultured with the 
BMP antagonist noggin or chordin (or transfected with a noggin or chordin expression plasmid) 
differentiate into neural cells within 24 h (Gratsch and O’Shea, 2002). (iii) hESCs cultured at 
low density with noggin differentiate into neural progenitor cells (Dottori and Pera, 2008). (iv) 
mESCs cultured at low density (104 cells/ml) in chemically defined medium for 4 hours 
differentiate to Sox1+ neurectoderm. This is followed by the differentiation to Nestin+ neural 
progenitors, and then β3-tubulin+ neurons after an additional 20 h, at the expense of mesoderm 
and endoderm cell types (Smukler, 2006). This occurs even when mESCs are cultured in 
phosphate-buffered saline (PBS) (although the cells do not remain viable after 24 h) (Smukler, 
2006).  
 
However, a number of instructive factors are also required to stimulate neurectoderm induction.  
E.g., retinoic acid (RA) (which is also instructive in vivo) is used frequently for in vitro 
differentiation of mESCs and hESCs to the neural lineage (Engberg et al., 2010; Stavridis et 
al., 2010; Tonge and Andrews, 2010). In mESCs, RA mediates its effects through the ERK 
signalling pathway, firstly by repressing Oct4 (Gu et al., 2005), followed by regulating Fgf 
signalling. 
 
Fgf4 is the primary inducer of ERK signalling in mESCs and this pathway poises them for 
differentiation when conditions are favourable (see section 1.2.4). Fgf4–/– mESCs exhibit 
decreased ERK activity and as a result, poor ability to differentiate into Fgf5+ cells and mature 
cell types of any lineage (Kunath et al., 2007). Whilst Fgf-mediated ERK signalling is initially 
required for progression into an EPL cell population from mESCs (Stavridis et al., 2007), its 
down-regulation is then required for neurectoderm induction to take place. When mESCs are 
cultured in the presence of 5 nM RA, ERK activity increases, such that the balance is tipped 
towards differentiation, and mESCs are liberated from their self-renewing state. Following a 
short burst of Fgf4-mediated ERK activity, Fgf8 mRNA is up-regulated (Stavridis et al., 2010). 
It is this Fgf8-mediated ERK activity which promotes exit from pluripotency and induces 
neurectoderm commitment (Stavridis et al., 2010). Together, these results suggest that Fgf4-
mediated ERK signalling is required to instruct the commitment of mESCs firstly to an EPL 
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cell intermediate population, and then, via Fgf8-mediated ERK activity to neurectoderm. 
Similarly, in hESCs, Fgf-mediated ERK1/2 signalling activates Poly-(ADP-ribose)-
Polymerase-1 (PARP-1) which binds directly to the Pax6 promoter (the first neurectoderm 
marker expressed in the human, followed closely by the expression of Sox1 (Pankratz et al., 
2007; Zhang et al., 2010)), resulting in neurectoderm induction (Yoo et al., 2011). 
Pharmacological inhibition of either the Fgf receptor, ERK1/2 or PARP-1 prior to the onset of 
neurectoderm induction decreases the percentage of Pax6+ and Sox2+ cells.  
 
In conjunction with Fgf-mediated ERK signalling, the Notch signalling pathway has also been 
implicated in neurectoderm induction and the regulation of neurectoderm proliferation and 
neuronal differentiation (Lowell et al., 2006). The Notch signalling pathway is an 
evolutionarily conserved pathway involved in cell fate determination at multiple stages of 
development, including neurectoderm induction (Lowell et al., 2006; Souilhol et al., 2015). 
Notch works in conjunction with Fgf signalling from ~7.5 dpc to maintain the neurepithelial 
pool, whilst blocking neurogenesis (Lowell et al., 2006; Souilhol et al., 2015). Notch ligand is 
cleaved by γ-secretase after binding to its reciprocal membrane receptor on a neighbouring cell 
(Kopan, 2012). Now in its activated form, the Notch Intracellular domain (NotchIC) 
translocates to the nucleus where it controls the transcriptional regulation of downstream target 
genes, including the repressor genes Hes1 and Hes5 (Ohtsuka et al., 1999). Inhibition of Notch 
signalling by the γ-secretase inhibitor L-685-458 in 46C mESCs (Ying et al.,  2003) results in 
few Sox1-GFP+ neurectoderm cells, most of which remain as Oct4+ mESCs. Similarly, genetic 
ablation of NotchIC binding partner, RBPJ, results in less than 10% of cells expressing the pan 
neural marker Sox2 as well as Pax6 and BLBP (Lowell et al.,  2006). In the presence of the γ-
secretase inhibitor DAPT, a significant increase in the expression of p63, a marker of early 
surface ectoderm commitment occurs in hESCs (Tadeu and Horsley, 2013). This suggests that 
not only is Notch important for neural induction but also acts to control the fate of the definitive 
ectoderm lineage by also inhibiting surface ectoderm production.  
 
Notch maintains the neurepithelial cell pool via activation of Hes1. Oscillations in Hes1 
expression have been observed in both mESCs and mouse neural stem cells and it is these 
oscillations that are believed to regulate the balance between proliferation and differentiation 
(Shimojo et al., 2008). In wild type neural stem cells, up-regulation of Hes1 prevents premature 
neuronal differentiation from neurectoderm cells by repressing the expression of proneural 
genes including Neurogenin2 and Mash1 (Pfeuty, 2015). Sustained expression of Hes1 in 
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mESCs inhibits neurectoderm induction (and preferentially induces mesoderm differentiation), 
presumably as a result of the negative feedback on Notch signalling (Kobayashi and 
Kageyama, 2010). 
 
During the mammalian cell cycle, the time taken to move through interphase (G1, S and G2), 
and, in particular, how long cells spend in G1, largely determines their fate (Calegari and 
Huttner, 2003; Lange and Calegari, 2014). Notch expression increases the expression of 
CyclinD1, Cdk6 and phospho-retinoblastoma protein (p-Rb) in both mESC-derived and hESC-
derived neurepithelial cells allowing them to readily progress through the G1/S phases of the 
cell cycle (Figure 1.9), thereby increasing proliferation rates (Borghese et al., 2010; Das et al., 
2010; Hardwick and Philpott, 2014). Overexpression of CyclinD1/Cdk4 significantly shortens 
the G1-phase in neural stem cells, allowing cell cycle progression and progenitor expansion to 
occur, whilst inhibiting neurogenesis (Lange et al., 2009).  Increases in PI3K and MAPK 
signalling accompany increases in Cdk6 and CyclinD1 mRNA expression: Inhibition of PI3K 
and MAPK by pharmacological inhibition (by Wortmannin and UO126 respectively) in the 
presence of Notch signalling, reduces the Notch-mediated effects on proliferation (Das et al., 
2010). In addition, Notch-mediated increases in Hes1 activity also represses genes involved in 
negatively regulating the G1 phase of the cell cycle (including p21 (Kabos et al., 2002) and 
p27 (Murata et al., 2005)).  
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Figure 1.9: Notch signalling promotes cell cycle progression and inhibits neurogenesis. During the 
mammalian cell cycle, the length of time in takes cells move through interphase (G1, S and G2) and, in 
particular, how long they spend in G1, largely determines their fate. Transition between stages of the 
cell cycle is driven by a series of cyclin-dependent kinases (Cdks) binding to specific Cyclins to promote 
cell cycle progression. Notch signalling increases the expression of both CyclinD and Cdk4/6, indirectly 
allowing cells to progress past the restriction checkpoint (R) and through G1 promoting proliferation. 
Notch also inhibits the cell-cycle inhibitors p21 and p27, which also helps promote proliferation and 
helps prevent the expression of genes involved in neurogenesis such as Nestin and Neurogenin1/2. As 
a result, cells remain as proliferative, self-renewing neural stem cells. Figure composed with assistance 
from Glover, H. 	
Cell-cycle regulation within the developing CNS acts to regulate the balance of stem cells, 
progenitors, neurons and glia. Just prior to undergoing differentiation into neuronal fates, 
neural progenitor cells have an overall increased cell cycle length due to an increase in the 
length of time they remain in G1 phase (Calegari et al., 2005). Taken together, these data 
suggest that the length of time in which a neurepithelial cell remains in G1 phase is a 
determinant of differentiation (Calegari et al., 2005).  
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1.2.10   L-proline-mediated neurectoderm induction  
 
As discussed above, mESCs cultured in the conditioned medium MEDII undergo 
differentiation through EPL cell, definitive ectoderm-like cells and neurectoderm populations, 
followed by mature neuronal differentiation in the presence of serum-free (F12:DMEM) 
medium (Harvey et al., 2010; Rathjen et al., 2002). mESCs cultured under these conditions 
therefore recapitulate early embryonic neural development (Rathjen et al., 2002). L-proline is 
the bioactive molecule found within MEDII (Washington et al., 2010). Perhaps significantly, 
L-proline is also present in relatively high concentrations (compared to other amino acids) in 
F12 Serum-Free Medium (0.3 mM) which is commonly incorporated into neural differentiation 
protocols (Aubert et al., 2003; Lowell et al., 2006; Harvey et al., 2010). Whilst this medium is 
free of BMP sources (which according to the default pathway of neural development, inhibit 
neural induction), could the presence of L-proline actually be contributing to instructive neural 
induction and neural maturation? Given the role that L-proline plays in the transition of mESCs 
to EPL cells at a cell signalling, metabolic and epigenetic level, it is likely that L-proline plays 
a similar complex role in controlling the emergent properties required for neural-lineage 
commitment from the EPL-cell stage. However, this has not been tested yet, and thus forms 
the basis of this thesis.  
 
Understanding these complex mechanisms that L-proline may play in differentiation towards 
the neural lineage will be two-fold: (i) It will allow us to gain a better appreciation of the 
important role amino acids play during early embryonic development, and (ii) allow us to better 
devise protocols for neural cell production in order to gain a better understanding of how the 
nervous system develops at a molecular level.   														
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1.3 Aims and hypotheses  		
Aim: To develop a protocol that drives the sequential and homogenous differentiation of 
mESCs to neural cells via embryologically relevant cell populations including EPL-cell, 
definitive ectoderm and neurectoderm intermediates using the bioactive component found 
within MEDII, L-proline.  
 
Hypotheses 
 
1. L-proline will drive the differentiation to neurectoderm and more mature neural cell 
types from mESCs and therefore promote instructive differentiation over a default 
mechanism. 
 
2. L-proline-mediated differentiation of mESCs will recapitulate MEDII-mediated 
differentiation to neural cells via a series of embryologically relevant cell populations 
including EPL cells, definitive ectoderm, and neurectoderm.  
 
3. By driving the formation of cells at multiple stages of development L-proline will act 
consistently with that of a typical growth factor. 
 
4. Decreasing or removing LIF from the L-proline-based protocol will improve the 
homogeneity and synchronicity of differentiation to neural cells. 
  
For a brief overview of culture conditions used, refer to Table 1.2. 
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Table 1.2: Summary of embryoid body (EB) culture conditions used to drive the differentiation 
of mESCs to neural cells via EPL-cell, definitive ectoderm and neurectoderm intermediates. D3 
and 46C mESCs were cultured as EBs in 400 µM L-proline ± 1000 U/ml for the first 5 days (to drive 
the differentiation of mESCs to EPL cells). From Days 6–9, EBs were cultured in 400 µM L-proline (to 
continue to drive EPL cells to definitive ectoderm and neurectoderm) + 10 µM SB431542 (to inhibit 
off-pathway differentiation away from neurectoderm). Alternatively, EBs were cultured in Basal 
Medium (medium with no additional factors added) for the whole 9 days (to allow for spontaneous 
differentiation into cells of the three germ layers). At the end of Day 9, EBs were seeded down in Serum-
Free Medium on 0.1% gelatin-coated 48-well plates for a further 6 days, after which they were observed 
for neural phenotypes including neural progenitors and neurons.  	
 1000 U/ml LIF 
(L) 
(From Days 0–5) 
400 µM L-proline  
(P) 
(From Days 6–9) 
10 µM SB431542 
(SB) 
(From Days 6–9) 
Culture Conditions 
P/1000 L then P/SB + + + 
P/0 L then P/SB – + + 
Basal Medium –  – – 																			
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1.4 Significance 	
Understanding mammalian development up to the point of early nervous system formation 
remains one of the most challenging areas of developmental biology. Whilst a large number of 
studies have assessed how competent neurectoderm produces mature neural cells, less is known 
about the key molecular mechanisms that drive formation to definitive ectoderm and 
neurectoderm. This is partly due to (i) the relative inaccessibility of the embryo during 
embryonic development, (ii) the transient appearance of many cell types during early 
development and (iii) the lack of molecular signatures for the definitive ectoderm germ layer. 
Currently, debate over whether the neurectoderm arises as a result of a default or instructive 
mechanism of differentiation is, in part, at the core of our lack of understanding of its formation.  
 
When mESCs are cultured in MEDII conditioned medium from HEPG2 cells they undergo 
differentiation towards neurectoderm (Harvey et al., 2010; Rathjen et al., 2002), firstly via an 
EPL-cell population and followed by a transient population of cells consistent with that of 
definitive ectoderm (Harvey et al., 2010). However, MEDII is a complex medium and for this 
reason it is difficult to use it to assess the molecular mechanisms controlling differentiation. 
We have thus developed a simplified protocol, using the bioactive component in MEDII, L-
proline. In doing so, we have successfully mimicked the sequential differentiation observed 
when mESCs are cultured as EBs in MEDII but in a much simpler culture system. These are 
the first findings, to our knowledge, that show that an amino acid (in this case, L-proline) acts 
like a typical growth factor which stimulates differentiation at multiple stages of development.  
 
Furthermore, we provide evidence that the neurectoderm arises via an instructive model of 
differentiation (in this case driven by L-proline), rather than by a default mechanism. This 
protocol, and variations of it, will provide a means for studying the complex molecular circuitry 
that underlies the differentiation of the poorly understood definitive ectoderm lineage: Both 
how it arises from the primitive ectoderm and how it transitions into the neurectoderm. Up until 
recently, few defined markers for the definitive ectoderm lineage have been established 
(Harvey et al., 2010). Using our L-proline-based protocol, we have confirmed the presence of 
a transient in vitro population of cells that express Pard6b and Penk1 in a temporal pattern 
consistent with the presence of definitive ectoderm: This expression recapitulates that observed 
when EBs are cultured in MEDII (Harvey et al., 2010), and contributes to the growing body of 
knowledge about the important roles that amino acids play in controlling cell fate.  
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Ultimately, this protocol will contribute to a better understanding of the pathophysiology 
underlying neurodevelopmental and neurodegenerative diseases. It should also be useful for 
the development of effective cell-based therapies for diseases and injuries associated with the 
embryonic and adult nervous systems.  
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Chapter 2  
Materials and 
Methods 
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2.1 Materials 	
All water-based powders were made up in MQ unless specified otherwise. 
 
2.1.1 Cell culture reagents and plasticware 	
Reagents 
0.1% porcine gelatin (Sigma: #G1890-100G) in PBS 
0.25% Trypsin/EDTA (1X) (Gibco: #25200-072) 
Alkaline Phosphatase Kit (Sigma: #86c) 
b-Me (Sigma) 0.1 M stock in MQ 
F12 nutrient mixture (1X) (Gibco: #11765) 
FBS (AusGenex: #FBS500-S) 
DMEM (Gibco: #12800-017) or (Sigma: #D7777) 
ITSS (100X) (Sigma: #I1884)  
KOSR (Gibco: #10828:028) 
LIF (Millipore: #ESG1107) or (Neuromics: #PR80000)  
L-proline (Sigma: #P5607) 0.1 M stock in MQ 
Penicillin/streptomycin (100X) (5000 U/ml Penicillin G Sodium Salt (Sigma: 
#P3032-10MU), 5 mg/ml streptomycin sulfate (Sigma: #S-6501) in PBS) 
PBS (Gibco: #21600-010) or (Amresco: #E404) 
SB431542 (MedChemExpress: #HY-10431) 2.6 mM stock in DMSO 
Trypan blue: 0.4 g Trypan blue, 0.81 g NaCl, 0.06 g KH2PO4 in 95 ml MQ, pH: 7.2-7.3 
 
Plasticware 
ESC culture plates: 6 cm (Corning: #430196) 
ESC culture plates: 10 cm (Corning: #430591 or BD Falcon: #351029) 
EB culture plates: 10 cm petri dish (Technoplas: #S9014UV20) 
6-well culture plates (Nunc: #3140675) 
24-well culture plates (Corning: #3524) 
48-well culture plates (Corning: #3548 or BD Falcon: #353078) 
0.22 µm 150 ml bottle top filters (Corning: #431161) 
0.22 µm filter unit (Millipore: #SLGP33RS)  
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2.1.2 Molecular biology reagents and plasticware 	
AccuZol Total RNA Extraction Solution (Bioneer: #K3090) 
Gene Elute RNA Isolation Kit (Sigma: #RTN350) 
On-Column DNAse Digestion Set (Sigma: #DNAse70-1SET) 
High Capacity cDNA Reverse Transcriptase Kit (Applied Biosystems: #4368814) 
Individual Components:  
10X buffer (Applied Biosciences: #4319981) 
 dNTPs (Applied Biosciences: #4367381) 
 Random primers (Applied Biosciences: #4319978) 
 Reverse transcriptase (Applied Biosciences: #4308228) 
 RNAse Out (RNAse inhibitor) (Invitrogen: #10777-019) 
Kapa SYBR FAST qPCR Kit (Kapa Biosystems: #KK4602) 
RQ1 RNAse-free DNAse Kit (Promega: #M6101) 
Individual Components: 
RQ1 DNase 10X reaction buffer: #M198A 
 RNase-free DNase: #M610A 
 DNase stop solution: #M199A 
qPCR 96-well plate (ThermoFisher Scientific: #AB-0700) 
qPCR 384-well plate (Roche: #04729749001) 
qPCR QIAgility tips for Tecan EVO75 Robotic Workstation (Tecan: #30126097) 
qPCR strip tubes: (Axygen: #321-15-051) 
Agarose gel: 1% (w/v) in 1X Tris-Borate-EDTA, EtBr (1 µl/10 ml) 
6X gel stabilizer: 1.5% Ficoll-400® 11 mM EDTA, 3.3 mM Tris-HCl, 0.0017% SDS, 
0.015% bromophenol blue, pH 8.0 
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2.1.3 Primers 
All primers were designed to recognize mouse cDNA (Table 2.1).  
Table 2.1: qPCR primers designed to recognize mouse cDNA. Primers were designed for qPCR on 
Roche Probe Finder software, and were checked on BLAST Ensemble software using the cDNA 
transcript database. Individual forward (5’–3’) and reverse (3’–5’) primers were diluted to 5 µM stocks 
in MQ. A working primer stock was diluted to a final concentration of 1 µM (containing 500 nM 
forward + 500 nM reverse primers). All primer stocks were stored at -20 °C until required. 
b-actin (89 bp)  
Forward: CTG CCT GAC GGC CAG G 
  Reverse: GAT TCC ATA CCC AAG AAG GAA GG 
Oct4 (81 bp) 
  Forward: AAT GCC GTG AAG TTG GAG AA 
  Reverse: CCT TCT GCA GGG CTT TCA T 
Nanog (76 bp) 
  Forward: GCC TCC AGC AGA TGC AAG 
  Reverse: GGT TTT GAA ACC AGG TCT TAA CC 
Rex1 (118 bp) 
  Forward: CGT GTA ACA TAC ACC ATC CG 
  Reverse: GAA ATC CTC TTC CAG AAT GG 
Dnmt3b (169 bp) 
  Forward: AGT GCA GAC AAT AAC CAC CAA G 
  Reverse: ACG TCG TCC TTG CCA TTC A 
Fgf5 (182 bp) 
  Forward: CTG CAG ATC TAC CCG GAT G 
  Reverse: TAA ATT TGG CAC TTG CAT GG 
Pard6b (97 bp) 
  Forward: GGG CAC TCA GCA TGA ACC 
  Reverse: CGA CGA AAC TCA GCT CCA A 
Penk1 (74 bp) 
  Forward: CCC AGG CGA CAT CAA TTT 
  Reverse: TCT CCC AGA TTT TGA AAG AAG G 
Sox1 (171 bp) 
  Forward: CCT CTC AG ACG GTG GAG TTA TAT T 
  Reverse: GAC TTG CAG GCT ATG TAC AAC ATC 
Nestin (68 bp) 
  Forward: TCC CTT AGG CTG GAA GTG GCT A 
  Reverse: GGT GTC TGC AAG CGA GAG TT 
Mixl1 (91 bp) 
  Forward: CCA TGT ACC CAG ACA TCC ACT 
  Reverse: CGG TTC TGG AAC CAC ACC T 	
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2.1.4 Fluorescence microscopy and flow cytometry reagents and plasticware 
Reagents 
Triton-X (Sigma: #9002931) 
Goat serum (Institute of Medical and Vet Science, Adelaide) 
PFA (Sigma) 
Saponin (Sigma: #S4521) 
Solutions 
4% PFA: 4 g EM-grade PFA, 10 ml PBS, 1 ml NaOH (1 M), 1 M HCl in MQ, pH 
7.4. Filtered through a 0.45 µm filter.  
1% PFA:  4% PFA diluted to 1% in PBS 
Cell permeabilizing solution (PBST): 0.1% Triton-X in PBS 
Antibody blocking solution (Immunofluorescence): 10% goat serum in PBS-T 
Antibody diluting solution (Flow cytometry): 0.1% saponin, 2% FBS in PBS 
Antibody diluting solution (Immunofluorescence): 5% goat serum in PBST 
FACS running buffer: 2% FBS in PBS  
Fluoroshield with DAPI (Sigma: #F6057) 
Vectashield Antifade Mounting Medium (Vector Laboratories: #H-1000) 
 
Plasticware 
Round bottom tube with 35 µm mesh cell strainer cap: (Falcon: #352235) 
Round bottom tube without cap (FACS tube): (Falcon: #352008) 
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2.1.5 Antibodies 
 
Table 2.2: Primary antibodies used for fluorescence microscopy and flow cytometry. Antibodies 
were produced in mouse (m), rabbit (rab), rat or goat (g) against mouse.  
Antibody Company Catalogue # Species [Stock] Localization Marker 
Oct4 Santa Cruz (Sc5279) (m ∝ m) IgG 0.2 mg/ml Nuclear Pluripotency 
Nanog Cell Signalling (D2A3) (rab ∝ m) IgG 0.2 mg/ml Nuclear mESC 
Dnmt3b Santa Cruz (Sc10236) (g ∝ m) IgG 0.2 mg/ml Nuclear EPL cell 
Nestin 
Developmental 
Studies 
Hybridoma Bank 
(401-c) 
(rat ∝ m) IgG 0.14 mg/ml Cytoplasmic Neural 
progenitor 
BLBP Millipore  (ABN14) (rab ∝ m) IgG 0.5 mg/ml Cytoplasmic 
NeuN Millipore (MAb377) (m ∝ m) IgG 1 mg/ml Nuclear Neuron 		
Table 2.3: Secondary antibodies used for fluorescence microscopy and flow cytometry. 
Antibodies were produced in goat (g) or donkey (d) against mouse (m), rat or rabbit (rab).  
Fluorescent dye Company/Cat # Species [Stock]  
Alexa-488 Invitrogen (A11001) (g  m) IgG 2 mg/ml 
Alexa-647 Invitrogen (A21235) (g  m) IgG 2 mg/ml 
R-PE Invitrogen (M32404) (g  m) IgG2b 2 mg/ml 
R-PE Invitrogen (A10545) (g  rat) IgG 1 mg/ml 
Alexa-488 Invitrogen (A11008) (g  rab) IgG 2 mg/ml 
CruzFluorTM-647 Santa Cruz (Sc362292) (g  rab) IgG 0.4 mg/ml 
PerCP-Cy5.5 SantaCruz (Sc45102) (d  g) IgG 0.4 mg/ml 
DyeLight®-650  Abcam (Ab96934) (d  g) IgG 0.5 mg/ml 				
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2.2 Tissue culture methods 	
2.2.1 mESC cell lines 	
The D3 and 46C-Sox1-GFP mESC cell lines were used in this work. The D3 cells are a wild-
type mESC cell line, derived from blastocysts of the 129/Sv mouse strain (Doetschman et al., 
1985). 46C cells are a Sox1-GFP cell line that was generated using gene targeting in the 
E14Tg2a.IV mESCs (derived from blastocysts of the 129/Ola mouse strain) (Ying et al., 2003; 
Aubert et al., 2003). Briefly, the open reading frame of the Sox1 gene (the first and most-
specific neurectoderm marker in the mouse) was replaced with GFP linked to a puromycin 
resistant gene through an internal ribosomal entry site. 46C cells were used in this body of work 
to assess Sox1-driven GFP expression during differentiation to neurectoderm.   
2.2.2 Maintenance of mESCs 	
D3 and 46C-Sox1-GFP mESCs were removed from liquid nitrogen in vials containing 106 
cells/ml and thawed in a room temperature water bath before being gently transferred to 6 ml 
mESC Complete Medium (Table 2.4). Cells were gently suspended as single cells and 
centrifuged at 1200 rpm for 3 min after which the medium was aspirated to remove the DMSO. 
Cells were suspended in 1 ml mESC Complete Medium and were seeded on a pre-gelatinized 
6 cm tissue culture-treated plate in mESC Complete Medium before being placed in a 37°C, 
5% CO2 humidified incubator. Cells were passaged the next day: The medium was aspirated, 
and two PBS washes were performed. 350 µl 0.25% trypsin was added for 15–20 s and trypsin 
was deactivated by the addition of 650 µl mESC Complete Medium. Cells were dislodged from 
the plate by gentle trituration before being collected and pelleted by pulse centrifuging. The 
medium was aspirated and the cells were re-suspended in 1 ml mESC Complete Medium before 
being re-plated on to a 6 cm tissue culture-treated dish and placed in the incubator as above. 
Passaging was repeated 3 days in a row before the cells were allowed to grow to ~70% 
confluence and then split for use in experiments or for maintenance passaging.  
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Table 2.4: Seeding densities, plate sizes and media volumes used for adherent mESC and EPL-
cell culture. mESCs were passaged and re-plated in either mESC Complete Medium or EPL Cell 
Medium for EPL cell differentiation experiments on tissue culture-treated plates.  
 Passaging Plating cells 
Plate 
Type 
Trypsin 
volume 
(µl) 
Medium 
volume 
(µl) 
Medium type 
Volume 
medium 
(ml) 
Seeding 
density 
(cells) 
Application 
6 cm  350 650 
 
mESC Complete 
Medium 
 
Basal medium 
90% DMEM 
10% FBS 
0.1 mM b-Me  
1X Pen/Strep 
 
+ 1000 U/ml LIF 
5  1–5 x 105 
Routine 
maintenance 
10 cm  1000 1000 10  5 x 105–106 
6-well  200 200 
 
Basal medium 
90% DMEM 
10% FBS 
0.1 mM b-Me  
1X Pen/Strep 
 
+ 1000 to 0 U/ml LIF 
2  105 Alkaline phosphatase assay 
24-well  100 100 
 
EPL Cell Medium 
 
Basal medium 
90% DMEM 
10% FBS 
0.1 mM b-Me  
1X Pen/Strep 
 
+ 1000 U/ml LIF 
+ 400 µM L-proline 
1 104 Monolayer EPL cell differentiation 
 
 
For routine passage, cells were passaged as described above. Once the cells were pelleted and 
resuspended in 1 ml mESC Complete Medium (Table 2.4), a cell count was performed: 10 µl 
of single cell suspension was added to 40 µl trypan blue and the cell count was performed using 
a haemocytometer. Only cells that were viable (i.e., excluding trypan blue) were included in 
the live-cell count, and the percentage of dead cells was ~5% or less. The live-cell count was 
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used to seed cells at an appropriate density for the next passage and for experiments. These 
seeding densities depended on the size of the plate or well used (Table 2.4).   
 
For mESCs grown for immunofluorescence imaging, glass coverslips were prepared 24 h prior 
to culturing. The coverslips were placed in 70% ethanol and air-dried under UV to sterilize. 
Following this, single glass cover slips were placed in each well on a 24-well plate and were 
gelatinized overnight in a 37°C, 5% CO2 humidified incubator. mESCs were split as above, and 
seeded in the pre-gelatinized wells in either mESC Complete Medium or EPL Cell Medium as 
described in Table 2.4. Cells were incubated for 6 days with passage on Day 3 at the same 
seeding density. Samples were collected on Day 6 for immunofluorescence and phase contrast 
imaging.  
 
2.2.3 Alkaline phosphatase staining  	
mESCs were passaged 3 times in mESC Complete Medium (Table 2.4) before being seeded in 
a pre-gelatinized 6-well plate (Table 2.4). Cells were seeded at a density of 105 cells per well 
in Basal Medium containing 1000 U/ml, 500 U/ml, 250 U/ml, 100 U/ml, 33 U/ml, 10 U/ml or 
0 U/ml LIF (Table 2.4) and cultured for 3 days before being passaged twice in the respective 
media. Staining was performed as per manufacturer’s instructions (Sigma). Briefly, nitrate and 
FRV were mixed together for 2 min. Medium was aspirated and cells were gently washed in 
PBS. Fix solution (citrate, acetone, formaldehyde) was added to each well for 30 s, before being 
removed and cells were washed with MQ for 45 s. Stain solution (nitrate, FRV, water, napithol) 
was applied to the cells, after which they were covered in foil and placed on the rocker for 15 
min. Images were taking under the phase microscope. Intensity of alkaline phosphatase staining 
is indicative of pluripotency. 
 
2.2.4 Embryoid body formation 	
D3 or 46C ESCs were grown as embryoid bodies (EBs) in suspension as per Table 2.5, before 
being incubated in a 37°C, 5% CO2 humidified incubator. Medium was replaced on Day 3 with 
the same medium by swirling the EBs into the middle of the plate such that the medium could 
be aspirated from the sides. At the end of Day 5 and 7, medium was replaced with Day 6–9 
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medium (Table 2.6). At the end of Day 9, individual EBs were transferred to gelatinized 48-
well plates (2–3 EBs per well) in Day 10–15 medium (Tables 2.5 and 2.6) and were incubated 
as above for a further 6 days. Media were replaced on Day 12 and the experiment was 
terminated on Day 15. 
 
Table 2.5: Seeding densities, plate sizes and media volumes used for embryoid body (EB) 
experiments. For suspension culture, mESCs were passaged and seeded on Day 0 as single cells. 
Medium was changed on Days 3, 5, 7 and 9 by swirling EBs into the centre of the plate and aspirating 
the medium from the sides of the plate. On Day 9, EBs were seeded in Serum-Free Medium on 0.1%-
gelatin-coated 48-well plates for a further 6 days.  	
 EB Experiments 
 
Suspension culture 
(Day 0–9) 
Adherent culture 
(Day 10–15) 
Plate type 10 cm  48-well  
Medium type Day 0–5 medium or Day 6–9 medium 
Serum-Free 
Medium 
Medium volume  10 ml 0.5 ml/well 
Seeding density 5 x 105 (on Day 0) ~3 EBs/well 
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Table 2.6 Culture conditions for embryoid body (EB) experiments. D3 and 46C mESCs were cultured in suspension as EBs for 9 days using time– and 
concentration–dependent additions of LIF (L), L-proline (P) and the ALK4/5/7 inhibitor SB431542 (SB). On Day 9, individual EBs were seeded in a 48-well 
plate (~3 EBs per well) in Serum-Free Medium and cultured for an additional 6 days. Media was changed at the end of each day. Key: b-mercaptoethanol (b-
Me) Foetal bovine serum (FBS), Knock-out serum replacer (KOSR), Penicillin/streptomycin (Pen/Strep), insulin + transferrin + sodium-selenite (ITSS).  																		
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EB Suspension culture condition 
Day 0–5 
P/1000 L 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM b-Me, 1X Pen/Strep 1000 U/ml LIF, 400 µM L-proline 
P/500 L 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep 500 U/ml LIF, 400 µM L-proline 
P/330 L 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep 330 U/ml LIF, 400 µM L-proline 
P/0 L 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep 0 U/ml LIF, 400 µM L-proline 
   
Day 6–9 
then P/SB 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep, 400 µM L-proline, 10 µM SB431542 
then P 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep, 400 µM L-proline 
then SB 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep, 10 µM SB431542 
then no addition 80% DMEM, 10% (v/v) FBS, 10% (v/v) KOSR, 0.1 mM β-Me, 1X Pen/Strep 
   
Day 0–9 Basal Medium 90% DMEM, 10% (v/v) FBS, 0.1 mM β-Me, 1X Pen/Strep 
   
Seeded EB culture conditions 
Day 10–15 
Serum-Free 50% DMEM, 50% F12, 1X Pen/Strep, 1X ITSS 
Serum-Free + 
 L-proline 
50% DMEM, 50% F12, 1X Pen/Strep, 1X ITSS, 250 µM *additional L-proline to make final [L-proline] = 400 µM 
(* F12 contains 150 µM L-proline) 
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2.3 qPCR 	
Samples were collected on Days 0, 3, 5, 7 and 9: Day 0 samples were passaged and collected 
as described in 2.2.4. Day 3–9 samples were collected from suspension culture. 
 
2.3.1 RNA purification 
Purified RNA was prepared from cells using either phenol-chloroform extraction or by using 
spin columns. 
 
Phenol-chloroform extraction 
 
Day 0, 3, 5, 7 and 9 EBs were prepared as per manufacturer’s instructions. Briefly, samples 
were centrifuged for 10 s and medium was removed, before being washed in PBS twice. 500 
µl AccuZol was added and samples were homogenized by tritruation, before being stored at  
-80°C. When required, samples were thawed, 100 µl chloroform was added, the samples 
shaken vigorously for 15 s, then centrifuged at 12 000 g for 15 min at 4°C. The aqueous phase 
containing RNA was transferred to a new tube and 250 µl of isopropanol was added and mixed 
by inversion. Samples were incubated on ice for 10 min before being centrifuged at 12 000 g 
for 10 min at 4°C. Supernatant was removed and the samples were washed in 80% ethanol, 
followed by being vortexed and then centrifuged at 12 000 g for 5 min at 4°C. The supernatant 
was again removed and the pellets were left to air dry for 5–10 min before being re-suspended 
in 40 µl MQ and stored at -80°C. Samples were assessed for concentration and purity using the 
Nanodrop (see 2.3.2) before being DNase-treated. 
 
DNase treatment was undertaken as per manufacturer’s instructions. Briefly, a master mix of 
2 µl of 10X DNase buffer and 2µl 10X DNase1 was prepared. Up to 2 µg of purified RNA in a 
total of 16 µl of MQ water was added and incubated at 37°C for 15 min. 2 µl of stop solution 
was added and the samples were incubated at 70°C for 10 min to terminate the reaction. A 
NanoDrop (Thermo Scientific) was used to quantify the concentration of RNA and assess its 
purity.  
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If phenol contamination was observed (represented by a broad maximum in the wavelength 
which extended from 260 nm to 270 nm), 15 µl 2.5 M NaCl was added and the protocol was 
repeated as above from the addition of isopropanol.  
RNA samples were stored at -80°C until required. 
 
Spin column purification 
RNA was extracted as per manufacturer’s instructions (Sigma), with the additional DNase-
treatment step included (Sigma). 
 
2.3.2 RNA concentration and purity assessment  	
RNA concentration and purity were assessed using the NanoDrop. 1 µl of sample was loaded 
onto the Nanodrop and a wavelength scan recorded from 220–350 nm.  
The concentration of RNA (ng/ul) was determined using the Beer-Lambert Law: 
 
       A=ecl  
 
Where A = absorbance (A260 nm), e = RNA extinction coefficient (40 µg/ml),  
c = concentration, l = path length (1 mm) 
 
RNA purity was determined by calculating the A260/A280 ratio. A ratio above 1.8 was deemed 
to be sufficiently pure for use in further analysis. A ratio significantly below 1.8 indicated 
unacceptably high protein contamination. 
 
2.3.3 RNA integrity assessment 	
Gel electrophoresis was used to assess the integrity of the 28S and 18S RNA bands.  
A 1% agarose gel was made which included EtBr. 200 ng of RNA was mixed with 2 µl of 6X 
loading dye buffer and was loaded into the wells. The gel was run at 100 V for 15–20 min, and 
the 28S (3.3 kb) and 18S (1.8 kb) ribosomal bands were visualized under UV light. Clearly 
identifiable bands without smearing and with a roughly 2:1 ratio of intensity indicated intact 
RNA. 
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2.3.4 cDNA production 	
cDNA production protocol was followed as per manufacturer’s instructions (Applied 
Biosystems). Briefly, a master mix was prepared for ‘plus reverse transcriptase (+RT)’ and 
‘minus reverse transcriptase (–RT)’ samples. To the master mix, 1 µl 10X reaction buffer, 0.4 
µl dNTP mix, 0.5 µl RT, 0.5 µl RNase inhibitor and 1.6 µl MQ water was added per sample. 
For the –RT samples, MQ replaced RT. 5 µl of +RT master mix was added to 5 µl RNA (up to 
1 µg). For –RT samples, 2.5 µl of –RT master mix was added to 2.5 µl RNA. The samples were 
run in the Mastercycler Gradient thermocycler (Biorad) under the following program:  
 
1. Initialization: 25°C for 10 min 
2. Synthesis: 37°C for 120 min 
3. Termination: 85°C for 10 min  
4. Hold: 4°C 
 
Samples were either stored as concentrated cDNA or diluted to 0.5 ng/µl in MQ and stored at  
-80°C until required. 
 
2.3.5 qPCR  	
To test the quality of the cDNA, a housekeeping b-actin test was performed on all samples. 
qPCR was performed as per manufacturer’s instructions (Kapa Biosystems). Briefly, 5 µl 
SYBR-green was added to 2 µl of 1 µM (final concentration) forward and reverse primers to 
which 3 µl of cDNA (at 0.5 ng/µl)* was added. These were run in duplicate. –RT and no 
template controls (NTC) were run as singlets. 
 
*Note that concentration of cDNA was taken to be that of the final concentration of RNA used 
in the reaction to produce cDNA. 
 
Samples were run using the Rotorgene qPCR machine (Qiagen) under the following cycling 
program:  
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1. Initialization: 95°C for 15 min  
40 cycles of: 
2. Denaturation: 95 °C for 30 sec   
3. Annealing: 60 °C for 60 sec  
4. Elongation: 72 °C for 30 sec (including data acquisition at the end of this phase) 
 
Followed by a melt curve analysis: 
Ramp from 65 °C to 97 °C, rising by 2.5 °C/s with 5 acquisitions/°C  
 
The standard deviation of Ct values for b–actin was calculated to determine the spread of b–
actin variability between samples. The average Ct value per experiment was 20 ± 1.9 (n>3 
experiments): The Ct values for b–actin below 22 indicated efficient cDNA production. cDNA 
was remade for any sample with a Ct value greater than 22. 
 
Following these preliminary tests, samples were run on the Rotorgene or the LightCycler480 
(Roche). For 384-well runs on the LightCycler480, the TECAN Freedom EVO75 Robotic 
Workstation was used for dispensing samples and master mixes. Briefly, a master mix + 
primers plate was set up by hand pipetting master mixes into a 96-well plate. A separate 96-
well plate was prepared for +RT, –RT and NTC samples. The plates were spun and loaded onto 
the robot for dispensing into the 384-well plate (10 µl reaction volume consisting of 7 µl master 
mix + primers and 3 µl sample). The 384-well plate was sealed, shaken at 1500 rpm for 30 s at 
room temperature in the Mixer MixMate (Eppendorf) and centrifuged for 1 min at 1000 rpm 
at 4°C, before being loaded into the LightCycler480. The above cycling program was run.  
 
Fluorescence curves and melt curves were assessed using LightCycler480 software.  
Relative expression was analysed using REST software analysis, and data was log2-tranformed 
for the data presentation. 
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2.4 Microscopy  
2.4.1 Phase contrast imaging 
 
Samples collected on Days 0, 3, 5, 7, 9, 12 and 15 were assessed using phase-contrast 
microscopy.  
Adherent cultures including Day 0 mESCs, Day 6 EPL cells and Day 15 and 12 EBs were 
imaged on the plate using either the Olympus IX-81 Inverted Fluorescence Microscope or the 
EVOS FL Auto Cell Imaging System (ThermoFisher Scientific) under the 10x, 20x or 40x 
objectives. For suspension cultures, EBs were swirled into the centre of the plate and imaged 
under the 10x, 20x or 40x objectives using the microscopes above.  
 
2.4.2 Immunofluorescence imaging 
 
Samples collected on Days 0, 3, 5, 7, 9 and 15 were assessed using immunofluorescence 
imaging.  
1) For Day 0, mESCs had been passaged as described in 2.2.2, and seeded on pre-
gelatinized sterile cover slips in 24-well plates for 3 days.  
 
2) Day 3, 5, 7 and 9 EBs were collected from suspension culture.  
 
3) Day 15 samples were prepared from Day 9 EBs which had been seeded down onto pre-
gelatinized sterile cover slips, or directly onto gelatinized wells (without cover slips).  
  
To prepare the samples, medium was removed and followed by two washes with PBS. Samples 
were then fixed in 4% PFA for 20 min and left to incubate at room temperature on a rocker. 
PFA was removed followed by 2 x 10 min washes with PBST. Samples were then blocked for 
an hour at room temperature on a rocker in 10% goat serum (GS) in PBST. Blocking solution 
was removed gently, and primary antibodies (Table 2.2) were made up to 1:100 in 5% GS in 
PBST followed by incubation either overnight at 4°C with rocking or for 1 hour at room 
temperature with rocking. 3 x 5 min gentle washes were performed with PBS. Secondary 
antibodies (Table 2.3) were made up to 1:300 in 5% goat serum in PBST in the dark and added 
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followed by incubation for 2 h at room temperature with rocking, in the dark. Samples were 
gently washed in the dark 6 x 5 min with PBS.  
 
After this processing:  
 
1) 15 mm-diameter glass coverslips of Day 0 samples were removed from the wells, Vaseline 
was placed around the circumference, and placed on top of a few drops of Fluroshield with 
DAPI on a glass slide. Nail varnish was painted around the coverslip to seal the edges.  
 
2) Day 3–9 EBs were mounted onto glass slides, avoiding picking up excessive volumes of 
liquid. Fluroshield mounting solution with DAPI was added and Vaseline applied to the area 
on the glass slide around which the circumference of the coverslip would be placed. The edge 
of the coverslip was sealed with nail varnish.   
 
3) For Day 12 and 15 EBs stained directly on the plate, samples were washed in the dark for 3 
x 10 min with PBS and Fluroshield with DAPI was applied before a 10 mm-diameter cover 
slip was gently placed onto the samples.  
 
Samples were imaged using either the Zeiss LSM 510 Meta Spectral Confocal Microscope, 
Zeiss LSM 800 Meta Spectral Confocal Microscope plus Airyscan, Olympus BX51 Polarizing 
Microscope BX51 or Invitrogen EVOS FL Auto Cell Imaging System under the 10x, 20x or 
40x objectives.  
 
2.4.3 Time-lapse imaging 	
Time-lapse footage was obtained during my Honours year (Shparberg, 2012). However, during 
my PhD candidature, interpretation of these data has been extended beyond that made during 
Honours.   
 
Day 9 P/1000 L then P/SB EBs were seeded onto a gelatinized (0.1% gelatin) 3 cm glass bottom 
culture dish with 3 ml of Serum-Free Medium (Table 2.6). The plate was incubated at 37°C, 
5% CO2 in a humidified incubator for three days, after which it was transferred into the Cell 
Voyager CV1000 confocal system (Visitron Systems). Areas containing seeded EBs were 
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selected using the CellVoyager™ CV1000 software, and the machine was run for three days 
under conditions of 37°C, 5% CO2 in a humidified incubator, taking photos at a 10X 
magnification every 10 min. After three days, a movie was produced from the still images. 
  
Day 5 EBs from all culture conditions were seeded onto gelatinized (0.1% gelatin) 48-well 
plates in Day 6–9 medium (Table 2.6). On day 6, the plate was loaded into the IncuCyte Zoom 
(Essen BioScience). The field of view (grid area) was selected and both green fluorescence and 
phase images were taken at a 10x magnification every hour for 6 days on the 46C-GFP cells. 
Medium was changed as per Table 2.6 with the only difference being that the EBs were 
adherent rather than in suspension. Images were assessed within, during– and post–run using 
IncuCyte Zoom desktop software.  	
2.5 Flow cytometry 	
Samples were collected on Days 0, 3, 5, 7, and 9. Day 0 mESCs were passaged and suspended 
as single cells, pulse centrifuged and washed twice in PBS. EBs were collected and left to 
sediment, the medium removed and washed twice in PBS. EBs were then trypsinised for 15 s, 
and the trypsin was neutralised with the appropriate medium (Table 2.4). Trypsinised EBs were 
loaded into 35 µm cell strainer lids attached to flow cytometry tubes and spun for 2 min at 1000 
rpm. 
 
All samples were fixed in 50 µl 1% PFA for 45 min on the rocker at room temperature. Cells 
were pelleted and washed in PBS before being either stored in PBS at 4°C or were gently re-
suspended in 50 µl 0.1% saponin/2% FBS/PBS. 25 µl from each tube was transferred to a 
separate tube for use as secondary-only controls. Primary antibodies (Table 2.2) were made up 
to 1:100 in 0.1% saponin/2% FBS/PBS and 25 µl was aliquoted to each appropriate tube 
making a final dilution of 1:200. Samples were incubated at room temperature on the rocker 
for an hour or left to incubate overnight on the rocker at 4°C, before being pulse spun and 
washed twice in 0.1% saponin/2%FBS/PBS. Secondary antibodies (Table 2.3) were made up 
to a 1:500 dilution in 0.1% saponin/2% FBS/PBS and 50 µl was aliquoted to each tube before 
being incubated in the dark at room temperature on the rocker for 45 min. Cells were pelleted 
and washed twice in PBS before being resuspended in 250 µl FACS buffer (2%FBS/PBS) and 
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run on the FACSCalibur. No-label controls were used to adjust the forward and side scatter 
plots whilst single-label only samples were used to adjust fluorescence channels.  
 
46C cells that were used for GFP expression analysis were fixed in 50 µl 1% PFA for 45 min 
on the rocker at room temperature. Cells were pelleted and washed in PBS before being either 
stored in PBS at 4°C or resuspended in 250 µl FACS buffer (2%FBS/PBS) and run on the 
FACSCalibur. Day 0 cells were used to adjust the forward and side scatter plots as well as for 
the GFP– control.  
 
2.6 Statistical analysis 	
Statistics were performed as per Table 2.7 and all graphs were made using GraphPad Prism. 
Statistical significance was set at P<0.05.  
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Table 2.7: Statistical design for phenotype, qPCR and flow cytometry analysis.	Neural phenotype scoring data was 
obtained from phase microscopic analysis of neural cell types including neural progenitors and neurons. qPCR relative 
expression data was obtained using REST software and was log transformed on Excel. Flow cytometry data obtained on 
the FACSCalibur was analysed using FlowJo software.  All statistics were performed using GraphPad Prism software. 
Statistical significance was set at P<0.05. 	
Data type Data presentation Reason to perform statistics 
Comparisons 
made 
Statistical 
Test 
Multiple 
comparisons 
test 
Neural 
phenotype 
scoring 
mean % ± 
SEM 
To test the difference between 
neural EB production between 
different culture conditions 
within a cell line 
All conditions 
within a cell line 
(i.e. D3 or 46C 
cells) 
One-way 
ANOVA Tukey's 
To test the difference in neural 
EB production between cell 
lines cultured in the same 
culture conditions 
Individual culture 
condition: D3 
verses 46C  
One-way 
ANOVA Sidak's  
qPCR  
mean log2 
fold change 
(relative to 
Day 0) ± 
SEM 
To test changes in gene 
expression over time compared 
to Day 0 mESCs 
Day 3, 5, 7 and 9 
gene expression 
compared to Day 0 
(per gene) 
Two-way 
ANOVA Dunnett's  
To test differences in gene 
expression between D3 and 
46C cell lines 
 D3 gene 
expression verses 
46C gene 
expression per day 
Two-way 
ANOVA Sidak's  
Summed 
expression ± 
SEM 
To test the difference of total 
gene expression across 9 days 
between different culture 
conditions 
All conditions 
within a cell line 
(i.e. D3 or 46C 
cells) 
One-way 
ANOVA Tukey's 
Flow 
cytometry 
mean % ± 
SEM 
To test changes in protein 
expression compared to Day 0 
mESCs 
Day 3, 5, 7 and 9 
compared to Day 0 
(per protein) 
Two-way 
ANOVA Dunnett's  
To test the difference between 
protein expression in different 
culture conditions 
All conditions 
within a cell line 
(i.e. D3 or 46C 
cells) 
One-way 
ANOVA Tukey's 						
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Chapter 3  
Results 
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3.1 Determining the appropriate concentrations of LIF to use for mESC 
maintenance 
 
mESCs require STAT3 and BMP4 signalling to maintain self-renewal and pluripotency (Hirai 
et al., 2011; Niwa et al., 1998; Ying et al., 2003a). For this body of work, we cultured mESCs 
as a self-renewing population in LIF (to maintain STAT3 signalling) and 10% FBS (which 
contains BMP4) to maintain these properties. To determine the appropriate concentration of 
LIF to use, and to test the activity of each batch of LIF, we cultured D3 mESCs in different 
concentrations of LIF over a period of 6 days, after which colonies were stained for the 
pluripotency marker alkaline phosphatase (AP) (Figure 3.1).   
 
mESCs cultured in concentrations of LIF above 250 U/ml maintained their characteristic 
round, dome-shaped colonies, and showed uniform AP staining (Figure 3.1). When mESCs 
were cultured in concentrations of LIF below 250 U/ml, colonies lost their characteristic 
morphology, and grew as flat, epithelial-like colonies (Figure 3.1). In these conditions, 
individual cells could be identified, indicative of differentiation. Weak and/or heterogeneous 
AP staining was evident, which was often localized to the center of the colonies suggesting 
differentiation from the outside inwards (Figure 3.1). Even in the absence of LIF, an AP+ 
population sometimes remained at the center of the colonies.  
 
On the basis of these and similar results, pluripotency of the mESCs could be maintained in 
concentrations of LIF ranging from 250–1000 U/ml, with 1000 U/ml being used for routine 
passaging. 	
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Figure 3.1: mESCs maintained pluripotency in the presence of LIF. D3 mESCs were cultured on 
plates coated in 0.1% gelatin in medium (90% DMEM + 10% FBS) containing various concentrations 
of LIF ranging from 0–1000 U/ml. Cells were passaged three times over six days before being stained 
for the pluripotency marker alkaline phosphatase (AP). (A) Representative phase contrast images of 
mESC colonies prior to staining. 10X objective; scale bar = 100 µm. (B) Representative phase contrast 
images following AP staining. 20X objective; scale bar = 50 µm, n>3. 						
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3.2 mESCs express markers of pluripotency including Oct4 and Nanog 	
Both the D3 cell line (Doetschman et al., 1985) and the 46C Sox1-GFP reporter cell line  (Ying 
et al.  2003) were used for experiments conducted in this thesis. As Sox1 is the first 
neurectoderm marker expressed in the mouse (Aubert et al., 2003; Pevny et al., 1998; Wood 
and Episkopou, 1999), and there are no reliable Sox1 antibodies available, the 46C Sox1-GFP 
cell line allowed us to track temporal and spatial Sox1 expression within EBs as a measure of 
neurectoderm formation, via the expression of GFP.  
 
Along with AP, mESCs express the pluripotency markers Oct4 and Nanog. When cultured in 
adherent conditions in mESC Complete Medium (Figure 3.2), ~100% of both D3 and 46C 
mESCs co-stained positive for Oct4 and Nanog (Figure 3.3).  	
		
 
Figure 3.2: Culture conditions used to maintain mESCs and to promote differentiation to EPL 
cells. D3 and 46C mESCs were maintained on plates coated with 0.1% gelatin in mESC Complete 
Medium. Addition of EPL Cell Medium for 6 days promoted a change in colony morphology from 
dome-shaped to flat epithelial-like colonies (consistent with the production of EPL cells) in adherent 
culture (Washington et al., 2010). Cells were passaged every two days and imaged after six days using 
the Olympus BX51 polarizing microscope (10X objective; scale bar = 100 µm). 
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Figure 3.3: mESCs co-express markers of pluripotency including Oct4 and Nanog. (A) D3 and 46C mESCs were cultured on plates coated with 0.1% gelatin in mESC 
Complete Medium for three days after which they were imaged under bright field using 10X (i and iii; scale bar = 200 µm) and 20X (ii and iv; scale bar = 100 µm) objectives 
on the EVOS microscope. (B) Colonies were fixed and stained for the presence of Oct4 and Nanog, and the nucleus stained with DAPI, before being imaged using fluorescence 
microscopy (10X objective; scale bar = 200 µm). 46C cells were also imaged for the expression of GFP as a reporter for the expression of Sox1. (C, D) A single-cell suspension 
of mESCs was fixed and stained for Oct4 and Nanog and run on the FACSCalibur flow cytometer (1o + 2o). A 2o-only control was also run to assist with gating. Expression was 
assessed using FlowJo software. Data presented in C are representative dot plots of the co-expression of Oct4 and Nanog and D shows representative histogram plots of total 
Oct4 or Nanog expression, n≥3. The percentages shown in the panels represent the percentage of cells gated within each quadrant (Q1–4): Q1: Oct+/Nanog– cells; Q2: 
Oct4+/Nanog+ cells; Q3: Oct4–/Nanog+ cells; Q4: Oct4–/Nanog– cells. 
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The expression of Dnmt3b in mESCs was also examined. Flow cytometry analysis showed that 
69 ± 23% (n=3) cells were Dnmt3b+ even in undifferentiated mESCs (Figure 3.4). However, 
Dnmt3b expression was weak and localized to the cytoplasm when cells were cultured in mESC 
Complete Medium (Figure 3.5). When adherent mESCs were cultured in EPL Cell Medium 
(i.e., with the addition of 400 µM L-proline; Figure 3.2) over five days, Dnmt3b (along with 
Oct4 and Nanog) was localized to the nucleus where its expression intensity was increased 
(Figure 3.5).   
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Figure 3.4: mESCs can co-express Dnmt3b with Oct4 and Nanog. A single-cell suspension of D3 mESCs were fixed and stained for Dnmt3b and either 
Oct4 or Nanog and run on the FACSCalibur flow cytometer (1o + 2o). A 2o-only control was also run to assist with gating. Expression was assessed using 
FlowJo software. Data presented in (A) are representative dot plots of the co-expression of Dnmt3b and Oct4 or Dnmt3b and Nanog and (B) shows representative 
histogram plots of total Dnmt3b expression, n=3 The percentages shown in the panels represent the percentage of cells gated within each quadrant (Q1–4): Q1: 
Dnmt3b+/Oct4– or Dnmt3b+/Nanog– cells; Q2: Dnmt3b+/Oct4+ or Dnmt3b+/Nanog+ cells; Q3: Dnmt3b–/Oct4+ or Dnmt3b–/Nanog+ cells; Q4: Dnmt3b–/Oct4– or 
Dnmt3b–/Nanog– cells.  
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Figure 3.5: Dnmt3b is weakly expressed in the cytoplasm of mESCs and strongly expressed in the nuclei of EPL cells.		D3 mESCs were cultured on glass 
cover slips coated in 0.1% gelatin in mESC Complete Medium for six days and were passaged every two days in (A) mESC Complete Medium or (B) EPL Cell 
Medium. Cells were fixed and stained with primary and secondary antibody for the presence of Dnmt3b and either Oct4 or Nanog. Nuclei were stained with 
DAPI. (C) Secondary-only antibody stains using mouse or rabbit Alexa-488 (m488 or r488) and goat DyeLight®-650 (g650). Confocal images were taken on 
the Zeiss LSM800 confocal microscope (20X objective; scale bar = 50 µm). Insets highlight differences in the localization of staining of Dnmt3b: In A expression 
is localized to the cytoplasm and in B expression is localized to the nucleus.																										
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3.3 Developing an L-proline-based protocol for the production of 
neurectoderm and neural cells via EPL cell and definitive ectoderm 
intermediates  
 
mESCs cultured as embryoid bodies (EBs) for nine days in the presence of the conditioned 
medium MEDII give rise to populations of cells similar to those that arise during embryonic 
development up to and including the early nervous system, including pluripotent EPL cells, the 
multipotent germ layer definitive ectoderm, and neurectoderm. Subsequent culture in Serum-
Free Medium gives rise to more mature neural cells such as neurons and glia (Figure 3.6) 
(Harvey et al., 2010; Rathjen et al., 2002).  
 	
	
	
Figure 3.6: MEDII promotes the differentiation of mESCs to neurectoderm (NE) via EPL cell, 
definitive ectoderm (DE) and neurectoderm (NE) populations during EB differentiation, with 
subsequent culture in Serum-Free Medium (SF) resulting in the generation of more mature neural 
cell types (N).	L-proline is a bioactive molecule found within MEDII that has been shown to drive the 
differentiation of mESCs to EPL cells in EB and monolayer culture conditions (Rathjen et al., 1999, 
2003; Washington et al., 2010). However, as indicated by the ‘?’, it is not known if L-proline is also 
involved in driving the differentiation of EPL cells to DE and NE as does MEDII, or if it promotes 
further differentiation to more mature neural cells. As MEDII is a complex medium, a simplified EB-
based protocol containing the bioactive molecule L-Pro, LIF and Nodal inhibitor, SB431542 (a 
mesendoderm inhibitor), should help elucidate the largely unknown molecular mechanisms driving 
neural lineage commitment.  	
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As MEDII is a complex conditioned medium, we wanted to develop a protocol using L-proline, 
the bioactive molecule found in MEDII, to recapitulate MEDII-mediated neurectoderm 
differentiation (Figure 3.6) (Washington et al., 2010; Rathjen et al., 2003). This would then 
allow further assessment of the molecular mechanisms driving the differentiation of mESCs to 
neurectoderm, and perhaps beyond. The basic strategy for developing an L-proline-based 
protocol is shown in Figure 3.6.  
 
Given that in adherent culture LIF is required in combination with L-proline to produce EPL 
cells (Washington et al., 2010; Tan et al., 2011; Rathjen, et al., 2003) (Figures 3.2 and 3.5), we 
hypothesized that both of these factors would also be required to produce EPL cells from 
mESCs using an EB culture system. Figure 3.7 outlines the various culture conditions used in 
this set of experiments to test this hypothesis. Briefly, mESCs were cultured as EBs for nine 
days and then seeded down on Day 10 in Serum-Free Medium (DMEM:F12) for a further six 
days. For the first 5 days, cells were grown in 400 µM L-proline and 1000 U/ml LIF. This 
combination was used to drive the differentiation of mESCs to a second pluripotent EPL-cell 
population (as has been observed in adherent culture (Washington et al., 2010)). From Days 6–
9, LIF was removed to permit loss of pluripotency and various combinations of 400 µM L-
proline and 10 µM ALK–4/5/7 receptor inhibitor/mesendoderm inhibitor, SB431542 (Inman 
et al., 2002), were used. The purpose of the latter was to help prevent off-pathway 
differentiation (i.e., differentiation away from neurectoderm). As a control, EBs were grown 
in Basal Medium suitable for allowing spontaneous (rather than directed) differentiation of the 
ESCs.  
 
During the course of this 15-day protocol, EBs were tested for the expression of selected genes 
and proteins, photographed to assess morphology, and analysed for the presence of various 
neural cell types.  
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Figure 3.7: L-proline and LIF-based protocols used to test the differentiation of mESCs to neural 
cells via a series of embryologically relevant cell types. D3 and 46C mESCs were cultured as EBs in 
the presence of 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, 
EBs were cultured in (i) 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB), (ii) 400 µM L-
proline (P/1000 L then P), (iii) 10 µM SB (P/1000 L then SB) or (iv) without L-proline or SB (P/1000 
L then no addition). Alternatively, EBs were cultured in Basal Medium for the whole nine days. At the 
end of Day 9, EBs were seeded down in Serum-Free Medium for a further six days, after which they 
were assessed for neural morphology. Populations of cells expected at various time points are listed 
(mESCs, EPL cells, DE = definitive ectoderm, NE = neurectoderm, NP = neural progenitor, N = neuron, 
ME  = mesendoderm), and markers for each cell type are shown underneath (Harvey et al., 2010; 
Rathjen et al., 2002; Tropepe et al., 2001; Smukler 2006; Suter et al., 2009; Lowell et al., 2006; Pevny 
et al., 1998; Pearce and Evans 1999; Wood and Episkopou 1999; Hart et al., 2002; Aubert et al., 2003; 
Pevny and Placzek 2005).  
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3.3.1 mESCs cultured as EBs in L-proline and LIF are smooth and spherical 
and increase in size over time 	
Over the first five days, D3 and 46C EBs cultured in P/1000 L (Figure 3.7) remained smooth 
and spherical with diameters from 100–200 µm on Day 3, approximately doubling by Day 5 
(Figure 3.8). EBs cultured in Basal Medium (which promotes spontaneous differentiation) had 
smaller diameters on Day 3 (50–100 µm), amorphous shapes, and a rough surface indicative 
of a rind of extra-embryonic primitive endoderm (Doetschman et al., 1985; Kurosawa, 2007; 
Liu et al., 2009). EBs derived from the 46C cell line were, on average, smaller than those 
derived from the D3 cell line but retained a smooth, spherical shape (Figure 3.8). 	
	
 
Figure 3.8: mESCs cultured in suspension in LIF and L-proline form smooth, spherical EBs. (A) 
D3 and (B) 46C mESCs were cultured in suspension in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) 
for the five days. Alternatively, EBs were cultured in Basal Medium for the five days. Images are 
representative of n>3 using phase-contrast microscopy and a 10X objective; scale bar = 200 µm. 	
From Day 5, EBs continued to increase in size across all conditions. Those which had been 
cultured in LIF for the first five days remained spherical even after the removal of LIF (Figure 
3.9), while those cultured in Basal Medium continued to develop amorphously, and by Day 9 
many had begun to form cysts (Figures 3.9 and 3.10).  
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Figure 3.9: mESCs cultured in suspension for the first five days continue to differentiate as 
smooth, spherical EBs following the removal of LIF.	D3 and 46C mESCs were cultured as EBs in 
the presence of 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, 
EBs were cultured in (i and vi) 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB) (ii and vii) 
400 µM L-proline (P/1000 L then P) (iii and viii) 10 µM SB (P/1000 L then SB) or (iv and ix) without 
L-proline or SB (P/1000 L then no addition). Alternatively, EBs were cultured in Basal Medium for the 
whole 9 days (v and x). EBs were imaged using phase contrast microscopy with a 10X objective; except 
for Ax (20X). White arrows indicate cysts.              
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Figure 3.10: Cyst formation in an EB produced from mESCs cultured in Basal Medium.	 D3 
mESCs were cultured in suspension to form EBs for nine days and imaged using phase contrast 
microscopy at four different planes of focus to highlight this cyst. 20X objective; scale bar = 50 µm. 	
3.3.2 EBs cultured in L-proline give rise to neural cells including neural 
progenitors and neurons 	
At the end of Day 9, EBs were seeded down into gelatinized wells in Serum-Free Medium 
(DMEM:F12) and allowed to differentiate for a further 6 days, after which they were scored 
for the presence of neural phenotypes, including neurites, axonal bundles, neural progenitors 
and focal rosettes. Figures 3.11 and 3.12 show representative examples of these phenotypes. 
The majority of the neural phenotypes observed by Day 15 were neural progenitors (Figures 
3.11 and 3.12).  
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Figure 3.11: L-proline-mediated differentiation of mESCs to mature neural cells including neural progenitors and neurons.	D3 mESCs were cultured 
as EBs in the presence of 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 
µM SB431542 (P/1000 L then P/SB). At the end of Day 9, EBs were seeded down in Serum-Free Medium on 0.1% gelatin-coated 48-well plates for a further 
six days, after which they were observed for neural phenotypes including axonal projections and bundles (broken black arrows), individual neurites (broken 
white arrows), neural progenitors (solid white arrows) and neural rosettes (solid black arrows). Insets have been used to zoom in on the structures of interest. 
Representative images were taken using phase-contrast microscopy using a 10X objective, scale bar = 400 µm; 20X, scale bar = 200 µm or 40X, scale bar = 100 
µm. 																								
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Figure 3.12: EBs cultured in L-proline give rise to Nestin+, BLBP+ and NeuN+ cells with neural 
morphologies.	D3 mESCs were cultured as EBs in the 400 µM L-proline ± 1000 U/ml LIF (P/1000L 
or P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM 
SB431542 (P/1000 L then P/SB). At the end of Day 9, EBs were seeded down in Serum-Free Medium 
on 0.1% gelatin-coated 48-well plates for a further six days after which they were fixed and stained 
with primary and secondary antibodies for the presence of the neural progenitor markers BLBP and 
Nestin and the mature neuron marker NeuN. Nuclei were stained with DAPI. Images were taken either 
on the Zeiss LSM 510 Meta Spectral confocal microscope (20X objective. Scale bar = 50 μm), the Zeiss 
LSM800 confocal microscope (20X objective; scale bar = 200 μm) or the EVOS (20X objective; scale 
bar = 200 μm). Insets have been used to zoom in on the structures of interest showing neural cell 
morphologies including bipolar cell bodies (solid arrows) and neurites (dashed arrows). 
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3.3.3 EBs cultured in L-proline give rise to the highest proportion of EBs 
with neural morphologies 	
To begin to quantify the production of neural cells, Day 15 seeded-down EBs were scored for 
the presence of neural phenotypes. EBs cultured for 9 days in the P/1000 L then P/SB condition 
from both cell lines produced a statistically significant increase in the percentage of EBs with 
neural phenotypes compared to when L-proline was removed from day 5 (P/1000 L then no 
addition) and Basal Medium (Figures 3.13 and 3.14 and Table 3.1). With the D3 cell line this 
was an ~4X and ~8X increase, respectively. No significant differences were observed between 
(i) P/1000 L then P/SB, (ii) P/1000 L then P or (iii) P/1000 L then SB culture conditions in 
either cell line (Figure 3.14 and Table 3.1). When comparing the two cell lines, no significant 
differences were observed between the same culture conditions. 																															
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Figure 3.13: L-proline promotes the differentiation of mESCs to neural cell types in EBs. D3 mESCs were cultured as EBs in the presence of (A–D) 400 
µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From days 6–9, EBs were cultured in either (A) 400 µM L-proline + 10 µM SB431542 (P/1000 
L then P/SB) (B) 400 µM L-proline (P/1000 L then P) (C) 10 µM SB alone (P/1000 L then SB) or (D) without L-proline or SB (P/1000 L then no addition). (E) 
Alternatively, EBs were cultured in Basal Medium for the whole nine days. At the end of Day 9, EBs were seeded in Serum-Free Medium for a further six days, 
after which they were assessed for neural morphology. Neural phenotypes, including axonal projections (black arrows) and neural progenitors (white arrows) 
were observed in EBs cultured in L-proline ± SB431542 (A–D), whilst beating patches (asterisk) within EBs were observed in both D and E. 10X objective; 
scale bar = 200 µm. Insets have been used to zoom in on the structures of interest showing neural cell morphologies including bipolar cell bodies and neurites.  
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Figure 3.14: mESCs cultured as EBs for nine days in the presence of LIF and L-proline give rise 
to EBs with neural cell types by Day 15.	(A) D3 and (B) 46C mESCs were cultured as EBs in 400 µM 
L-proline + 1000 U/ml LIF for five days (P/1000 L). From days 6–9, EBs were cultured in (i) 400 µM 
L-proline + 10 µM SB431542 (P/1000 L then P/SB), (ii) 400 µM L-proline (P/1000 L then P), (iii) 10 
µM SB (P/1000 L then SB) or (iv) without L-proline or SB (P/1000 L then no addition). Alternatively, 
EBs were cultured in Basal Medium (BM) for the whole nine days. At the end of Day 9, EBs were 
seeded down in Serum-Free Medium for a further six days, after which they were assessed for neural 
morphologies including axonal projections, axonal bundles and neural progenitors. Data presented as a 
mean percentage (of the total number of EBs per condition) ± SEM (n≥3). One-way ANOVA, Tukey’s 
multiple comparisons test; *P<0.05, **P<0.01. 																
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Table 3.1: mESCs cultured as EBs for five days in the presence of LIF and L-proline give rise to 
EBs with neural cell types by Day 15. These are the tabulated values for the data presented in Figure 
3.14. D3 and 46C mESCs were cultured as EBs 400 µM L-proline + 1000 U/ml LIF (P/1000) for the 
first five days. From days 6–9, EBs were cultured in (i) 400 µM L-proline + 10 µM SB431542 (P/1000 
L then P/SB), (ii) 400 µM L-proline (P/1000 L then P), (iii) 10 µM SB (P/1000 L then SB) or (iv) the 
absence of L-proline and SB (P/1000 L then no addition) Alternatively, EBs were cultured in Basal 
Medium for the whole nine days. At the end of Day 9, EBs were seeded down in Serum-Free Medium 
for a further six days, after which they were assessed for neural morphology including axonal 
projections, axonal bundles and neural progenitors. Data presented as a mean percentage (of the total 
number of EBs per condition) ± SEM (n≥3). One-way ANOVA, Tukey’s multiple comparisons test; 
*P<0.05 compared to P/1000 L then P/SB; ^P<0.05 compared to P/1000 L then P; #P<0.05 compared 
to P/1000 L then SB. 	
D3 
 
46C 
 
Mean (%) ± SEM (%) Mean (%) ± SEM (%) 
P/1000 L then 
P/SB 57 8 46 5 
P/1000 L then 
P 55 15 40 6 
P/1000 L then 
SB 49 10 33 9 
P/1000 L then 
no addition 15 *^# 6 12 *^ 2 
Basal 
Medium 7 *^# 1 10 *^# 3 																	
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3.3.4 Is there a concentration-dependent effect of L-proline in Serum-Free 
Medium? 	
The Serum-Free Medium used to culture the seeded down EBs for six days after Day 9 contains 
DMEM:F12. F12 contains L-proline, and its final concentration in Serum-Free Medium is 150 
µM. To test whether there was a concentration-dependent effect of L-proline on neural-cell 
production during Days 10–15, formulations of the Serum-Free Medium were made up in the 
absence of L-proline (100% DMEM), 50% DMEM:50% F12 (150 µM L-proline), and 50% 
DMEM:50% F12 supplemented with additional L-proline (400 µM L-proline final). Figure 
3.15 shows that the percentage of EBs with neural phenotype was significantly reduced in the 
absence of L-proline compared to that seen with 150 and 400 µM L-proline but no differences 
were observed between these higher concentrations. Thus, for the remainder of this work, EBs 
were cultured using the standard serum-free conditions outlined in Figure 3.7 (i.e., DMEM:F12 
containing 150 µM L-proline).  
 
	
 
Figure 3.15: Inclusion of L-proline from Days 10–15 significantly increases the percentage of EBs 
showing neural phenotypes. 46C mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF 
(P/1000 L) for the first five days. Between Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM 
SB431542 (P/1000 L then P/SB). At the end of Day 9, EBs were seeded down in Serum-Free Medium 
containing (i) 50% DMEM/50% F12 (150 µM L-proline) (ii) 50% DMEM/50% F12 + 250 µM 
additional L-proline (400 µM L-proline) or (iii) 100% DMEM (0 µM L-proline). On Day 15, EBs were 
scored for the presence of neural phenotypes, including axonal projections, axonal bundles and neural 
progenitors. Data presented as a mean percentage (of the total number of EBs per condition) ± SEM 
(n≥3); one-way ANOVA, followed by Tukey’s multiple comparisons test; *P<0.05. 
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3.3.5 EBs cultured in L-proline produce neural progenitors and neurons 
that express the neuronal markers Nestin, BLBP and NeuN 	
To determine the direction of differentiation inside the EBs, we used immunofluorescence 
imaging of the neural progenitor markers Nestin and BLBP, as well as the neuronal marker 
NeuN (Figure 3.16). Note that nominally we used Nestin as a marker of neural progenitors, but 
it can also be expressed in muscle progenitor cells (for further discussion, see Chapter 4).   									
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Figure 3.16: Day 15 EBs cultured in L-proline express the neural progenitor marker Nestin in the core of EBs and BLBP and NeuN in the rind of the 
EBs. D3 mESCs were cultured as EBs in (A) 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for five days. From Days 6–9, EBs were cultured in 400 µM L-
proline + 10 µM SB431542 (P/1000 L then P/SB). (B) Alternatively, EBs were cultured in Basal Medium for the whole nine days. At the end of Day 9, EBs 
were seeded down in Serum-Free Medium for a further 6 days after which they were fixed and stained with primary and secondary antibodies for the presence 
of the neural progenitor markers BLBP and Nestin and the mature neuron marker NeuN. Nuclei were stained with DAPI. (C) Secondary-only antibody stains 
using mouse or rabbit Alexa-488 (m488 or r488) and rat Alexa-647 (rat647). Images were taken on the Zeiss LSM 510 Meta Spectral confocal microscope 
(10X objective; scale bar = 200 μm).																								
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3.3.6 Time-lapse imaging of Day 12–15 EBs reveals dynamic cell 
proliferation and cell–cell interaction 	 	
 
Using time-lapse imaging of seeded-down EBs, cells were observed to migrate from the edges 
of the EBs as flat epithelial cells, which were generally bipolar or triangular in shape and 
possessed multiple small neurites at the vertices (Figures 3.11, 3.12 and 3.17). These cells not 
only migrated, they also divided frequently and made and broke contact with one another 
(Figure 3.17). Individual neurites from these neural progenitors were evident as early as the 
first image taken (t = 0 h) (Day 12 of culture) and ranged in length from ~10 µm to >150 µm 
(Figure 3.17). These neurites were frequently seen to extend and retract as they ‘explored’ their 
environment. 
 
Long neurite bundles that extended from the EBs were also evident as early as t = 0 h (Day 12) 
(Figure 3.17). Over the time course, these axons often merged with one another starting from 
the end closest to the EB, ultimately forming thick axonal bundles up to ~15 µm in diameter 
and > 300 µm in length (Figure 3.17).   
 
Individual cells attached to and migrated along these axonal bundles and the neurites extending 
from them (see section 1.1.8). Axonal bundles and neurites were often associated with small 
clusters of round cells (Figure 3.17) that appeared to ‘grab’ surrounding cells and recruit them 
to the cluster. The clusters associated with the axonal bundles moved with the bundles as they 
extended and retracted. These clusters contrasted with the bipolar and triangular neural 
progenitor cells, which were proliferative and migrated along the tissue-culture surface, 
independent of the axonal bundles. 
  
As well as the individual cells being dynamic in nature, it was consistently observed that the 
entire EB migrated along the surface of the tissue culture plate, often out of the field of view 
(Figure 3.17).  
 
Due to technical issues with the equipment (throughout the course of my PhD), we were unable 
to perform fluorescence time-lapse imaging on the 46C cell line to identify temporal and spatial 
Sox1-GFP expression in real time. 	
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Figure 3.17: Time-lapse imaging of Day 12–15 mESC-derived neural cells cultured in L-proline. D3 mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF 
(P/1000 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). At the end of Day 9, EBs were seeded 
down in Serum-Free Medium for a further six days. On Day 12, EBs were loaded into the Cell Voyager CV1000 and were imaged (10X objective; scale bar = 164 µm) every 
10 minutes to produce a movie. Time displayed indicates hours following the first image taken. EBs were assessed for the production of neural phenotypes including neural 
progenitors, axonal bundles (black arrows) and rosette structures (white circle). Clusters of round cells (black circle) were also associated with these phenotypes. A and B are 
representative still images taken from two independent EBs.  
105		
3.4 Differentiation of mESCs to EPL cells in EB culture 	
Having confirmed that the L-proline-based protocol described in Figure 3.7 produces neural 
cell types following EB culture, we wanted to investigate the differentiation pathway that the 
cells were undertaking to reach the neurectoderm stage and beyond. As such, the EBs were 
cultured as described in Figure 3.7 and assessed for marker expression at various time points 
(Figure 3.18) using qPCR, flow cytometry and immunofluorescence imaging. 
 
We hypothesized that mESCs cultured using our L-proline-containing protocols would 
recapitulate MEDII-mediated Dnmt3b+ and Fgf5+ EPL cell differentiation between Days 0–5 
(Figure 3.18) (Harvey et al., 2010).  
	
	
 
Figure 3.18: Protocol design and rationale for L-proline-mediated EPL-cell differentiation from 
mESCs expected to occur between Days 0-5. D3 and 46C mESCs were cultured as EBs in 400 µM 
L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, EBs were cultured in 400 
µM L-proline + 10 µM SB431542 (P/1000 L then P/SB) and at the end of Day 9, EBs were seeded 
down in Serum-Free Medium for a further six days. Populations of cells expected at various time points 
are listed (mESC, EPL-cell, DE = definitive ectoderm, NE = neurectoderm, NP = neural progenitor, N 
= neuron, ME  = mesendoderm) and markers for each cell type are shown underneath (Harvey et al., 
2010; Rathjen et al., 2002; Tropepe et al., 2001; Smukler 2006; Suter et al., 2009; Lowell et al., 2006; 
Pevny et al., 1998; Pearce and Evans 1999; Wood and Episkopou 1999; Hart et al., 2002; Aubert et al., 
2003; Pevny and Placzek 2005). 
106		
3.4.1 EPL cell differentiation in EB culture is slow in the presence of LIF 
 
In the presence of MEDII, mESCs cultured as EBs and as a monolayer transition into a second 
pluripotent population of EPL cells (Rathjen et al., 1999, 2003; Tan et al., 2011; Washington 
et al., 2010). These cells down-regulate the expression of the mESC marker Rex1, up-regulate 
the expression of the EPL-cell markers Dnmt3b and Fgf5, whilst maintaining the expression of 
the pluripotency markers Oct4 and Nanog (Rathjen et al., 2003; Tan et al., 2011, 2016; 
Washington et al., 2010) (Figure 3.18). Based on these data, this Section will focus on the 
expression of these markers at the gene and protein levels in the P/1000 L then P/SB EB 
protocol (Figures 3.7 and 3.18) and compare the results to the differentiation in Basal Medium. 
All qPCR data are expressed as log2-transformed data and statistics were performed using a 
two-way ANOVA, followed by Dunnett’s multiple comparisons test, unless specified 
otherwise. 
 
When EBs were cultured in P/1000 L then P/SB, there were few signs that any differentiation 
occurred at the level of gene expression. Figure 3.19 and Table 3.2 showed that in D3 cells, the 
only significant change in gene expression was the up-regulation of Fgf5 at Day 9, providing 
evidence for EPL-cell differentiation. In comparison, D3 cells cultured in Basal Medium 
showed a significant up-regulation in Dnmt3b and Fgf5 expression on Day 3, indicating EPL-
cell formation had occurred earlier than in P/1000 L then P/SB EBs. This was accompanied by 
a significant down-regulation in Rex1 expression from Day 3, also indicative of mESC 
differentiation (Figure 3.19 and Table 3.2). Nanog expression was significantly down-
regulated on Day 9 in Basal Medium EBs, whilst no significant difference was observed in 
Oct4 expression, indicative of the maintenance of pluripotency. Taken together, D3 mESCs 
cultured in P/1000 L then P/SB differentiated into EPL cells six days slower than EBs cultured 
in Basal Medium with no loss of pluripotency in either culture condition.    
 
46C cells cultured in P/1000 L then P/SB showed a significant up-regulation of Fgf5 expression 
from Day 5, indicating EPL-cell formation. Significant down-regulation of Oct4 expression 
was observed at Day 9, indicating some cells had lost pluripotency. No other significant 
changes were observed in gene expression. When 46C cells were cultured in Basal Medium, 
no changes in the expression of Rex1, Nanog or Oct4 were observed. However, a significant 
up-regulation in both Dnmt3b and Fgf5 was observed between Days 3–9, indicative of EPL-
cell differentiation. Taken together, 46C mESCs cultured in P/1000 L then P/SB differentiated 
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into EPL cells by Day 5 with loss of pluripotency occurring at Day 9, whilst EBs cultured in 
Basal Medium maintained a Dnmt3b+/Fgf5+ EPL cell population with no loss of pluripotency.  				
108		
	
109		
Figure 3.19: EBs cultured in P/1000 L then P/SB differentiate into EPL cells more slowly than EBs cultured in Basal Medium. (A, B) D3 and (C, D) 46C 
mESCs were cultured as EBs in (A, C) 400 µM L-proline + 1000 U/ml LIF for five days (P/1000 L). From Days 6–9, EBs were cultured in 400 µM L-proline 
+ 10 µM SB431542 (P/1000 L then P/SB). (B, D) Alternatively, EBs were cultured in Basal Medium for the whole nine days. Samples were taken at Days 0, 3, 
5, 7 and 9 and assessed for mESC (Rex1), EPL-cell (Dnmt3b and Fgf5) and pluripotency (Nanog and Oct4) marker expression by qPCR. Results are expressed 
as log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. The 4 coloured bars for each gene represent expression as mean ± 
SEM (n≥3) sequentially from Day 3 (left most bar) through Days 5, 7 and 9. A two-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s 
multiple comparisons test; *P<0.05; **P<0.01. 																								
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Table 3.2:	EBs cultured in P/1000 L then P/SB differentiate into EPL cells more slowly than EBs cultured in Basal 
Medium. These are the tabulated values for the data presented in Figure 3.19. (A, B) D3 and (C, D) 46C mESCs were 
cultured as EBs in (A, C) 400 µM L-proline + 1000 U/ml LIF for five days (P/1000 L). From Days 6–9, EBs were 
cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). (B, D) Alternatively, EBs were cultured in 
Basal Medium for the whole nine days. Samples were taken at Days 0, 3, 5, 7 and 9 and assessed for mESC (Rex1), EPL 
cell (Dnmt3b and Fgf5) and pluripotency (Nanog and Oct4) marker expression by qPCR. Results are expressed as log2 
fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. Two-way ANOVA (compared to 
Day 0) was performed, followed by Dunnett’s multiple comparisons test; *P<0.05; **P<0.01. 	
   P/1000 L then P/SB Basal Medium 
   
Log2 fold 
change 
expression 
± SEM 
Log2 fold 
change 
expression 
± SEM 
Day 3 
Rex1 D3 
-0.3 0.4 -3* 0.2 
46C 1 0.2 0.3 1 
Nanog D3 -0.4 0.7 -0.5 0.5 
46C 0.5 0.6 -0.9 0.8 
Oct4 D3 
0.0 0.2 0.7 1 
46C -0.3 0.3 -0.5 0.7 
Dnmt3b D3 
0.4 0.8 4** 0.7 
46C -0.9 0.2 2* 0.8 
Fgf5 D3 -0.7 2 5** 2 
46C 0.3 0.9 3* 2 
Day 5 
Rex1 D3 -0.3 0.3 -2* 0.3 
46C 0.6 0.0 -0.5 0.9 
Nanog D3 
0.8 0.2 -0.3 0.7 
46C 1 0.8 0.5 0.6 
Oct4 D3 
-0.4 0.7 -0.3 0.7 
46C -0.3 0.3 -0.1 0.6 
Dnmt3b D3 0.9 0.6 1 0.9 
46C -0.2 0.3 4** 0.3 
Fgf5 D3 
2 1 5** 2 
46C 3* 2 6** 0.2 
Day 7 
Rex1 D3 -1 0.6 -4** 0.4 
46C -0.3 0.6 -2 0.5 
Nanog D3 
-0.5 1 -2 1 
46C -0.1 0.7 -0.5 0.6 
Oct4 D3 
-1 0.9 -2 1 
46C -1 0.3 0.2 0.9 
Dnmt3b D3 1 0.5 -0.4 0.6 
46C 1 0.1 4** 0.2 
Fgf5 D3 
2 1 3** 2 
46C 4** 2 7** 0.1 
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Table 
continued   
P/1000 L then P/SB Basal Medium 
   
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Day 9 
Rex1 D3 -2 0.9 -3** 0.7 
46C -0.8 0.3 2 0.5 
Nanog D3 
-0.3 0.4 -3* 2 
46C -0.3 0.4 -0.5 0.6 
Oct4 D3 
-1 0.2 -2 1 
46C -4 2 -0.8 1 
Dnmt3b D3 2 1 0.8 0.3 
46C 1 0.3 3** 0.5 
Fgf5 D3 
4** 2 3* 1 
46C 7** 0.3 7** 1 		 	
3.4.2 Oct4, Nanog and Dnmt3b protein expression decrease as mESCs lose 
pluripotency and differentiate  
 
D3 cells cultured in P/1000 L then P/SB showed no changes in Oct4 and Nanog gene 
expression. However, at the level of protein expression evidence for the loss of pluripotency 
was observed by the gradual decrease in Oct4+ and Nanog+ cells over time. The percentage of 
Oct4+ cells significantly decreased from 89 ± 7% in Day 0 mESCs to 2 ± 0.4% in Day 9 cells 
(Figure 3.20 and Table 3.3). Similarly, the percentage of Nanog+ cells significantly decreased 
from 87 ± 8% to 1 ± 0.4% by Day 9 (Figure 3.20 and Table 3.3).  
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Figure 3.20: mESCs down-regulate the expression of Oct4 and Nanog upon differentiation in L-proline. D3 
mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, 
EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). EBs were suspended as single cells 
on Days 0, 3, 5, 7 and 9 before being fixed and stained for the presence of Nanog and Oct4 and run on the FACSCalibur 
flow cytometer (1o + 2o). A 2o-only control was also run to assist with gating. Expression was assessed using FlowJo 
software. Data presented in (A) are representative dot plots of the co-expression of Oct4 and Nanog and (B and C) show 
the mean % cells ± SEM, n≥3. A one-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s 
multiple comparisons test; *P<0.05. The percentages shown in the panels represent the percentage of cells gated within 
each quadrant (Q1–4): Q1: Nanog+/Oct4–cells; Q2: Nanog+/Oct4+ cells; Q3: Nanog–/Oct4+ cells; Q4: Nanog–/Oct4– 
cells.  	
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Table 3.3: Changes in Oct4, Nanog and Dnmt3b expression when mESCs are cultured in P/1000 L then P/SB 
assessed by flow cytometry. These are the tabulated values for the data presented in Figures 3.20 and 3.22. D3 mESCs 
were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, EBs 
were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). EBs were suspended as single cells on 
Days 0, 3, 5, 7 and 9 before being fixed and stained for the presence of Oct4, Nanog or Dnmt3b and were run on the 
FACSCalibur flow cytometer. A 2o-only control was also run to assist with gating. Expression was assessed using 
FlowJo software. Data collected from the total cell population is presented as mean % cells ± SEM, n≥3. A one-way 
ANOVA (compared to Day 0) was performed per protein, followed by Dunnett’s multiple comparisons test; *P<0.05. 	
 
EB Day 
Mean (%) 
cells 
expressing 
Oct4 
± SEM 
(%) 
Mean (%) 
cells 
expressing 
Nanog 
± SEM 
(%) 
Mean (%) 
cells 
expressing 
Dnmt3b 
± SEM 
(%) 
 0 89 7 87 8 69 23 
P/1000 L 
then 
P/SB 
3 63* 6 52* 9 56 5 
5 46* 4 42* 3 46 4 
7 8* 4 13* 5 7* 3 
9 2* 0.4 1* 0.4 2* 1 		
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At Day 6, EBs were analysed by confocal microscopy for the expression of Oct4 and Nanog. 
Oct4-staining cells were distributed throughout the EBs, whilst Nanog expression was 
localized to cells near the surface of the EBs (Figure 3.21). A 25% decrease in Dnmt3b+ cells 
was observed between Days 0–5, and by Day 7, only 7 ± 3% of cells continued to express 
Dnmt3b (Figure 3.22).  
 
		
Figure 3.21: EBs cultured in the presence of LIF and L-proline express Nanog on the 
circumference of the EB. D3 mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF 
(P/1000 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM 
SB431542 (P/1000 L then P/SB). On Day 6, EBs were fixed and stained for the expression of Nanog 
and Oct4 and imaged using the Zeiss LSM 510 Meta Spectral confocal microscope (z-stack: 1µm slices; 
20X objective; scale bar = 100 µm). 
115		
	
 
Figure 3.22: mESCs maintain the expression of Dnmt3b until Day 7 when cultured in L-proline. D3 mESCs were 
cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for five days. From Days 6–9, EBs were cultured in 
400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). EBs were suspended as single cells on Days 0, 3, 5, 7 and 
9 before being fixed and stained for the presence of Nanog and Dnmt3b and run on the FACSCalibur flow cytometer 
(1o + 2o). A 2o-only control was also run to assist with gating. Expression was assessed using FlowJo software. Data 
presented in (A) are representative dot plots of the co-expression of Dnmt3b and Nanog and (B) mean % cells ± SEM, 
n≥3. A one-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple comparisons test; 
*P<0.05. The percentages shown in the panels represent the percentage of cells gated within each quadrant (Q1–4): Q1: 
Dnmt3b+/Nanog–cells; Q2: Dnmt3b+/Nanog+ cells; Q3: Dnmt3b–/Nanog+ cells; Q4: Dnmt3b–/Nanog– cells. 	
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3.4.3 EBs cultured in Basal Medium give rise to Dnmt3b+/Fgf5+ EPL cells 	
As described in section 3.4.1 and shown in Figure 3.19 and Table 3.2, when D3 cells were 
cultured as EBs in Basal Medium they transiently up-regulated Dnmt3b on Day 3, whilst Fgf5 
expression remained significantly up-regulated until Day 9. This was accompanied by a 
significant down-regulation in Rex1 expression, indicating mESC differentiation into EPL cells 
by Day 3. In the 46C cell line, no significant changes were observed in Rex1, whilst significant 
up-regulation in both Dnmt3b and Fgf5 from Day 3 was observed until Day 9 (Figure 3.19 and 
Table 3.2), also indicating EPL-cell differentiation. The pluripotency marker Oct4 showed no 
significant differences compared to Day 0 samples at the gene expression level in either cell 
line. However, at the level of protein expression, evidence for the loss of pluripotency in D3 
cells was observed by the decrease in the percentage of Oct4+ and Nanog+ cells over time. The 
percentage of Oct4+ cells significantly decreased from 89 ± 7% in Day 0 mESCs to 2 ± 0.2% 
in Day 9 cells. The percentage of Nanog+ cells also significantly decreased from 87 ± 8% in 
Day 0 mESCs to 2 ± 1% in Day 9 cells (Table 3.4 and Figure 3.23). Meanwhile, Dnmt3b 
protein expression rose and fell: A 14% increase in Dnmt3b+ cells was observed in Day 3 Basal 
Medium cells compared to mESCs (indicative of EPL-cell differentiation), decreasing to 7 ± 
5% (n≥3) cells expressing Dnmt3b by Day 7 (Figure 3.24).  																							
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Figure 3.23: mESCs down-regulate the expression of Oct4 and Nanog protein upon differentiation in Basal 
Medium. D3 mESCs were cultured as EBs in Basal Medium for nine days. EBs were suspended as single cells on Days 
0, 3, 5, 7 and 9 before being fixed and stained for the presence of Oct4 and Nanog and run on the FACSCalibur flow 
cytometer (1o + 2o). A 2o-only control was also run to assist with gating. Expression was assessed using FlowJo software. 
Data presented in (A) are representative dot plots of the co-expression of Oct4 and Nanog and (B and C) mean % cells 
± SEM, (n=3). A one-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple comparisons 
test; *P<0.05. The percentages shown in the panels represent the percentage of cells gated within each quadrant (Q1–
4): Q1: Nanog+/Oct4–cells; Q2: Nanog+/Oct4+ cells; Q3: Nanog–/Oct4+ cells; Q4: Nanog–/Oct4– cells. 			
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Table 3.4: Changes in Oct4, Nanog and Dnmt3b expression assessed by flow cytometry when mESCs are cultured 
in Basal Medium. These are the tabulated values for the data presented in Figures 3.23 and 3.24. D3 mESCs were 
cultured as EBs in in Basal Medium for nine days. EBs were suspended as single cells on Days 0, 3, 5, 7 and 9 before 
being fixed and stained for the presence of Nanog and Dnmt3b and run on the FACSCalibur flow cytometer (1o + 2o). 
A 2o-only control was also run to assist with gating. Expression was assessed using FlowJo software. Data collected 
from the total cell population (using forward and side scatter plots) and is presented as mean % cells ± SEM, n≥3. A 
one-way ANOVA (compared to Day 0) was performed per protein, followed by Dunnet’s multiple comparisons test; 
*P<0.05.  
 
EB Day 
Mean (%) 
cells 
expressing 
Oct4 
± SEM 
(%) 
Mean (%) 
cells 
expressing 
Nanog 
± SEM 
(%) 
Mean (%) 
cells 
expressing 
Dnmt3b 
± SEM 
(%) 
 0 89 7 87 8 69 23 
Basal 
Medium 
3 64* 13 87 5 79 10 
5 61* 9 47* 9 46 6 
7 15* 6 14* 3 7* 5 
9 2* 0.2 2* 1 1* 0.2 																																
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Figure 3.24: mESCs maintain the expression of Dnmt3b until Day 7 when cultured in Basal Medium. D3 mESCs 
were cultured as EBs in Basal Medium for nine days. EBs were suspended as single cells on Days 0, 3, 5, 7 and 9 before 
being fixed and stained for the presence of Nanog and Dnmt3b and run on the FACSCalibur flow cytometer (1o + 2o). 
A 2o-only control was also run to assist with gating. Expression was assessed using FlowJo software. Data presented in 
(A) are representative dot plots of the co-expression of Nanog and Dnmt3b and (B and C) mean % cells ± SEM, n≥3. 
A one-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple comparisons test; *P<0.05. 
The percentages shown in the panels represent the percentage of cells gated within each quadrant (Q1–4): 
Dnmt3b+/Nanog–cells; Q2: Dnmt3b+/Nanog+ cells; Q3: Dnmt3b–/Nanog+ cells; Q4: Dnmt3b–/Nanog– cells. 
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3.5 L-proline-based protocol promotes the differentiation of the 
neurectoderm lineage at the expense of mesendoderm  
 
EPL cells represent the in vitro-equivalent population of in vivo primitive ectoderm (Rathjen 
et al., 1999). As such, they are capable of differentiating into each of the three multipotent 
definitive germ layers: definitive endoderm, mesoderm and ectoderm. In the embryo, cells of 
the definitive mesoderm and endoderm (collectively known as the mesendoderm), undergo an 
EMT and migrate through the primitive streak, expressing the primitive streak marker Mixl1 
(Hart et al., 2002) (Figure 1.2 and Figure 1.3). Cells that do not ingress through the primitive 
streak give rise to the definitive ectoderm, which forms the precursor tissue for the Sox1+ 
neurectoderm (Figure 1.2 and Figure 1.3). However, unlike the definitive mesoderm and 
endoderm lineages, which are relatively well characterized, there are currently no established 
markers of the definitive ectoderm germ layer.  
 
Following the transition of mESCs into EPL cells in the presence of MEDII, a population of 
Penk1 and Pard6b cells arise, immediately preceding that of Sox1 expression (Harvey et al., 
2010). It has been suggested that this population represents in vitro definitive ectoderm (Harvey 
et al., 2010). As L-proline is a bioactive molecule found in MEDII, we hypothesized that the 
continued culture of EBs in 400 µM L-proline would drive the differentiation of EPL cells 
towards a Penk1+/Pard6b+ population of cells that represent the multipotent definitive 
ectoderm. Figure 3.25 outlines the protocol design and rationale for this hypothesis, 
highlighting the area of interest for this section of work. EBs were assessed for the expression 
of the potential definitive ectoderm markers Pard6b and Penk1, as well as the neurectoderm 
marker Sox1 and neural progenitor marker Nestin by qPCR. Similarly, Mixl1 expression was 
assessed as a measure of mesendoderm formation. All qPCR data is expressed as log2-
transformed data and statistics were performed using a two-way ANOVA, followed by 
Dunnett’s multiple comparisons test, unless specified otherwise (Figure 3.25).  
 
The 46C cell line was used in this analysis to track temporal and spatial Sox1 expression within 
EBs as a measure of neurectoderm formation, via the expression of GFP.  	
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Figure 3.25: Protocol design and rationale for L-proline-mediated definitive ectoderm and 
neurectoderm differentiation from mESCs expected to occur between Days 6–9. D3 and 46C 
mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first 5 days. From 
Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). At the end 
of Day 9, EBs were seeded down in Serum-Free Medium for a further 6 days. Populations of cells 
expected at various time points are listed (mESCs, EPL cells, DE = definitive ectoderm, NE = 
neurectoderm, NP = neural progenitor, N = neuron, ME  = mesendoderm) and markers for each cell type 
are shown underneath (Harvey et al., 2010; Rathjen et al., 2002; Tropepe et al., 2001; Smukler 2006; 
Suter et al., 2009; Lowell et al., 2006; Pevny et al., 1998; Pearce and Evans 1999; Wood and Episkopou 
1999; Hart et al., 2002; Aubert et al., 2003; Pevny and Placzek 2005). 
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3.5.1 EBs cultured with L-proline and LIF for the first five days 
differentiate into Sox1+ neurectoderm at the expense of Mixl1+ 
mesendoderm  
 
When EBs were cultured in P/1000 L then P/SB, there were few signs that any differentiation 
into Penk1+ or Pard6b+ definitive ectoderm occurred with either D3 or 46C cell lines. Figure 
3.26 and Table 3.5 showed that in D3 cells the only significant changes in gene expression was 
the up-regulation of Sox1 and down-regulation of Mixl1 at Day 9, indicative of neurectoderm 
differentiation at the expense of mesendoderm differentiation. By contrast, EBs cultured in 
Basal Medium produced a significant up-regulation in Mixl1 (from Days 3–7) and a significant 
down-regulation in Sox1 expression (from Day 3 onwards) was observed (Figure 3.26 and 
Table 3.5), indicative of mesendoderm differentiation at the expense of neurectoderm. 
However, some neural lineage commitment did occur based on the significant up-regulation of 
the definitive ectoderm and neural progenitor markers Penk1 and Nestin, respectively, on Day 
5.  
 
When 46C cells were cultured as EBs in P/1000 L then P/SB, a significant down-regulation in 
Penk1 and Mixl1 expression was observed on Day 9 and no other significant changes were 
observed in gene expression. When 46C cells were cultured as EBs in Basal Medium, a 
significant up-regulation in the expression of Mixl1 was observed between Days 7–9 and Nestin 
was significantly up-regulated between Days 5–9. Sox1 expression was significantly down-
regulated at Day 9. Although the results are not as clear as with the D3 cell line, collectively 
they suggest that the 46C cells produce neural cell types over mesendoderm in the presence of 
L-proline and the opposite in the presence of Basal Medium (Figure 3.26 and Table 3.5).  													
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Figure 3.26: mESCs transition to Sox1+ neurectoderm at the expense of Mixl1+ mesendoderm in the presence of L-proline. (A-B) D3 and 46C (C-D) 
mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline 
+ 10 µM SB431542 (P/1000 L then P/SB). Alternatively, EBs were cultured in Basal Medium for the whole nine days. Samples were taken at Days 0, 3, 5, 7 
and 9 and assessed for definitive ectoderm (Penk1 and Pard6b), neurectoderm (Sox1), neural progenitor (Nestin) and mesendoderm (Mixl1) marker expression 
by qPCR. Results are expressed as log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. The 4 coloured bars for each gene 
represent expression as mean ± SEM (n≥3) sequentially from Day 3 (left most bar) through Days 5, 7 and 9. A two-way ANOVA (compared to Day 0) was 
performed, followed by Dunnett’s multiple comparisons test; *P<0.05, **P<0.01. 
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Table 3.5: mESCs transition to Sox1+ neurectoderm at the expense of Mixl1+ mesendoderm in the 
presence of L-proline. These are the tabulated values for the data presented in Figure 3.26. D3 and 
46C mESCs were cultured as EBs in 400 µM L-proline + 1000 U/ml LIF for the first five days (P/1000 
L). Between Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then 
P/SB). Alternatively, EBs were cultured in Basal Medium for the whole nine days. Samples were taken 
at Days 0, 3, 5, 7 and 9 and assessed for definitive ectoderm (Penk1 and Pard6b), neurectoderm (Sox1), 
neural progenitor (Nestin) and mesendoderm (Mixl1) marker expression by qPCR. Results are 
expressed as log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene 
(n≥3). For comparisons made between time points per condition, a two-way ANOVA (compared to 
Day 0) was performed, followed by Dunnett’s multiple comparisons test; *P<0.05, **P<0.01. For 
comparisons made between cell lines, a two-way ANOVA was performed, followed by Tukey’s 
multiple comparisons test; ^ denotes P<0.05 for D3 cells compared to (day- and gene- matched) 46C 
cells. 	 	 	 	 P/1000 L then P/SB Basal Medium 
	 	 	
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Day 3 
Penk1 
D3 0.02 0.8 2 0.4 
46C  -2 1 -9 0.2 
Pard6b D3 -0.1 0.4 0.3 0 
46C  0.1 0.4 -0.6 0.8 
Sox1 
D3 -0.3 0.9 -3*^ 0.6 
46C  -1 0.2 0.3 0.5 
Nestin 
D3 1 0.3 0.9* 0.4 
46C  -0.7 2 0.8 0.1 
Mixl1 
D3 0.7 0.6 3*^ 0.5 
46C  0.9 0.7 -4* 2 
Day 5 
Penk1 
D3 1 0.2 3*^ 0.5 
46C  -0.7 1 0 0.2 
Pard6b 
D3 1 0.3 0.8 0.4 
46C  0.5 0.6 0.3 0.7 
Sox1 D3 0.4 0.5 -4*^ 0.5 46C  0.4 0.6 1* 0.5 
Nestin 
D3 1 0.2 3* 0.7 
46C  2 0.6 2 0.3 
Mixl1 
D3 0.4 0.4 8*^ 1 
46C  -1 0.7 0.9* 0.3 				
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Table 
continued 	 	 P/1000 L then P/SB Basal Medium 
	 	 	
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Day 7 
Penk1 D3 2* 1.2 1.1 1 46C  -1 1.1 -0.5 1 
Pard6b 
D3 2 0.3 0.9 0.2 
46C  0.7 0.7 1.8 0.4 
Sox1 
D3 0.02 1.6 -4.1*^ 1 
46C  1 0.2 -0.3 0.5 
Nestin D3 2 0.5 0.6*^ 0.8 46C  2.2 0.4 3.5 0.3 
Mixl1 
D3 -0.8 0.4 4.3* 1 
46C  -2 2.1 3.2* 0.5 
Day 9 
Penk1 D3 0.7 0.5 2^ 1 46C  -4 3 -0.9 0.7 
Pard6b 
D3 1 0.2 1 0.7 
46C  1 0.5 0.1 1 
Sox1 
D3 3* 0.5 -3* 2 
46C  1 0.3 -3 0.8 
Nestin D3 2 0.7 0.4*^ 0.9 46C  2 0.7 3 0.7 
Mixl1 
D3 -2* 1 2* 0.3 
46C  -4* 2 3 1 																	
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3.5.2 Sox1-GFP expression increases over time when EBs are cultured in L-
proline 	
The 46C cell line was used in this section to track temporal and spatial Sox1 expression 
within EBs as a measure of neurectoderm formation, via the expression of GFP. 
 
When cells were cultured in P/1000 L then P/SB, 40 ± 3% cells expressed Sox1-GFP by Day 9, 
and this expression was maintained within the core of the seeded Day 15 EBs (Figure 3.27). 
Neural progenitor cells that had migrated from the Day 15 EBs down-regulated the expression 
of Sox1-GFP. In comparison, 28 ± 4% of cells in Basal Medium expressed Sox1-GFP, 
plateauing at Day 7 (Figure 3.27). Patches of faint Sox1-GFP expression were observed 
scattered through Day 15 EBs cultured in Basal Medium, indicative of spontaneous 
differentiation (Figure 3.27). In addition, few neural progenitors were observed in these EBs.  																														
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Figure 3.27: L-proline promotes the differentiation of Sox1-GFP+ neurectoderm. 46C mESCs were 
cultured as EBs in 400 µM L-proline + 1000 U/ml LIF (P/1000 L) for the first five days. From Days 6–
9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). Alternatively, 
EBs were cultured in Basal Medium for the whole nine days. (A) EBs were suspended as single cells 
on Days 0, 3, 5, 7 and 9 before being fixed and run on the FACSCalibur flow cytometer. Day 0 mESCs 
were used to assist with gating. Expression was assessed using FlowJo software. Data was collected 
from the total cell population and presented as mean % cells ± SEM, n≥3. A one-way ANOVA 
(compared to Day 0) was performed per condition, followed by Dunnett’s multiple comparisons test. 
To test differences between culture conditions per day, a two-way ANOVA, followed by Sidak’s 
multiple comparisons test was performed; *P<0.05. (B) At the end of Day 9, EBs were seeded in Serum-
Free Medium on 0.1%-gelatin-coated 48-well plates for a further six days, after which they were fixed 
and imaged for Sox1-GFP expression. Arrows point to neural progenitors which have lost Sox1-GFP 
expression (10X objective; scale bar = 200 µm).	
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3.6 Can mESCs form neurectoderm when cultured in L-proline in the 
absence of LIF? 	
When mESCs were cultured in P/1000 L then P/SB, a significantly increased percentage of 
EBs with neural phenotypes was produced compared to that observed (i) without the addition 
of L-proline and SB4325142 after Day 5 (P/1000 L then no addition) and (ii) Basal Medium 
(Figures 3.11, 3.12, 3.13 and 3.14 and Table 3.1). However, qPCR indicated that little 
differentiation beyond mESCs and EPL cells was observed with both D3 cells and 46C cell 
lines until LIF was removed on Day 6 (Figure 3.19 and Table 3.2). In comparison, EBs cultured 
in Basal Medium showed significant down-regulation of Rex1 and significant up-regulation of 
Fgf5 and Dnmt3b by Day 3, indicating mESCs differentiated into EPL cells in the absence of 
LIF much more quickly that EBs cultured in P/1000 L then P/SB. However, EBs that were 
cultured in Basal Medium had a significant reduction in neural cells by Day 15 compared to 
P/1000 L then P/SB (Figures 3.14 and 3.13 and Table 3.1) and down-regulated the expression 
of Sox1 (Figures 3.26 and 3.27 and Table 3.5).  
 
With these results in mind, we combined aspects of these two protocols (P/1000 L then P/SB 
and Basal Medium) by testing a number of different concentrations of LIF (from 0–1000 U/ml) 
while maintaining L-proline and SB431542. We hypothesized that decreasing the 
concentration of LIF would promote faster and more homogeneous differentiation to EPL cells. 
Figure 3.28 outlines the various protocol for this hypothesis, including the presence or absence 
of L-proline + SB431542 after Day 5. As a control, EBs were grown in Basal Medium suitable 
for allowing spontaneous (rather than directed) differentiation of the ESCs.  
 
Over the course of 15 days, EBs were tested for the expression of selected genes and proteins, 
photographed to assess morphology, and were analysed for the presence of various neural cell 
types (Figures 3.11 and 3.12).  
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Figure 3.28: L-proline-based protocols using different concentrations of LIF to test the 
differentiation of mESCs to neural cells via embryologically relevant cell types. D3 and 
46C mESCs were cultured as EBs in the presence of 400 µM L-proline + 1000, 500, 330 or 0 U/ml LIF 
(P/1000 L, P/500 L, P/330 L, P/0 L) for the first five days. From Days 6–9, EBs were cultured in (i) 
400 µM L-proline + 10 µM SB431542 (P/SB) or (ii) without L-proline or SB431542 (no addition). 
Alternatively, EBs were cultured in Basal Medium for the whole nine days. At the end of Day 9, EBs 
were seeded down in Serum-Free Medium for a further six days, after which they were assessed for 
neural morphology. Populations of cells expected at various time points are listed (mESCs, EPL-cells, 
DE = definitive ectoderm, NE = neurectoderm, NP = neural progenitor, N = neuron, ME = 
mesendoderm) and markers for each cell type are shown underneath (Harvey et al., 2010; Rathjen et 
al., 2002; Tropepe et al., 2001; Smukler 2006; Suter et al., 2009; Lowell et al., 2006; Pevny et al., 1998; 
Pearce and Evans 1999; Wood and Episkopou 1999; Hart et al., 2002; Aubert et al., 2003; Pevny and 
Placzek 2005). 																							
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3.6.1 EBs cultured in the presence of L-proline without LIF differentiate 
into neural progenitors and mature neurons 	
D3 and 46C mESCs were grown as EBs in L-proline and different concentrations of LIF over 
the first five days. From Days 6–9, LIF (if present) was removed and the EBs continued to be 
cultured either in the presence of L-proline + SB431542 (P/SB) or in their absence (no 
addition). In all cases, the continued presence of L-proline + SB431542 over Days 6–9 resulted 
in a statistically significant increase in EBs showing neural phenotypes at Day 15 compared to 
(i) the absence of L-proline + SB431542 over Days 6–9 (the single exception being that for D3 
P/330 L mESCs) and (ii) EBs grown in Basal Medium.  
 
However, there was no significant LIF concentration-dependent effect as measured by this 
criterion, although there appears to be an inverse trend between the production of neural cell 
types as the LIF concentration decreases. For this reason, we looked at other measures of the 
effect of LIF concentration on the differentiation process, with particular respect to the 
synchronization of differentiation. 	
	
Figure 3.29: mESCs cultured as EBs in L-proline for nine days in the absence of LIF produce the 
highest percentage of neural phenotypes including neural progenitors and neurons. (A) D3 and 
(B) 46C mESCs were cultured as EBs in the presence of 400 µM L-proline + 1000, 500, 330 or 0 U/ml 
LIF (P/1000 L, P/500 L, P/330 L, P/0 L) for the first five days. From days 6–9, EBs were cultured in 
(i) 400 µM L-proline + 10 µM SB431542 (P/SB) or (ii) without L-proline and SB431542 (then nothing 
additional). Alternatively, EBs were cultured in Basal Medium (BM) for the whole nine days. At the 
end of Day 9, EBs were seeded down in Serum-Free Medium for a further six days, after which they 
were assessed for neural morphology. Data presented as a mean percentage (of the total number of EBs 
per condition) ± SEM (n≥3). One-way ANOVA, Tukey’s multiple comparisons test; *P<0.05, 
**P<0.01. 
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3.7 Removing LIF in the presence of L-proline promotes the synchronous 
and sequential differentiation of mESCs to EPL-cells, definitive 
ectoderm and neurectoderm prior to neural cell production  	
When mESCs were cultured in P/0 L then P/SB there was a trend towards a higher percentage 
of EBs with neural phenotypes compared to when LIF was present (Figure 3.29). We were then 
interested to see if, in the absence of LIF, mESCs progressed through to neurectoderm faster 
and more homogeneously than those cultured in P/1000 L then P/SB (Figures 3.19 and 3.26 
and Tables 3.2 and 3.5). Figure 3.30 outlines the protocol design and rationale for these 
experiments, focusing on the absence of LIF and initially on the transition of mESCs to EPL 
cells.  
 
EBs cultured in P/0 L then P/SB were tested for the expression of the EPL-cell markers Dnmt3b 
and Fgf5, as well as the mESC marker Rex1 and pluripotency markers Oct4 and Nanog by 
qPCR. All qPCR data is expressed as log2-transformed data and statistics were performed using 
a two-way ANOVA, followed by Dunnett’s multiple comparisons test, unless specified 
otherwise. Oct4, Nanog and Dnmt3b expression were also assessed via flow cytometry.		
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Figure 3.30: Protocol design and rationale for L-proline-mediated EPL cell differentiation from 
mESCs expected to occur between Days 0–5 in the absence of LIF. D3 and 46C mESCs were cultured 
as EBs in 400 µM L-proline (P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM 
L-proline + 10 µM SB431542 (P/0 L then P/SB), and at the end of Day 9, EBs were seeded down in 
Serum-Free Medium for a further six days. Populations of cells expected at various time points are listed 
(mESCs, EPL-cells, DE = definitive ectoderm, NE = neurectoderm, NP = neural progenitor, N = neuron, 
ME  = mesendoderm) and markers for each cell type are shown underneath (Harvey et al.,  2010; Rathjen 
et al., 2002; Tropepe et al., 2001; Smukler 2006; Suter et al., 2009; Lowell et al., 2006; Pevny et al., 1998; 
Pearce and Evans 1999; Wood and Episkopou 1999; Hart et al., 2002; Aubert et al., 2003; Pevny and 
Placzek 2005). 
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3.7.1 Absence of LIF promotes faster and more homogeneous 
differentiation into EPL cells when mESCs are cultured in L-proline 		
D3 and 46C EBs cultured in P/0 L then P/SB showed signs of differentiation into EPL cells by 
Day 3 (Figure 3.31 and Table 3.6): For the D3 cell line, the expression of both Dnmt3b and 
Fgf5 was transiently up-regulated from Days 3–7, coupled with the down-regulation of 
expression of Rex1. In addition, the expression of Oct4 was down-regulated from Day 5 
indicating differentiation beyond EPL cells and loss of pluripotency. No significant change in 
Nanog expression was seen. Similar results were obtained for the 46C cell line. 
 																			
136		
	
 
Figure 3.31: mESCs transiently up-regulate the expression of EPL cell markers in the presence of L-proline and absence of LIF. (A) D3 and (B) 46C mESCs were 
cultured as EBs in 400 µM L-proline LIF (P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). Samples 
were taken at Days 0, 3, 5, 7 and 9 and assessed for mESC (Rex1), EPL cell (Dnmt3b and Fgf5) and pluripotency (Nanog and Oct4) marker expression by qPCR. Results are 
expressed as log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. The 4 coloured bars for each gene represent expression as mean ± SEM 
(n≥3) sequentially from Day 3 (left most bar) through Days 5, 7 and 9. A two-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple comparisons 
test; *P<0.05; **P<0.01. 			
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Table 3.6: mESCs transiently up-regulate the expression of EPL cell markers in the presence of L-proline and absence of LIF. These are the 
tabulated values for the data presented in Figure 3.31. D3 and 46C mESCs were cultured as EBs in 400 µM L-proline (P/0 L) for the first five days. 
From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB). Samples were taken at Days 0, 3, 5, 7 and 9 and 
assessed for mESC (Rex1), EPL cell (Dnmt3b and Fgf5) and pluripotency (Nanog and Oct4) marker expression by qPCR. Results are expressed as log2 
fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. (n≥3). For comparisons made of mRNA expression between days, 
a two-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple comparisons test; *P<0.05, **P<0.01. 
	
  Day 3 Day 5 Day 7 Day 9 
 
Cell line Log2 Expression ± SEM 
Log2 
Expression ± SEM 
Log2 
Expression ± SEM 
Log2 
Expression ± SEM 
Rex1 D3 -3** 0.2 -2** 0.6 -2* 0.4 -2* 0.0 
46C  -0.1 0.6 -1 0.5 -2** 1 -2** 0.7 
Nanog D3 -1 0.3 -0.6 0.1 -1 0.3 -1 0.3 
46C  -0.7 0.5 -0.6 0.4 -1 0.7 -2** 0.9 
Oct4 D3 -0.8 0.6 -2** 0.7 -4** 1 -5** 0.7 
46C  -1* 0.2 -1 0.1 -3** 0.2 -3** 0.4 
Dnmt3b D3 3** 0.5 3** 0.5 2** 0.3 0.9 0.2 
46C  1* 0.3 1 0.4 0.6 0.1 0.6 0.3 
Fgf5 D3 3** 2 5** 0.3 2** 0.7 1 0.9 
46C  5** 0.7 5** 1 4** 1 4** 0.7 					
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3.7.2 EBs cultured in P/0L then P/SB transition from EPL cells earlier than 
EBs cultured in P/1000 L then P/SB or Basal Medium  	
When EBs were cultured in P/0 L then P/SB they transitioned through pluripotent mESCs and 
EPL cell populations faster than EBs cultured in P/1000 L then P/SB and Basal Medium. D3 
cells cultured in P/0 L then P/SB showed a significant down-regulation in both Oct4 gene 
(Figure 3.31 and Table 3.6) and protein expression (Figure 3.32): The percentage of Oct4+ cells 
decreased by 33% by Day 5, and to 2 ± 0.4% by Day 9, indicative of the loss of pluripotency. 
Whilst no change in Nanog mRNA expression was observed in P/0 L then P/SB EBs (Figure 
3.31 and Table 3.6), a significant ~50% reduction in Nanog+ cells was observed by Day 3, 
decreasing to 1 ± 0.3% by Day 9 (Figure 3.32). At Day 5, the percentage of Dnmt3b+ 
significantly decreased by 35% compared to Day 0 mESCs (Figure 3.32). This significant 
reduction in the percentage of cells expressing Dnmt3b was 2 days earlier than when EBs were 
cultured in P/1000 L then P/SB (Figure 3.22 and Table 3.3) and Basal Medium EBs (Figure 
3.24 and Table 3.4).  								
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Figure 3.32: mESCs cultured in L-proline without LIF transition through EPL cells from Day 5. 
D3 mESCs were cultured as EBs in 400 µM L-proline (P/0 L) for the first five days. From Days 6–9, 
EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). Samples were taken at 
Days 0, 3, 5, 7 and 9 and assessed for the expression of Oct4, Nanog and Dnmt3b using the 
FACSCalibur flow cytometer. A 2o-only control was also run to assist with gating. Data was collected 
from the total cell population and analysed using FlowJo software. Data is expressed as mean % cells 
± SEM (n≥3). A one-way ANOVA (compared to day 0) was performed, followed by Dunnett’s multiple 
comparisons test; *P<0.05, **P<0.01. 	
3.8 L-proline induces the differentiation of mESCs to neurectoderm via a 
definitive ectoderm intermediate 	
When mESCs are cultured as EBs in MEDII for 9 days they give rise to a transient Penk1+ and 
Pard6b+ population following Fgf5+ EPL-cell differentiation. When treated with BMP4, these 
Penk1+/Pard6b+ cells give rise to surface ectoderm derivatives, whilst in the absence of BMP4-
treatment, Penk1+/Pard6b+ cells give rise to Sox1+ neurectoderm. This Penk1+/Pard6b+ 
population is consistent with it being definitive ectoderm (Harvey et al., 2010). Based on these 
data, we next wanted to assess whether EBs cultured in P/0 L then P/SB would recapitulate this 
MEDII-mediated differentiation into definitive ectoderm by giving rise to a transient Penk1+ 
and Pard6b+ population. Figure 3.33 outlines the protocol design and rationale for these 
experiments.  
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Figure 3.33: L-proline-based protocol design for the in vitro differentiation of definitive ectoderm 
and neurectoderm from mESCs expected to occur between Days 6–9 in the absence of LIF. D3 
and 46C mESCs were cultured as EBs in 400 µM L-proline (P/0 L) for the first 5 days. From Days 6– 
9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB) and at the end of Day 
9, EBs were seeded down in Serum-Free Medium for a further 6 days. Populations of cells expected at 
various time points are listed (mESCs, EPL-cells, DE = definitive ectoderm, NE = neurectoderm, NP = 
neural progenitor, N = neuron, ME  = mesendoderm) and markers for each cell type are shown 
underneath (Harvey et al., 2010; Rathjen et al., 2002; Tropepe et al., 2001; Smukler 2006; Suter et al., 
2009; Lowell et al., 2006; Pevny et al., 1998; Pearce and Evans 1999; Wood and Episkopou 1999; Hart 
et al., 2002; Aubert et al., 2003; Pevny and Placzek 2005).									
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3.8.1 EBs cultured with L-proline in the absence of LIF differentiate into 
Sox1+ neurectoderm at the expense of Mixl1+ mesendoderm 
  
 
In P/0 L then P/SB EBs, both 46C and D3 mESCs showed signs of definitive ectoderm and 
neurectoderm differentiation. In the D3 cells both Penk1 (at Day 3) and Pard6b (from Days 5–
9) expression was significantly up-regulated, indicating definitive ectoderm differentiation had 
occurred (Figure 3.34 and Table 3.7). This was followed by the significant up-regulation of 
Sox1 and Nestin from Days 5–9, and a significant down-regulation in Mixl1 was observed by 
Day 9. Together these data indicate neurectoderm differentiation had occurred at the expense 
of mesendoderm in P/0 L then P/SB.  
 
Similar trends were seen in the 46C cells but no significant differences in gene expression were 
observed (Figure 3.34 and Table 3.7).  However, at the level of protein expression, 68 ± 2% of 
46C cells expressed Sox1-GFP by Day 9 (Figure 3.35). In Day 15 EBs this expression was 
expressed in cells that were found in the core of the EBs (Figure 3.35). Neural progenitor cells 
that migrated out of the EBs had presumably down-regulated the expression of Sox1-GFP. 														
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Figure 3.34: mESCs transition to Sox1+ neurectoderm in the presence of L-proline without LIF, via a Penk1+/Pard6b+ intermediate population. D3 and 46C mESCs 
were cultured as EBs in 400 µM L-proline for (P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). 
Samples were taken at Days 0, 3, 5, 7 and 9 and assessed for definitive ectoderm (Penk1 and Pard6b), neurectoderm (Sox1), neural progenitor (Nestin) and mesendoderm 
(Mixl1) marker expression by qPCR. Results are expressed as log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene. The 4 coloured bars for 
each gene represent expression as mean ± SEM (n≥3) sequentially from Day 3 (left most bar) through Days 5, 7 and 9. A two-way ANOVA (compared to Day 0) was performed, 
followed by Dunnett’s multiple comparisons test; *P<0.05, **P<0.01. 
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Table 3.7: mESCs transition to Sox1+ neurectoderm in the presence of L-proline without LIF, via a Penk1+/Pard6b+ intermediate population. These are the tabulated 
values for the data presented in Figure 3.34. D3 and 46C mESCs were cultured as EBs in 400 µM L-proline for (P/0 L) for the first five days. From Days 6–9, EBs were cultured 
in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). Samples were taken at Days 0, 3, 5, 7 and 9 and assessed for definitive ectoderm (Penk1 and Pard6b), neurectoderm 
(Sox1), neural progenitor (Nestin) and mesendoderm (Mixl1) marker expression by qPCR. Results are expressed as log2 fold changes relative to mESCs (i.e., at Day 0) using β-
actin as the reference gene. For comparisons made between time points per condition, a two-way ANOVA (compared to Day 0) was performed, followed by Dunnett’s multiple 
comparisons test; *P<0.05, **P<0.01. For comparisons made between cell lines, a two-way ANOVA was performed, followed by Tukey’s multiple comparisons test;  ^  denotes 
P<0.05 for D3 cells compared to (day- and gene- matched) 46C cells. 	 	 	 Day 3 Day 5 Day 7 Day 9 
	 Cell line 
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Log2 Fold 
Change 
Expression 
± SEM 
Penk1 D3 0.0 0.7 1* 0.6 0.2 0.4 -0.7 0.1 
46C  -2 1 -0.7 1 -1 1 -4 3 
Pard6b 
D3 0.9 0.3 1* 0.6 1* 0.0 2* 0.1 
46C  0.1 0.4 0.5 0.6 0.7 0.7 1 0.5 
Sox1 
D3 0.4 1 2* 0.9 3* 0.3 2* 0.5 
46C  -1 0.2 0.4 0.6 1 0.3 1 0.3 
Nestin D3 0.4 0.2 2* 0.2 2* 0.3 2* 0.4 
46C  -0.7 2 2 0.6 2 0.4 2 0.7 
Mixl1 
D3 0.1^ 0.1 0.2 1 -0.1 0.3 -2* 1 
46C  0.9* 0.7 -0.6 0.5 -0.8 2 -4 2 					
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Figure 3.35: L-proline promotes the differentiation of mESCs to Sox1-GFP+ neurectoderm in 
the absence of LIF. 46C mESCs were cultured in 400 µM L-proline (P/0 L) for the first five days. 
From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). (A) 
EBs were suspended as single cells on Days 0, 3, 5, 7 and 9 before being fixed and run on the 
FACSCalibur flow cytometer. Day 0 mESCs were used to assist with gating and expression was 
assessed using FlowJo software. Data was collected from the total cell population and presented as 
mean % cells ± SEM, n≥3. A one-way ANOVA (compared to Day 0) was performed, followed by a 
Dunnett’s multiple comparisons test; *P<0.05, **P<0.01. (B) Representative Day 9 EBs that were 
fixed and imaged for Sox1-GFP expression under the following objectives: (i) 10X (ii) 20X and (iii) 
40X objectives. (C) At the end of Day 9, EBs were seeded in Serum-Free Medium on 0.1%-gelatin-
coated 48-well plates for a further six days, after which they were fixed and imaged for Sox1-GFP 
expression. Arrows point to neural progenitors which have lost Sox1-GFP expression. 10X objective; 
scale bar = 200 µm. 
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3.8.2 The P/0 L then P/SB protocol produces a significant up-regulation of 
Sox1 gene and protein expression compared to the P/1000 then P/SB 
or Basal Medium protocols 	
As well as looking at expression patterns at different time points across the Days 0–9 we also 
calculated the average expression of each gene by measuring the summed expression across 
the time points over 9 days (Figure 3.36 and Table 3.8).  
 
When cells were cultured in P/1000 L then P/SB the only significant summed expression 
observed was an increase in Fgf5. In comparison, when EBs were cultured in Basal Medium, 
both Fgf5 and Mixl1 produced a significant increase in expression over the 9 days: Mixl1 
summed expression was ~7X higher in EBs cultured in Basal Medium compared to those 
cultured in P/1000 L then P/SB and P/0 L then P/SB. No other significant changes in the 
summed expression were observed in EBs cultured in Basal Medium. In P/0 L then P/SB, a 
significant increase in the summed expression for both Dnmt3b and Fgf5 was observed (Figure 
3.36 and Table 3.8). This was the only condition where the summed expression for Sox1 was 
significantly increased, and significantly higher than the summed expression for Sox1 in 
P/1000 L then P/SB (~2X higher) and Basal Medium (~5X higher) cells (Figure 3.36 and Table 
3.8).    
 
Similarly, flow cytometry analysis showed that a statistically significant increase in the 
percentage of cells expressing Sox1-GFP was observed in EBs cultured in P/0 L then P/SB 
compared to P/1000 L then P/SB and Basal Medium EBs (Figure 3.37 and Table 3.9).  
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Figure 3.36: Average summed mRNA expression over nine days when EBs are cultured in P/1000 L then P/SB, P/0 L then P/SB and Basal Medium. D3 mESCs were 
cultured as EBs in 400 µM L-proline ± 1000 U/ml LIF (P/1000 L or P/0 L) for the first nine days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 
(P/1000 L then P/SB or P/0 L then P/SB). Alternatively, EBs were cultured in Basal Medium for the whole nine days. Samples were taken at Days 0, 3, 5, 7 and 9 and assessed 
for mESC (Rex1), pluripotency (Nanog and Oct4), EPL cell (Dnmt3b and Fgf5), definitive ectoderm (Penk1 and Pard6b), neurectoderm (Sox1), neural progenitor (Nestin) and 
mesendoderm (Mixl1) marker expression by qPCR. Results are expressed as mean log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin as the reference gene ± 
SEM (n≥3). To assess differences in averaged summed expression over the nine days compared to Day 0 mESCs, a one-way ANOVA was performed, followed by Dunnett’s 
multiple comparisons test; #P<0.05 compared to Day 0. To assess differences between culture conditions, a one-way ANOVA was performed, followed by Tukey’s multiple 
comparisons; *P<0.05, **P<0.01.  
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Table 3.8: Average summed mRNA expression over nine days when EBs are cultured in P/1000 
L then P/SB, P/0 L then P/SB and Basal Medium. These are the tabulated values for the data presented 
in Figure 3.36. D3 mESCs were cultured as EBs in 400 µM L-proline ± 1000 U/ml LIF (P/1000 L or 
P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM 
SB431542 (P/1000 L then P/SB or P/0 L then P/SB). Alternatively, EBs were cultured in Basal Medium 
for the whole nine days. Samples were taken at Days 0, 3, 5, 7 and 9 and assessed for mESC (Rex1), 
pluripotency (Nanog and Oct4), EPL cell (Dnmt3b and Fgf5), definitive ectoderm (Penk1 and Pard6b), 
neurectoderm (Sox1), neural progenitor (Nestin) and mesendoderm (Mixl1) marker expression by 
qPCR. Results are expressed as mean log2 fold changes relative to mESCs (i.e., at Day 0) using β-actin 
as the reference gene ± SEM (n≥3). To assess differences in averaged summed expression over the 
nine days compared to Day 0 mESCs, a one-way ANOVA was performed, followed by Dunnett’s 
multiple comparisons test; #P<0.05 compared to Day 0. To assess differences between culture 
conditions, a one-way ANOVA was performed, followed by Tukey’s multiple comparisons; ^ P<0.05 
compared to P/1000 L then P/SB; *P<0.05 compared to P/0 L then P/SB.   
	 	 P/1000 L then P/SB P/0 L then P/SB Basal Medium 	 Mean ± SEM Mean ± SEM Mean ± SEM 
Rex1 -0.4 0.3 -1 0.1 -2^ 0.4 
Nanog 0.2 0.4 -0.8 0.1 -1 1 
Oct4 -0.3 0.3 -1 0.4 1 0.8 
Dnmt3b 2 0.3 3# 0.3 2 0.3 
Fgf5 3# 1 4# 0.7 5# 1 
Penk1 1 0.5 0.5 0.5 2 0.7 
Pard6b 1 0.3 1 0.2 0.6 0.1 
Sox1 0.5 0.5 2# 0.5 -2^* 0.2 
Nestin 1 0.1 1 0.2 2 0.8 
Mixl1 0.3 0.2 0.1 0.5 7#^* 0.8 
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Figure 3.37: L-proline promotes the differentiation of mESCs to Sox1-GFP+ neurectoderm in Day 
5–9 EBs. 46C mESCs were cultured as EBs in 400 µM L-proline ± 1000 U/ml LIF (P/1000 L or P/0 L) 
for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 
(P/1000 L then P/SB or P/0 L then P/SB). Alternatively, EBs were cultured in Basal Medium for the 
whole nine days. EBs were suspended as single cells on Days 0, 3, 5, 7 and 9 before being fixed and 
run on the FACSCalibur flow cytometer. Day 0 mESCs were used to assist with gating and expression 
was assessed using FlowJo software. Data was collected from the total cell population and presented as 
mean % cells ± SEM, n≥3. A one-way ANOVA (compared to Day 0) was performed per condition, 
followed by Dunnett’s multiple comparisons test. To test differences between culture conditions per 
day, a two-way ANOVA, followed by Sidak’s multiple comparisons test was performed; *P<0.05, 
**P<0.01. 
																				
149		
Table 3.9: L-proline promotes the differentiation of mESCs to Sox1-GFP+ neurectoderm in Day 
5–9 EBs. These are the tabulated values for the data presented in Figure 3.37. 46C mESCs were cultured 
as EBs in 400 µM L-proline ± 1000 U/ml LIF (P/1000 L or P/0 L) for the first five days. From Days 6–
9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/1000 L then P/SB or P/0 L then P/SB). 
Alternatively, EBs were cultured in Basal Medium for the whole nine days. EBs were suspended as 
single cells on Days 0, 3, 5, 7 and 9 before being fixed and run on the FACSCalibur flow cytometer. 
Day 0 mESCs were used to assist with gating and expression was assessed using FlowJo software. Data 
was collected from the total cell population (using forward and side scatter plots) and presented as mean 
% cells ± SEM, n≥3. A one-way ANOVA (compared to Day 0) was performed per condition, followed 
by Dunnett’s multiple comparisons test. To test differences between culture conditions per day, a two-
way ANOVA, followed by Sidak’s multiple comparisons test was performed; *P<0.05, **P<0.01. To 
assess differences between culture conditions, a two-way ANOVA, followed by Tukey’s multiple 
comparisons test was used. ^ denotes a significant difference (P<0.05) for comparisons made against 
day-matched P/0 L then P/SB. 	
 
EB Day 
Mean (%) cells 
expressing Sox1-
GFP 
± SEM 
(%) 
 P<0.05 
Compared to  
*Day 0  
^ P/0 L then P/SB 
 0 2.4 0.8  
P/0 L  
then P/SB 
3 6.2 0.8  
5 15.6 7.6  
7 26.3 5.7 * 
9 67.6 1.8 ** 
P/1000 L 
then P/SB 
3 2.8 1.4  
5 5.5 1.6  
7 17.2 1.0 * 
9 39.9 2.9 * ^ 
Basal 
medium 
3 5.1 1.2  
5 9.4 2.6  
7 28.3 4.1 * 
9 30.6 3.4 * ^ 												
150		
3.9 L-proline-based protocols increase the differentiation of mESCs to 
mature neural cell types in the absence of LIF 
 
When EBs were cultured in P/0 L then P/SB, the highest percentage of EBs with neural 
phenotypes was observed compared to EBs culture in LIF (Figures 3.14 and 3.38 and Tables 
3.1 and 3.10). This was confirmed by immunofluorescence imaging using the neural progenitor 
markers Nestin and BLBP (Figures 3.39 and 3.40). 	
	
 
Figure 3.38: mESCs cultured in the presence of L-proline without LIF increases the production 
of EBs with neural cell types by Day 15. (A) D3 and (B) 46C mESCs were cultured as EBs 400 µM 
L-proline + 0 U/ml LIF (P/0 L) for the first five days. From Days 6–9, EBs were cultured in (i) 400 µM 
L-proline + 10 µM SB431542 (P/0 L then P/SB), (ii) 400 µM L-proline (P/0 L then P), (iii) 10 µM SB 
(P/0 L then SB) or (iv) without L-proline or SB (P/0 L then no addition). Alternatively, EBs were 
cultured in Basal Medium (BM) for the whole nine days. At the end of Day 9, EBs were seeded down 
in Serum-Free Medium for a further six days, after which they were assessed for neural morphology 
including axonal projections, axonal bundles and neural progenitors. Data presented as a mean 
percentage (of the total number of EBs per condition) ± SEM (n≥3). A one-way ANOVA, followed by 
a Tukey’s multiple comparisons test was performed; *P<0.05, **P<0.01.  
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Table 3.10: mESCs cultured in the presence of L-proline without LIF increases the production of 
EBs with neural cell types by Day 15. These are the tabulated values for the data presented in Figure 
3.38. D3 and 46C mESCs were cultured as EBs 400 µM L-proline ± 1000 U/ml LIF for the first five 
days (P/1000 L or P/0 L). From Days 6–9, EBs were cultured in (i) 400 µM L-proline + 10 µM 
SB431542 (P/0 L then P/SB) (ii) 400 µM L-proline (P/0 L then P) (iii) 10 µM SB (P/0 L then SB) or 
(iv) the absence of L-proline or SB (P/0 L then no addition). Alternatively, EBs were cultured in Basal 
Medium for the whole nine days. At the end of Day 9, EBs were seeded down in Serum-Free Medium 
for a further six days, after which they were assessed for neural morphology including axonal 
projections, axonal bundles and neural progenitors. Data presented as a mean percentage (of the total 
number of EBs per condition) ± SEM (n≥3). To assess differences between culture conditions within 
the same cell line, a two-way ANOVA, followed by Tukey’s multiple comparisons test was used; 
Matching symbols (* and #) denotes P<0.05 between culture conditions.  
	
	
  D3 46C 
Day 0 – 5 
culture 
Day 6–9 
culture 
Mean (%) 
 
± SEM (%) 
 
Mean (%) 
 
± SEM (%) 
 
P/1000 L 
P/SB 57 8 46 5 
P 55 15 40 6 
SB 49 10 33 9 
No addition 15* 6 12# 2 
P/ 0 L 
P/SB 65 11 68 9 
P 50 3 35 8 
SB 30 2 25 4 
No addition 31* 5 26# 2 
Basal Medium 7 1 10 3 
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Figure 3.39: EBs cultured in L-proline in the absence of LIF express the neural progenitor markers Nestin and BLBP. D3 mESCs were cultured as EBs in 400 µM L-
proline (P/0 L) for the first five days. From Days 6–9, EBs were cultured in 400 µM L-proline + 10 µM SB431542 (P/0 L then P/SB). At the end of Day 9, EBs were seeded in 
0.1% gelatin-coated 48-well plates in Serum-Free Medium for a further six days, after which they were fixed and stained for the presence of the neural progenitor markers 
Nestin and BLBP. The nuclei were stained with DAPI. Images were taken on the EVOS on (A) 10X objective; scale bar = 200 µm. (B) Image (i) and (iii) were taken on 20X 
objective; scale bar = 400 µm and image (ii) was taken on 10X objective; scale bar = 200 µm. Arrows indicate neural rosette structures and insets have been used to zoom in on 
the structures of interest showing bipolar neural-cell morphologies. 
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Chapter 4  
Discussion 
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It has only recently been established that amino acids play key roles in influencing the emergent 
properties of cells, including proliferation rates, morphological changes, apoptosis and, in the 
case of ESCs, the ability to self-renew or differentiate (Washington et al., 2010; Casalino et 
al., 2011; Tan et al., 2011; Ryu and Han, 2011; Shyh-Chang et al., 2013; Shan et al., 2013; 
Chen and Wang 2014; Shiraki et al., 2014; Ryu et al., 2015; Kilberg et al., 2016). Whilst several 
amino acids have been shown to control these various aspects that govern cell fate, this study 
focused on the amino acid L-proline and its novel growth factor-like role in development; in 
particular its ability to induce differentiation to neural cells from mESCs via EPL-cell, 
definitive ectoderm and neurectoderm intermediates.  
 
The rationale for this work stems from the following:  
(i) The conditioned medium, MEDII, derived from human HEPG2 cells, stimulates mESC 
differentiation to neurectoderm (Harvey et al., 2010; Rathjen et al., 1999). It is also known to 
contain concentrations of L-proline consistent with the efficient uptake into cells via amino-
acid transporters (Tan et al., 2011) and that found in relevant mammalian extracellular fluids 
such as tubule fluid and serum (Kermack et al., 2015; Aguilar and Reyley 2005; Lakhiani 2017) 
– i.e., of the order of hundreds of micromolar.  
(ii) That L-proline, like MEDII, would drive differentiation through a sequence of 
embryologically relevant cell types required to generate neural cells, including pluripotent EPL 
cells, the multipotent germ layer definitive ectoderm, and the first cells of the nervous system, 
neurectoderm (Washington et al., 2010). In addition, we hypothesized that it would be 
responsible for neural differentiation beyond neurectoderm – e.g., to neural progenitor cells 
and more mature neural cell types. That is, if L-proline is acting as a novel growth factor, it 
would be expected to act like other molecules in the limited pool of growth factors and be 
‘recycled’ and contribute to multiple stages of development. 
(iii) L-proline, in combination with LIF, has already been shown to differentiate mESCs to the 
next step of embryologically relevant development – i.e., to EPL cells – using concentrations 
similar to those found in MEDII (Washington et al., 2010). 
(iv) That information consistent with L-proline acting as a novel growth factor is not only that 
it modulates a range of emergent cell properties (including differentiation, rate of proliferation, 
cell shape change and motility, and apoptosis) but does so via a range of molecular 
mechanisms, including cell signalling, changes to the epigenetic landscape, autophagy and 
metabolic effects (Casalino et al., 2011; Comes et al., 2013; Washington et al., 2010).  
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(v) mESCs are poised for differentiation and self-limit the production of L-proline, consistent 
with these cells awaiting an extracellular source of the amino acid to initiate the processes of 
further development (D’Aniello et al., 2015).  
 
4.1 Summary of possible mechanisms for L-proline-mediated EPL-cell 
differentiation from mESCs 
 
When mESCs are cultured in LIF and serum (which contains BMP4) they are capable of 
maintaining pluripotency and self-renew over extended periods. However, like their in vivo 
counterparts, the ICM, they are poised to respond rapidly to differentiation signals. This is 
highlighted in a number of ways: (i) LIF- and BMP4-mediated signalling, which collectively 
is finely balanced between promoting self-renewal versus differentiation (see Section 1.2; 
Figure 1.7; (Ying et al., 2003; Hamazaki et al., 2006; Chen et al., 2008; Medvedev et al., 2008; 
Niwa et al., 2009; Kim et al., 2012). (ii) The presence of opposing bivalent marks – repressive 
and inductive – on histones regulating the expression of key genes (Bernstein et al., 2006; Voigt 
et al., 2013). (iii) The fact that mESCs carry a normal complement of ribosomes but these 
ribosomes largely remain unloaded with mRNA (Sampath et al., 2008). (iv) The self-limited 
production of L-proline in mESCs (D’Aniello et al., 2015). Ultimately, the decision to self-
renew or to differentiate is centered around the core pluripotency network (Oct4, Nanog and 
Sox2) (Figure 1.6), whose activity is the point of integration of these cell signalling, epigenetic 
and metabolic mechanisms (Figure 4.1). Perturbations to this delicately balanced system by, 
for example, the removal of LIF and/or the addition of differentiation-inducing signals such as 
L-proline, tip the balance from self-renewal to differentiation (Figure 4.1).  
 
When L-proline is added to this culture system, mESCs differentiate to a second pluripotent 
population of Dnmt3b+/Fgf5+ EPL cells. This is achieved, in part, by stimulating the activity 
of the differentiation-inducing MEK/ERK pathway (Lonic, 2007) and that of the amino-acid 
sensing mTOR pathway (Washington et al., 2010) (Section 1.2; Figure 4.1). L-proline-
mediated stimulation of these pathways results in significant increases in H3K9 methylation, 
allowing mESCs to exit from self-renewal (Comes et al., 2013) and differentiate to EPL cells 
(Tan et al., 2016; Washington et al., 2010). This is accompanied by an increase in proliferation 
rate and changes in morphology from round, dome-shaped colonies to flat epithelial colonies 
(Figures 3.2 and 3.5) (Browne, 2017; Lonic, 2007; Washington et al., 2010).   
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A growing body of evidence suggests that amino acid-mediated metabolic regulation plays an 
important role in cell fate (Browne, 2017; Carey et al., 2014; Casalino et al., 2011; D’Aniello 
et al., 2015; Ryu et al., 2015; Shyh-Chang et al., 2013; Vuong, 2017; Wang et al., 2009, 2011; 
Yurka, 2015). Studies in our lab have shown an emerging paradigm that L-proline-mediated 
stimulation of anaerobic metabolism may be a driving force for differentiation of mESCs 
(Browne, 2017; Vuong, 2017; Yurka, 2015). Due to its pyrrolidine ring, L-proline has a unique 
metabolism: It is not a substrate for conventional transaminases and decarboxylases, but rather 
its breakdown relies on the rate-limiting enzyme proline oxidase (POX) (Casalino et al., 2011). 
In the presence of POX, L-proline is converted to P5C, and in the process produces NADP+ 
from NADPH (Figure 1.8). NADP+ is then able to contribute to the pentose phosphate pathway 
to promote anaerobic metabolism (Figure 4.1). Inhibition of the pentose phosphate pathway 
using 6-aminonicatinamine (6AN) (9 µM) inhibits L-proline-mediated differentiation at the 
level of morphology, proliferation rate and gene expression (Browne, 2017). Similarly, in the 
presence of the competitive inhibitor of POX, 3,4-dehydro-L-proline (DHP; 50 µM), mESCs 
fail to undergo the L-proline-mediated EPL-cell transition (Casalino et al., 2011).  																					
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Figure 4.1: Summary of possible mechanisms for L-proline-mediated EPL-cell differentiation from mESCs. In the absence of L-proline, signalling 
activity mediated by LIF and BMP4 favours self-renewal via STAT3 and PI3K/AKT activity and activation of Ids, which inhibit lineage commitment (Niwa et 
al., 1998; Qi et al., 2004; Ying et al., 2003a). When L-proline is added, it enters mESCs via the SNAT2 transporter (Tan et al., 2011) where it has been shown 
to mediate its effects via cell signaling, epigenetic and metabolic regulation to promote mESC differentiation to EPL cells. L-proline’s unique catabolism 
(Casalino et al., 2011) stimulates anaerobic metabolism in mESCs (Browne, 2017; Vuong, 2017; Yurka, 2015). This has been shown to promote the 
differentiation of mESCs to EPL cells via increased pentose phosphate pathway (PPP) activity as inhibition of the PPP by 6-aminonicatinamide prevents this 
differentiation (Browne 2017). Similarly, hypoxia (either by chemical inhibition or culture in 5% O2) promotes the transition of mESCs to EPL cells (Browne, 
2017). In conjunction with an increase in anaerobic metabolism, L-proline-mediated MEK/ERK and mTOR pathway activity, p38 activity (Tan et al., 2016) 
and Fgf4-mediated MEK/ERK activity (Zheng et al., 2010), stimulates the up-regulation of the EPL-cell markers Dnmt3b and Fgf5 (Lonic, 2007; Washington 
et al., 2010). L-proline-mediated up-regulation of Dnmt3b expression promotes DNA methylation of histone-3 (H3) at lysine (K) residues 27 and 36, as well as 
methylation at the Oct4 and Nanog locus to (i) switch off pluripotency and self-renewal and (ii) allow differentiation to proceed (Choi et al., 2016; Li et al., 
2007). This is accompanied by changes in morphology and an increase in cell proliferation rate consistent with EPL-cell differentiation (Washington et al., 
2010; Tan et al., 2016). Figure composed with assistance from Glover, H.  
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4.2 EBs cultured in L-proline and LIF give rise to a series of 
embryologically relevant cell populations  	
Summary of results from L-proline-based protocols in terms of gene and protein marker 
expression 
When mESCs are cultured as EBs in the presence of MEDII for nine days, they give rise to 
sequential populations of cells equivalent to those that arise up to and including early 
embryonic nervous system development (Harvey et al., 2010). These include Rex1+ mESCs, 
Dnmt3b+/Fgf5+ EPL cells, Penk1+/Pard6b+ definitive ectoderm and Sox1+ neurectoderm, and 
this is followed, in Serum-Free Medium, by differentiation to neural cell types (Figure 4.2). L-
proline is a biologically active component in MEDII, which in the presence of 1000 U/ml LIF, 
has been shown to drive the differentiation of mESCs to EPL cells in adherent and EB culture 
(Rathjen et al., 1999; Tan et al., 2016; Washington et al., 2010) (Figure 3.2). However, the 
ability of L-proline to stimulate the differentiation of mESCs to EPL cells and beyond in EB 
culture has not been attempted. To do this, EBs were cultured in 400 µM L-proline ± 1000 
U/ml LIF for five days to drive the differentiation of mESCs to EPL cells (P/1000 L or P/0 L 
then P/SB). From Days 6–9, LIF (if present) was removed to permit the loss of pluripotency 
and L-proline was added to continue driving the differentiation of EPL cells to definitive 
ectoderm and neurectoderm. Variations of this protocol were developed using combinations of 
L-proline and SB431542 from Days 6–9 with SB431542 being used to prevent off-pathway 
differentiation to mesendoderm (Figure 3.7). EBs were also cultured in Basal Medium for nine 
days as a control to allow for spontaneous differentiation rather than directed differentiation. 
At the end of Day 9, EBs were seeded in Serum-Free Medium for a further six days to allow 
for differentiation to neural cells to continue.   
 
Figure 4.2 shows a summary of the results of gene and protein marker expression for this work, 
compared to published results with MEDII (Harvey et al., 2010).  
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Figure 4.2: Summary of marker expression during EB differentiation of mESCs to neurectoderm using MEDII or a time-dependent combination of 
L-proline (P), LIF (L) and SB431542 (SB). mESCs were cultured as EBs in (i) MEDII, the conditioned medium from HEPG2 cells (Harvey et al., 2010) or 
(ii) L-proline-based protocols for nine days (P/1000 L then P/SB or P/0 L then P/SB). In the L-proline-based protocols, EBs were cultured in 400 µM L-proline 
± 1000 U/ml LIF from Days 0–5 to drive the differentiation of mESCs to EPL cells. From Days 6–9, LIF (if present) was removed and the EBs were cultured 
in 400 µM L-proline and 10 µM SB431542 to promote the differentiation of definitive ectoderm (DE) and neurectoderm (NE), followed by neural progenitors 
(NP). Thicker lines indicate significant increases in the expression of markers compared to mESCs. Thinner lines indicate expression that was not significantly 
different to mESCs.  																					
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4.3 Differentiation to neural cells is driven by L-proline rather than by a 
default mechanism 		
The results presented in this thesis support a mechanism in which mESCs differentiate to 
neurectoderm by an instructive process driven by L-proline rather than it occurring as a result 
of a default mechanism (Hemmati-Brivanlou and Melton, 1997; Munoz-Sanjuan and 
Brivanlou, 2002; Tropepe et al., 2001). Evidence for this is as follows for EBs cultured in 
P/1000 L conditions: (i) When EBs were cultured in L-proline for nine days (P/1000 L then 
P/SB or P/1000 L then P), a significant up-regulation in the expression of Sox1 and Sox1-
mediated GFP expression was observed at Day 9, at the expense of Mixl1+ mesendoderm in 
both D3 and 46C cell lines (Figures 3.26, 3.27, 3.34 and 3.35 and Table 3.5 and 3.7). (ii) This 
was followed by a significant increase in the percentage of Nestin+, BLBP+ and NeuN+ neural 
cells at Day 15 (Figures 3.11, 3.12, 3.13, 3.14, 3.16 and 3.39 and Table 3.1). (iii) Similar 
percentages of EBs with neural cell types were observed at Day 15 when EBs were cultured 
with just the addition of SB431542 (i.e., without L-proline) from Days 6–9 (Figures 3.14 and 
3.38 and Tables 3.1 and 3.10). (iv) No synergistic effect with respect to EBs with neural cell 
types was observed at Day 15 when EBs were cultured in a combination of L-proline and 
SB431542 from Days 6–9 (P/1000 L then P/SB) (Figure 3.14 and Table 3.1). These results 
show that L-proline is equally as effective as SB431542 in promoting the differentiation of 
mESCs into neural cell types (in both cell lines used). The key difference is that rather than 
permitting differentiation by default (as was achieved by inhibiting mesendoderm 
differentiation with SB431542), L-proline drives the directed differentiation of mESCs to 
neurectoderm. Therefore, as our L-proline-based protocol currently stands, the addition of 
SB431542 to inhibit off-pathway differentiation may not be necessary. 
 
When the protocol was refined, and LIF was removed from Day 0 (P/0 L), no significant 
difference in neural cell production at Day 15 was observed between EBs cultured in P/0 L 
then P/SB compared to EBs cultured in P/1000L then P/SB in either cell line. However, Sox1+ 
neurectoderm was produced five days earlier in EBs cultured in P/0 L then P/SB compared to 
EBs that were cultured in P/1000 L then P/SB. qPCR and flow cytometry analysis showed that 
a significant up-regulation in the expression of Sox1 and Sox1-mediated GFP expression in 
EBs cultured in P/0 L then P/SB had occurred prior to the addition of SB431542 and at the 
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expense of Mixl1+ mesendoderm in both D3 and 46C cell lines (Figures 3.26, 3.27, 3.34 and 
3.35 and Table 3.5 and 3.7). Based on these results, Day 5 EBs cultured in L-proline had 
already committed to neurectoderm (Figure 3.34 and Table 3.7), supporting the hypothesis that 
L-proline alone is capable of driving the differentiation of mESCs to neurectoderm: If the 
mesendoderm inhibitor, SB431542, is to play a useful role in promoting efficient production 
of neural cells, it may need to be added earlier than Day 5. 
 
Furthermore, L-proline was also shown to be required for continued differentiation to neural 
cells, as its removal from Day 6 significantly decreased the percentage of EBs with neural cell 
types at Day 15 in the D3 cell line. When EBs were cultured in L-proline for the whole 9 days, 
the percentage of EBs with neural cell types at Day 15 in the D3 cell line, with or without 
SB431542, was ~60% (Figure 3.38 and Table 3.10). However, when L-proline was removed 
from Day 6 and EBs were cultured with just the addition of SB431542 (P/0 L then SB), only 
30% of EBs produced neural cell types at Day 15. These results suggest that not only is L-
proline required for the induction of neurectoderm but it is also required for continued 
differentiation to more mature neural cell types.  
 
In the 46C cell line (and in contrast to the D3 cell line) a synergistic effect of L-proline and 
SB431542 was produced with respect to the percentage of EBs with neural cell types at Day 
15. That is, the percentage of EBs with neural cell types when cultured in P/0 L then P/SB was 
~70% but only ~30% for P/0 L then P or P/0 L then SB (Figure 3.38 and table 3.10). This could 
be a result of the heterogeneous, asynchronous and slow differentiation to neurectoderm that 
was observed between Days 0–9 with this cell line (Figures 3.31 and 3.34 and Tables 3.6 and 
3.7). The combination of L-proline and SB431542 in this case is likely acting via a combination 
of directed differentiation to neurectoderm (driven by L-proline) and inhibition of 
mesendoderm (by SB431542).  
 
As this synergistic effect was only observed in the 46C cell line (when EBs were cultured in 
the absence of LIF for the first five days), this may be an inherent property of the 46C cells 
themselves: Testing the parent cell line (E14g2a mESCs) (Ying, et al., 2003) under the same 
conditions should help address this. Using the parent cell line will also help to determine 
whether the temporal differences in Sox1 gene and Sox1-mediated GFP expression are inherent 
to the 46C cell line or whether the differences in expression are due to an artefact of the GFP 
knock-in.  
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Taken together, L-proline (with or without LIF and with or without SB431542) was shown in 
both cell lines to drive the differentiation of mESCs to neurectoderm followed by 
differentiation to neural cells, and at the expense of differentiation to mesendoderm (Figures 
3.26, 3.27, 3.34 and 3.35 and Tables 3.5 and 3.7). These results show that L-proline alone is 
capable of inducing the differentiation to neurectoderm and subsequently more mature neural 
cells without the requirement for other added cytokines, growth factors or inhibitors (except 
those contained in the serum). However, further optimization of the protocols for each cell line 
is required to improve the synchronicity and homogeneity of differentiation through the 
embryologically relevant cell populations. 	
4.3.1 Inclusion of LIF in the L-proline-based protocol reduces the 
homogeneity and synchronicity of differentiation to neurectoderm 
compared to MEDII 		
When mESCs were cultured in P/1000 L then P/SB over nine days, the EBs that were produced 
were smooth and spherical and without a rind of primitive endoderm (Figures 3.8 and 3.9). 
This is similar to the results obtained when EBs are cultured in MEDII (Harvey et al., 2010). 
In addition, as expected, mESCs cultured in Basal Medium produced EBs with amorphous 
shapes, cysts and what is likely to be primitive endoderm (Coucouvanis and Martin, 1995; 
Murray and Edgar, 2000).  
 
However, when we assessed, using qPCR, the differentiation of mESCs cultured in P/1000 L 
then P/SB over the first nine days compared to MEDII (Harvey et al., 2010) and Basal Medium 
differentiation to EPL cells was significantly slower – by seven days and six days, respectively 
– as measured by the fact that an up-regulation in the expression of the primitive ectoderm 
marker, Fgf5, only occurred at Day 9 (Figures 3.19 and 4.2 and Table 3.2). Furthermore, there 
was no significant change in Oct4 or Nanog gene expression even after the removal of LIF on 
Day 5 (Figure 3.19 and Table 3.2), although, the percentage of cells that expressed Oct4 and 
Nanog protein did significantly decrease by Day 7 (Figure 3.20 and Table 3.3), indicating some 
cells had lost pluripotency. This lack of change in Oct4 and Nanog gene expression but loss of 
protein expression might be accounted for by differences in half-life between the respective 
mRNAs and proteins. Oct4 and Nanog mRNA levels remain stable for up to 36 h upon the 
withdrawal of LIF in EB culture (Trouillas et al., 2009). In the presence of LIF and serum, 
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Oct4 mRNA has a half-life of ~4–4.5 h, whilst Nanog mRNA has a half-life of ~6 h (Sharova 
et al., 2009). However, both proteins have a much shorter half-lives: Oct4 protein has a half-
life of ~1.5 h whilst Nanog protein’s is ~2 h (Ramakrishna et al., 2011; Wang et al., 2015; Wu 
and Tzanakakis, 2013). Both proteins are rapidly degraded in mESCs predominantly by the 
ubiquitin proteasome pathway. The E3 ligase Wwp2 has been shown to bind directly to Oct4 
both in vivo and in vitro targeting it for ubiquitination (Xu et al., 2004). On the other hand, 
ERK1 has been shown to phosphorylate Nanog (specifically at Ser52), flagging it for 
ubiquitination (Kim et al., 2014).  
 
Differentiation of mESCs to neurectoderm is heterogeneous and asynchronous when EBs are 
cultured in P/1000 L then P/SB compared to culture in MEDII.  
When EBs were cultured in P/1000 L then P/SB, some differentiation to neurectoderm was 
observed, since a significant up-regulation in the expression of Sox1 was observed at Day 9 in 
the D3 cell line, similar to the increase in the expression of Pax6 (neurectoderm marker) 
observed at Day 9 in MEDII-treated EBs (Harvey et al., 2010). Overall, however, the process 
of differentiation in P/1000 L then P/SB appeared to be heterogeneous and asynchronous 
compared to EBs cultured in MEDII (Figure 4.2) (Harvey et al., 2010). In particular, 
differentiation to EPL cells was slow, while at the same time some cells were losing 
pluripotency (see above). In addition, unlike in MEDII-treated EBs, where a transient and 
synchronous expression of Penk1 and Pard6b was observed between Days 5–7 (Harvey et al., 
2010), no changes in the expression of these definitive ectoderm markers was observed when 
EBs were cultured in P/1000 L then P/SB (Figure 3.26 and Table 3.5). This could be due to the 
fact that (i) many of the mESCs had yet to differentiate to EPL cells (Figure 3.19 and Table 
3.2) and (ii) due to the transient nature of the definitive ectoderm, we may have missed the 
time points at which Penk1 and Pard6b were expressed. Collecting EBs at Days 6, 7 and 8 and 
performing qPCR on those samples to observe the transient expression of the purported 
definitive ectoderm markers Penk1 and Pard6b would be valuable. We predict this transient 
expression, at least in the D3 cell line, given that Sox1 was significantly up regulated on Day 
9 (Figure 3.26 and Table 3.5).  
 
To improve the synchronicity and homogeneity of the relevant marker expression profiles, we 
hypothesized that modifications to the protocol such as decreasing the concentration of LIF for 
the first five days, would better recapitulate MEDII-mediated changes in gene expression 
(Figure 4.2). To test this, the same basic protocol was used, whereby EBs were cultured in L-
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proline for 9 days but this time different concentrations of LIF were used between Days 0–5: 
0, 330, 500 and 1000 U/ml (Figure 3.28). The percentage of EBs at Day 15 containing neural 
cell types (based on morphology) did not change significantly with LIF concentrations between 
330–1000 U/ml. However, when LIF was removed entirely from the medium, qPCR analysis 
showed waves of expression of markers that more closely recapitulated the gene expression 
observed in EBs cultured in MEDII indicating more synchronous and homogeneous 
differentiation. For these reasons, we focused our attention on the P/0 L then P/SB protocol 
(Figure 3.30).    	
4.4 L-proline acts like a growth factor to induce the differentiation of 
mESCs to neurectoderm via embryologically relevant cell populations 
similar to MEDII-treated EBs 		
When EBs were cultured in P/0 L then P/SB, qPCR analysis showed waves of expression of 
markers consistent with cells moving through a well-ordered series of embryologically relevant 
cell populations including EPL cells (between Days 3–7; Figure 3.31 and Table 3.6), definitive 
ectoderm (at Day 5; Figure 3.34 and Table 3.7) and neurectoderm (between Days 5–9; Figure 
3.34 and Table 3.7). This was then followed by differentiation to Nestin+, BLBP+ and NeuN+ 
neural cells (between Days 12–15; Figures 3.38 and 3.39 and Table 3.10). These results are 
consistent with L-proline acting like a typical growth factor in that it can induce differentiation 
at multiple stages of the development pathway.   	
4.4.1 EBs cultured in P/ 0 L then P/SB give rise to a wave of pluripotent EPL 
cells before differentiating into the definitive ectoderm  		
When EBs were cultured in P/0 L then P/SB differentiation of mESCs to EPL cells occurred 
six days faster than that of EBs cultured in P/1000 L then P/SB, and in D3 cells, progressed 
beyond Fgf5+ EPL cells two days earlier than EBs cultured in Basal Medium (Figures 3.19 and 
3.31 and Tables 3.2 and 3.6). Flow cytometry analysis also showed that EBs cultured in P/0 L 
then P/SB down-regulated Dnmt3b expression two days earlier than EBs cultured in P/1000 L 
then P/SB or Basal Medium (Figures 3.22, 3.24, 3.32 and 4.2 and Tables 3.3 and 3.4). The 
absence of LIF in both P/0 L then P/SB and Basal Medium culture conditions is likely to be 
contributing to this increased rate of differentiation via (i) a decrease in STAT3 activity 
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(Trouillas et al., 2009) and (ii) an increase in activity of the differentiation-inducing mTOR 
and ERK pathways (Cherepkova et al., 2016; Washington et al., 2010). L-proline-mediated 
increases in both mTOR and ERK activity are required for the differentiation of mESCs to EPL 
cells (Lonic, 2007; Washington et al., 2010) and we speculate that the presence of L-proline 
continues to re-enforce mTOR and ERK activity in EPL cells to drive differentiation to 
definitive ectoderm (Figure 4.3). In support of this, when mESCs are cultured in retinoic acid 
(a potent inducer of Sox1+ neurectoderm) a short burst of Fgf8-mediated ERK activity is 
required following the differentiation of Fgf5+ cells (Stavridis et al., 2010; Stavridis et al., 
2007): The timing of this transient burst of ERK activity is consistent with the transient 
differentiation of EPL cells to definitive ectoderm cells observed. L-proline could be mediating 
ERK activity in a similar way to give rise to definitive ectoderm from EPL cells (Figure 4.3) 
just as it increases ERK activity in mESCs to generate EPL cells in the first place.  
 
Inhibition of SMAD2/3 signalling in hESCs via PI3K-mediated activation of the mTOR 
pathway results in neurectoderm induction (Yu et al., 2015). L-proline is known to stimulate 
the mTOR pathway in mESCs to promote differentiation to EPL cells (Figure 4.1) (Washington 
et al., 2010) and Nodal-mediated SMAD2/3 signaling is known to promote differentiation to 
mesendoderm cells (Figure 4.3) (Le Good et al., 2005). L-proline-mediated mTOR signaling 
could be acting in a similar way in our culture system by promoting the degradation of 
SMAD2/3 to prevent mesendoderm inductions and instead give rise to definitive ectoderm 
from EPL cells (Figures 3.26 and 3.34 and Table 3.5 and 3.7). Assessing the activity of mTOR 
and SMAD2/3 in EPL cells cultured in L-proline would help elucidate this potential 
mechanism of action for definitive ectoderm induction.   								
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Figure 4.3: Proposed mechanism for L-proline-mediated induction of the definitive ectoderm. As this stage of in vitro differentiation is currently relatively 
unexplored at the molecular level, the mechanisms of action of L-proline-mediated definitive ectoderm differentiation are based on what is currently published 
and unpublished on the differentiation of mESCs to EPL cells (Browne, 2017; Casalino et al., 2011; Choi et al., 2016; Li et al., 2007; Tan et al., 2011; Washington 
et al., 2010; Yurka, 2015). L-proline enters EPL cells, possibly via the SNAT2 transporter (as it does in mESCs), where it mediates its effects via cell signaling 
(mTOR and MEK), epigenetic and metabolic remodelling to promote the differentiation to the definitive ectoderm lineage. Fgf8-mediated signaling may also 
be required for differentiation to definitive ectoderm by increasing ERK activity (Stavridis et al., 2010). Thus, in the presence of L-proline and Fgf8-mediated 
signaling, cells maintain their epithelial connections and transition into cells of the definitive ectoderm lineage, whereas in the presence of Nodal and BMP4-
mediated SMAD signaling, cells undergo an epithelial-to-mesenchymal transition and the mesendoderm arises. Figure composed with assistance from Glover, 
H.  										
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4.4.2 EBs cultured in P/ 0 L then P/SB give rise to a transient population of 
Penk1+/Pard6b+ cells consistent with definitive ectoderm 
 
Following the differentiation of mESCs to EPL cells in MEDII, EBs up-regulate the expression 
of Penk1 (assessed by northern blot analysis) at Day 5, followed closely by that of Pard6b (as 
assessed by RT-PCR) on Day 6 (Harvey et al., 2010) (Figure 4.2). In our culture system, L-
proline appears to be following similar timing as MEDII-mediated differentiation to definitive 
ectoderm (Figure 4.2). When EBs were cultured in P/0 L then P/SB, a transient increase in the 
expression of Penk1 was observed in both cell lines on Day 5 (Figure 3.34 and Table 3.7) and 
a significant increase in the expression of Pard6b was observed from Days 5–9 (Figures 3.34 
and 4.2 and Table 3.7). This expression pattern followed the initial appearance of Dnmt3b+/ 
Fgf5+ EPL cells (Figures 3.31 and 4.2 and Table 3.6) and occurred before that of Sox1+ 
neurectoderm (Figure 3.34 and 4.2 and Table 3.7). The sequential differentiation to these 
populations in vitro is consistent with the early stages of embryonic development in the 
embryo.  
 
During gastrulation, cells on the anterior side of the embryo maintain their epithelial 
connections. They do not move through the primitive streak to form mesendoderm but instead 
give rise to the definitive ectoderm. Subsequent to this, the extraembryonic AVE apposing the 
newly formed definitive ectoderm plays an important role in its differentiation and patterning 
(see Section 1.1.5) by secreting BMP4, Wnt and Nodal antagonists to inhibit mesendoderm 
formation, as well as secreting retinoic acid which promotes induction of the neurectoderm 
(Albazerchi and Stern, 2007; Stern and Downs, 2012). We speculate that the AVE is also 
secreting L-proline into the local environment to drive the formation of Penk1+/Pard6+ 
definitive ectoderm and subsequent neurectoderm induction.  	
Par proteins, including Pard6b, are important for the maintenance of epithelial tissue as they 
regulate the expression of E-cadherin-based adherens junctions (Nolan et al., 2008) and tight-
junctions (Cunliffe et al., 2012; Joberty et al., 2000). Based on this, and the expression pattern 
observed when mESCs are cultured in MEDII (Harvey et al., 2010) or L-proline (Figures 3.31, 
3.34 and 4.2 and Table 3.7), Pard6b is a likely marker of the definitive ectoderm germ layer. 
On the other hand, whilst there is no available evidence about the role of Penk1 during 
definitive ectoderm lineage differentiation in vivo, it plays an important role as a 
neurotransmitter in the developing CNS in rats (Hauser et al., 1990). Based on its expression 
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pattern in vitro when EBs are cultured in MEDII (Harvey et al., 2010) or L-proline (Figures 
3.31, 3.34 and 4.2 and Table 3.7) it is possible the Penk1 may play an important role earlier in 
the development of the CNS.  
 
The expression of Pard6b and Penk1 in the embryo has yet to be established: Performing in 
situ hybridization on Penk1 and Pard6b over a range of embryo ages should confirm this, and 
if they are suitable markers they should be transiently expressed between days 6.0–7.5 dpc in 
the anterior portion of the embryo known to be definitive ectoderm (Li et al., 2013).  
 
Under the default model of neurectoderm induction, Penk1+/Pard6b+ definitive ectoderm cells 
give rise to derivatives of the neurectoderm and surface ectoderm in the absence and presence 
of BMP4-mediated signalling, respectively (Harvey et al., 2010; Li et al., 2013). However, we 
challenge the idea that the neurectoderm arises by default: The data presented in this thesis 
suggests that L-proline is involved in instructing the differentiation to neurectoderm from a 
Penk1+/Pard6b+ population of definitive ectoderm (Section 4.2, Figures 3.34 and 3.35 and 
Table 3.5). To confirm this, isolated Penk1+/Pard6b+ cells should give rise to Sox1+ 
neurectoderm and K18+ surface ectoderm in the presence and absence of L-proline, 
respectively. 		
4.4.3 L-proline is required for induction and maintenance of Sox1+ 
neurectoderm and subsequent differentiation to neural cell types 	
In line with L-proline acting like a typical growth factor at multiple stages of development 
leading up to and including the induction of neurectoderm by Day 5 (Figures 3.34 and 3.35 and 
Table 3.7), it was also shown to be important for the (i) the maintenance of a Sox1+ 
neurectoderm population within Day 15 EBs (Figure 3.35) and (ii) differentiation to neural cell 
types between Days 10–15 (Figures 3.38 and 3.39 and Table 3.10).   
 
L-proline is at a relatively high concentration (300 µM) compared to other amino acids in the 
commonly used serum-free medium F12, which many neurectoderm-induction protocols use 
(Chen et al., 2010; Ying et al., 2003; Lowell et al., 2006; Harvey et al., 2010; Aubert et al., 
2003; Watanabe et al., 2005; Hu and Zhang 2010). Based on the data presented in this thesis, 
it is possible that the production of neurectoderm in these protocols occurs in response to 
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stimulation by L-proline. Even when F12 is diluted by 50% with DMEM, as is the case in many 
of these protocols and in our Day 10–15 Serum-Free Medium, the concentration of L-proline 
is still high enough to stimulate differentiation of mESCs to EPL cells (150 µM) (Washington 
et al., 2010) and neural cells (Figure 3.15). In both cell lines, ~60–70% of EBs with neural cell 
types were produced when EBs were cultured in L-proline for the entire 15-day protocol 
(including the 150 µM found in Serum-Free Medium) (Figures 3.38, 3.39 and 3.40 and Table 
3.10). These are comparable percentages to previous neurectoderm-induction studies using 
both the 46C Sox1-GFP cell line (Chen et al., 2010; Ying et al., 2003; Lowell et al., 2006) as 
well as the D3 cell line (Lowell et al., 2006). When L-proline was removed from the Serum-
Free Medium on Days 10–15, a significant decrease in the production of neural cells (from 
EBs previously cultured in suspension in L-proline) was observed (Figure 3.15). These data 
highlight a novel role for L-proline in differentiation to more mature neural cells and highlights 
yet another stage of the development pathway that L-proline acts like a growth factor to 
promote differentiation. 
 
When EBs were cultured for 15 days in the presence of L-proline, they maintained a population 
of Sox1+ neurepithelium as shown by the continued expression of Sox1-GFP in the core of Day 
15 EBs (Figure 3.35). This is probably the result of L-proline still being present in the Serum-
Free Medium from Days 10–15, and is similar to the expression of a small pool of mitotically 
active Sox1+ neural stem cells present in vivo in the SVZ and dentate gyrus of the post-natal 
and adult brain (Fuentealba et al., 2012; Merkle et al., 2004; Ming and Song, 2011; Urbán and 
Guillemot, 2014). It is possible that L-proline may not only be involved in the induction of 
neurectoderm and subsequent neural differentiation, but also in maintaining this pool of neural 
stem cells in vivo as well.  
 
At this point, we are unsure what type of neurons have been produced from the L-proline-based 
protocol (i.e., whether they are derivatives of forebrain, midbrain, hindbrain or spinal cord 
development, and/or whether they are excitatory or inhibitory). When EBs are cultured in 
MEDII, they give rise to neural cells that represent a naïve midbrain population (Rathjen and 
Rathjen, 2002). It is thus possible that the Nestin+, BLBP+ and NeuN+ cells observed in our L-
proline-based protocol give rise to a similar naïve midbrain population. Immunofluorescence 
imaging and qPCR of the midbrain markers Lmx1a and Foxa2 will help to determine this 
(Gioele La Manno et al., 2016).  	
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4.4.4 Summary of mechanisms that may be involved in L-proline-mediated 
induction of neurectoderm from the definitive ectoderm  		
During the early stages of neural development before embryonic vascularization, oxygen 
concentrations surrounding the embryo are low (Fischer and Bavister, 1993). These hypoxic 
conditions are important for regulating normal differentiation: 9.5 dpc rat embryos cultured ex 
vivo in 20% oxygen have significant morphological abnormalities of the neural tube compared 
to those cultured in 5% oxygen (Morriss and New, 1979). Under hypoxic conditions, mTOR 
activity stabilizes the expression of HIF1α so that it can bind to HIF1β and move to the nucleus 
to regulate gene expression, including increasing the expression of genes involved in anaerobic 
metabolism (Ito and Suda, 2014). However, ChIP analysis has shown that HIF1α can also bind 
to hypoxia response elements in the regulatory region of the Sox1 gene, up-regulating its 
expression (Zhao et al., 2014). L-proline could be feeding in to this system by acutely 
increasing the activity of the mTOR pathway which in turn up-regulates the expression of Sox1 
and formation of the neurectoderm. 
 
mTOR has also been shown to increase the activity of POX, the enzyme responsible for the 
conversion of P5C to L-proline (Figure 1.8) (Pandhare et al., 2009). POX is expressed in the 
brain (Mitsubuchi et al., 2014), and mutations to this enzyme lead to a variety 
neurodevelopmental conditions (Mitsubuchi et al., 2008). When mESCs are cultured in L-
proline to drive differentiation to EPL cells, an increase in mTOR activity in observed along 
with an increase in anaerobic metabolism, (Browne, 2017; Yurka, 2015). L-proline may be 
acting in a similar way in our culture conditions: L-proline-mediated mTOR activity in 
definitive ectoderm could be stimulating POX activity to promote an increase in anaerobic 
metabolism and thus drive differentiation of definitive ectoderm to neurectoderm (Figure 4.4).  
 
The concentration of L-proline is only ~4.2 µM in the embryonic cerebrospinal fluid (CSF), 
which is low compared to other amino acids (Dolgodilina et al., 2016). Glutamate on the other 
hand is in high concentration (~520 µM). Via the intracellular proline cycle, L-glutamate can 
be converted into L-proline via a P5C intermediate (Casalino et al., 2011) (see Section 1.2.7; 
Figure 1.8). In the absence of appreciable concentrations of L-proline in the CSF, glutamate 
could be taken up into cells and, rather than being used as a neurotransmitter, could be 
converted to L-proline for potential metabolic use (Figure 4.4) (Velaz-Faircloth et al., 1995). 
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Based on the data presented in this thesis, it is possible that the uptake of L-proline is required 
for neurectoderm induction and differentiation to neural cells during nervous system 
development. Both L-proline and L-glutamate transporters have been identified in the 
mammalian brain (including SNAT2 and PROT), but neither has been studied in the definitive 
ectoderm or neurectoderm. The presence of the high affinity brain-specific L-proline 
transporter (PROT) (Shafqat et al., 1995; Velaz-Faircloth et al., 1995) suggests that L-proline 
uptake is important in cells of the CNS, but its role is currently unknown.  																																				
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Figure 4.4: Proposed mechanism for L-proline-mediated differentiation to neurectoderm from definitive ectoderm. As this stage of in vitro differentiation 
is currently relatively unexplored at the molecular level, the mechanisms of action of L-proline-mediated neurectoderm differentiation are based on what is 
currently known about L-proline’s role in the differentiation of mESCs to EPL cells (Tan et al., 2011; Casalino et al., 2011; Browne 2017; Yurka 2015; 
Washington et al., 2010; Choi et al., 2016; Li et al., 2007). L-proline may enter the definitive ectoderm cells via the SNAT2 or PROT transporters (González-
González et al., 2005; Shafqat et al 1995; Velaz-Faircloth et al., 1995) where it could mediate its effects via cell signaling (mTOR and MEK), epigenetic and 
metabolic remodeling to promote the differentiation of the neurectoderm. In addition, L-glutamate is in high concentration in the developing neural tube outside 
the cells (Dolgodilina et al., 2016): L-glutamate may enter the cell via the SNAT2 transporter and can be converted to L-glutamine, followed by L-proline via 
the  L-glutamine-L-proline cycle (Casalino et al., 2011). Figure composed with assistance from Glover, H.   																							
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4.5 EBs cultured in Basal Medium spontaneously differentiate into Mixl1+ 
mesendoderm at the expense of neurectoderm  		
Independent work in our lab using mass spectrometry has shown that in 3 different FBS 
preparations (from different companies) the final concentration of L-proline in Basal Medium 
ranges from ~30–100 µM (H. Glover, unpublished results), which is not considered sufficient 
to drive the differentiation to EPL cells (Washington et al., 2010) or to neurectoderm (Figure 
3.26 and Table 3.5). Rather, EBs cultured in Basal Medium spontaneously differentiate to cells 
representing all 3 germ layers, consistent with the withdrawal of LIF (Bratt-Leal et al., 2009; 
Kurosawa, 2007; Mummery et al., 1990; Murray and Edgar, 2001), and preferentially 
differentiate to Mixl1+ mesendoderm cells (Figure 3.26 and Table 3.5). Nestin expression also 
increased in EBs cultured in Basal Medium (Figure 3.26 and Table 3.5) but this may be due to 
spontaneous differentiation to muscle cells as Nestin is also expressed in muscle progenitors: 
Its expression in this cell type is regulated by a separate enhancer region to that of Nestin 
expressed in neural progenitors (Zimmerman et al., 1994). Primers designed specifically for 
the expression of neural-specific Nestin would help confirm this, as would the use of the 
Bresagen Pty Ltd transgenic cell line in which LacZ expression is driven by the neural-specific 
Nestin enhancer (unpublished data). 		
4.6 Dnmt3b localized to the nuclei of EPL cells in adherent culture where it 
may regulate pluripotency  	
Based on the work performed in this thesis, when mESCs were cultured in EPL Cell Medium 
(i.e. 1000 U/ml LIF + 400 µM L-proline) for six days in adherent culture they transitioned from 
round, dome-shaped colonies to flat epithelial colonies, consistent with EPL cells (Figure 3.2) 
(Rathjen et al., 1999; Tan et al., 2011, 2016; Washington et al., 2010). In mESCs, the 
expression of Dnmt3b was localized to the cytoplasm (Figure 3.5) where it is unlikely to be 
functionally active given its primary role as a methyltransferase. Instead, Dnmt3b may be 
expressed in mESCs in preparation for when conditions are favourable for differentiation. 
Following the addition of L-proline for six days, Dnmt3b had moved to the nucleus (Figure 
3.5) where it has previously been shown to promote the methylation of the Oct4 and Nanog 
promoter regions in spontaneously differentiating mESCs (i.e., after removal of LIF), thus 
suppressing their expression and preparing the exit from pluripotency (Li et al., 2007; Choi et 
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al., 2017; Leitch et al., 2013). As well as being now localized to the nucleus of EPL cells, 
Dnmt3b is also more highly expressed in EPL cells than mESCs, and this may assist in the exit 
from pluripotency (Figure 3.5) (Li et al., 2007). However, an additional possibility now 
presents itself: That the movement of Dnmt3b from the cytoplasm to the nucleus occurs as an 
acute response to the presence of exogenously added L-proline, and the first role of Dnmt3b is 
to assist in the conversion of one pluripotent state (ESCs) to a second pluripotent state (EPL 
cells).  
Oct4 expression in these two pluripotent cell populations is regulated by distinct enhancer 
regions: In naïve mESCs, Oct4 expression is under the regulation of the distal enhancer, whilst 
in primed pluripotent cells it is under the regulation of the proximal enhancer (Choi et al., 2016; 
Yeom et al., 1996). The switch between distal and proximal enhancer activity occurs within 
two days of differentiation of mESCs in vitro, and in vivo has been shown to occur at the time 
when the ICM transitions into the Fgf5+ primitive ectoderm (~4.5 dpc) (Choi et al., 2016). The 
acute L-proline-mediated movement of Dnmt3b into the nucleus could be acting to first 
modulate Oct4 enhancer activity to promote the conversion of mESCs to EPL cells, followed 
by methylation of the Oct4 promoter region to permit exit from pluripotency (Li et al., 2007; 
Leitch et al., 2013). As EBs cultured in P/1000 L then P/SB showed no changes in Dnmt3b 
gene expression compared to mESCs (Figure 3.19) and a significant decrease in Dnmt3b 
protein expression by Day 7 (Figure 3.22), it could be that rather than regulating mRNA and 
protein production in the initial phases of differentiation, L-proline is more importantly 
affecting Dnmt3b protein localization within cells of the EB, and thus its functionality. 
 
We did not investigate how rapidly this change in localization of Dnmt3b occurred upon 
addition of L-proline, but we infer it is rapid (of the order of minutes to hours). This could be 
tested easily by immunofluorescence time-course of Dnmt3b movement following addition of 
L-proline. 
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4.7 Conclusions and future directions 	
The aim of our study was to develop a protocol using mESCs to recapitulate the stepwise 
progression of neural lineage commitment via embryologically relevant populations. When 
EBs were cultured in L-proline in the absence of LIF, they sequentially and synchronously 
transitioned through embryologically relevant cell populations including Dnmt3b+/Fgf5+ EPL-
cells, Penk1+/Pard6b+ definitive ectoderm and Sox1+ neurectoderm, followed by Nestin+, 
BLBP+ and NeuN+ neural cells. This pattern and timing of differentiation was similar to that 
observed when EBs are cultured in MEDII (Harvey et al., 2010), and recapitulates the 
sequential transition of populations of cells observed during in vivo embryonic nervous system 
development. This is the first study to our knowledge that shows a novel growth factor-like 
role for a simple amino acid at multiple stages of a development pathway.   
 
Having established a simplified protocol that successfully recapitulates embryonic 
development in vitro, we can now begin to assess the molecular mechanisms that drive 
development, in particular for that of the poorly understood definitive ectoderm and 
neurectoderm populations. Understanding the molecular mechanisms underlying how 
pluripotent cells form definitive ectoderm and how the definitive ectoderm commits to 
neurectoderm during early embryonic development will help to better understand the normal 
molecular physiology and the pathophysiology behind neurodevelopmental and 
neurodegenerative conditions, as well as help to develop effective cell-based therapies for 
conditions and injuries associated with the embryonic and adult nervous system.  	
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